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This dissertation aims to measure the impact of technical change on OECD Healthcare in a multi-stage 
framework and identify the different sources of outcome losses to allow for comprehensive policy 
implications within a diverse dataset including countries from a large variety of development levels facing 
different healthcare issues. We adopt an output-oriented DEA (Data Envelopment Analysis) methodology 
to obtain the technical efficiencies in production and provision. Data used in this study is mainly obtained 
from the Organization for Economic Cooperation and Development (OECD) Health Data 2013 and 
consists of 34 OECD countries and 12 years between 2000 and 2011. 
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A Multi-Stage Efficiency Analysis of 
OECD Healthcare and the Impact of 
Technical Change: Introduction 
 
 
Can Bekaroglu 
Fall 2015 
 
Abstract 
 
This dissertation aims to measure the impact of technical change on OECD Healthcare in a 
multi-stage framework and identify the different sources of outcome losses to allow for 
comprehensive policy implications within a diverse dataset including countries from a large 
variety of development levels facing different healthcare issues.  
 
We adopt an output-oriented DEA (Data Envelopment Analysis) methodology to obtain the 
technical efficiencies in production and provision. Data used in this study is mainly obtained from 
the Organization for Economic Cooperation and Development (OECD) Health Data 2013 and consists 
of 34 OECD countries and 12 years between 2000 and 2011. The following introductory chapter gives 
a general summary of the study and its background, contributions, methodology, and the dataset used in 
the study. 
 
Keywords: Healthcare, Efficiency, DEA, Technical Change, Productivity Growth, OECD 
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1 Introduction 
 
In most developed countries, the state devotes a considerable share of resources to healthcare [4], and 
healthcare costs have been steadily increasing, to current levels, over 10% of GDP globally [36, 40], 
with few signs of slowing down in the future [38, 50]. 
 
To explain this trend, many studies [5, 23, 31, 32, 42, 45, 56, 64, 70] have tried to diagnose the 
underlying factors such as an ageing population, increased social expectations, broader insurance 
coverage, supplier induced demand and relative prices that may affect the utilization and costs of 
healthcare services. Efficiency and productivity of the healthcare systems, as well as technological 
change and productivity growth in healthcare have also been claimed to have a major impact on 
healthcare costs [22, 23, 43, 49].  
 
Technological advances in healthcare, notably hospital care, have been dramatic over the last four 
decades [19], but they have often been blamed for mounting costs of hospital care, especially in the 
United States. Various analysts (Aaron, (1991) [1]; Newhouse, (1993) [46]; Schwartz and Mendelson, 
(1994) [58]) have argued that technological change generates the underlying growth in expenditures.  
 
Another possibility is that increasing inefficiency in the hospital industry is causing real expenditure 
growth; a World Bank Health, Nutrition and Population Paper by Wang, et al. (1999) [65] and a WHO 
study (2000) [66] made early attempts to measure global healthcare efficiency using different 
performance indicators, resulting in enormous variance in health outcomes, despite similar income and 
education levels. This generated considerable interest in the measurement of healthcare efficiency. 
Among the seminal healthcare studies at the system level are Hollingsworth and Wildman (2002) [29], 
Jamison et al. (2001) [34], Salomon et al. (2001) [59], and Evans et al. (2001) [16]. 
 
Much of the literature finds diverse results with respect to healthcare efficiency. While there are studies 
that find countries like Turkey with relatively poor health outcomes to be efficient [53, 68] others find 
the opposite results [44, 63]. The problem mainly stems from the output choice (services vs. outcomes) 
and lack of consistent and reliable quality measurements. Additionally, measuring the impact of the 
environmental factors is the goal of a growing body of studies with diverse implications [6, 28, 39, 52]. 
As stressed by Jacobs et al. (2006) [33], efficiency analysis should be based on outcomes of healthcare. 
However, researchers are often forced to study efficiency on the basis of measured services like 
patients treated or hospital discharges. Many of the published studies use health services as outputs [2, 
2
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15, 57] but some studies include health outcomes as outputs [8, 14, 35, 61], and a few include quality, 
either explicitly [25] or as an explanatory variable [69]. Either way is problematic; since health services 
as intermediate goods do not tell us whether the patient’s health has improved, while the outcomes are 
not the direct products of the inputs used but of intermediate goods in conjunction with other non-
discretionary inputs. This critique was summarized in Newhouse (1994) [47] and fully discussed in 
Jacobs et al. (2006) [33], who conclude by suggesting the use of multivariate models and multi-stage 
models [26], where the objectives may include quality.  
 
Although there are numerous studies in the literature examining the technical changes of the OECD 
healthcare systems [7, 10, 15, 18, 19, 24, 41, 54, 62, 67], the relationship between the technical changes 
on production and provision is not well established. Fare et al. (1997) paper [19] for example, 
calculates the technical change for both health services and outcomes at one stage and from resources. 
However, health outcomes are a product of health services, rather than directly of resources, and 
skipping the production stage leads to underestimation of not only inefficiency but also the productivity 
growth of outcomes. 
2 Multi-Stage Healthcare System 
Färe and Grosskopf (2000) [20] introduced a multistage DEA (Data Envelopment analysis) model that 
later came to be known as network DEA. Following their paradigm, we devise a multi-stage healthcare 
system analysis where production takes place at the first stage and resources produce health services, 
which are, as intermediate goods, then transformed to health outcomes at the second (provision) stage. 
Additionally, non-discretionary inputs, which affect both the production and provision stages by 
shifting the frontiers, need to be controlled for.  
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The first paper is the initial step of a more comprehensive two-stage efficiency analysis and focuses on 
the production stage, by investigating the production efficiency in terms of health services and the 
impact of technical change on production. This helps us determine: a) if the rapid technical change still 
persists, b) what is the role of production inefficiency in health outcome losses.  
 
The second paper takes the results from the first paper and continues the analysis with the second 
(provision) stage. The study aims to investigate; a) the multi-stage efficiency of health outcomes, b) the 
impact of technical change on health outcomes. This enables us to establish a consistent relationship 
between the impact of technical change between the first (production) and the second (provision) stage. 
 
Finally, the third paper extends the results from the second paper, by analysing the impact of 
environmental variables such as patient-risk characteristics and healthcare inequality, as well as 
inadequate healthcare expenditures and increased use of resources. This is done through gradual 
relaxing of controls and by using hypothetical firms with increased resources. As part of this multi-
stage analysis, this paper’s main contribution will be to pinpoint where exactly and what type of 
inefficiencies occur, what is the impact of environmental variables on health outcomes, and which 
policies might be used to improve efficiency and health outcomes. 
 
Overall, this study has two main contributions to the literature: a) measure the impact of technical 
change on healthcare in a multi-stage framework, b) determine and quantify the sources of outcome 
losses along with the associated policy implications. 
3 Efficiency and Data Envelopment Analysis 
 
A healthcare provider (e.g., hospital, physician, healthcare system) is efficient if it maximizes output 
for a given bundle of inputs or minimizes inputs used to produce a given output. Data Envelopment 
Analysis (DEA) is a nonparametric approach which constructs a theoretical best-practice frontier from 
the observed data points to measure the efficiency of any observed point. The method can 
simultaneously handle multiple inputs and outputs, which are assumed to be homogeneous across units. 
The technique was first introduced by Charnes, Cooper, and Rhodes in 1978 [9] and further formalized 
by Banker, Charnes and Cooper in 1984 [3] based on Farrell’s (1959) [21] simple measure of firm 
efficiency that accounted for multiple inputs.  
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The first application of DEA to health issues (that we know of) is an unpublished work from 1979 
regarding family planning centers in Costa Rica and Guatemala (Ray 2004, p. xi) [55]. Nunamaker and 
Lewin (1983) [48] is the first published work applying DEA to healthcare, whereas Sherman (1984) 
[60] was the first author to use DEA to evaluate overall hospital efficiency. Today there is a very 
extensive DEA literature surveyed by O’Neill et al. (2008) [51], who emphasize national differences in 
hospital efficiency research, and Ozcan (2008) [36] who considers many aspects of healthcare delivery, 
as well as providing an overview of existing techniques. Hollingsworth (2008) [30] classifies 317 
published papers into various subcategories, including parametric techniques such as stochastic frontier 
analysis, and offers comments as to their practical usefulness.  
 
DEA relies on a number of fairly weak assumptions to construct the production technology but avoids 
any explicit functional relationship between the inputs and outputs through a production function [12]. 
These assumptions are summarized below. Let Ψ be the feasible set: 
 
a) all observed input-output combinations are possible; (x1, y1) ∈ Ψ. 
b) the production possibility set is convex; Let α ∈ [0, 1]; If (x1, y1), (x2, y2) ∈ Ψ, then (x, y) = 
α(x1, y1) + (1−α)(x2, y2) ∈ Ψ. 
c) inputs and outputs are freely disposable; Let x2 ≥ x1, and y2 ≤ y1. If (x1, y1) ∈ Ψ then (x2, y1) ∈ 
Ψ and (x1, y2) ∈ Ψ 
Let (xi, yi) represent the input-output bundle of a firm i, assuming input-output bundle observed 
for N firms. An important theoretical assumption in DEA is whether to apply constant or variable 
returns to scale. The first nonparametric models for efficiency estimation by Charnes et al. (1978) [9] 
assumed constant returns to scale (CRS) as shown in equation {1}.  
)},....,3,2,1(;0; y; x y); {(x, T ic Niyx i
N
i
ii
N
i
ii     {1} 
Later, Banker et al. (1984) [3] relaxed the CRS assumption to account for firms that do not operate at 
their optimal scale, allowing VRS. This further requires the condition 1
N
i
i . The corresponding 
possibility set under VRS: 
)},....,3,2,1(;0;1; y; x y); {(x, T iv Niyx i
N
i
i
N
i
ii
N
i
ii     {2} 
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We apply a CRS approach in the first stage {1} and VRS in the second stage {2} of our model as it is 
generally accepted that the production stage exhibits CRS, while the provision of health services 
demonstrates VRS.  In other words, doubling of all resources will lead to doubling of health services 
(CRS), but this will not necessarily lead to a similar increase in health outcomes (VRS). Therefore, the 
OECD healthcare system exhibits CRS in production but VRS in the provision stage and as a whole. 
 
One decision to make when performing DEA is whether to use an input- or output-orientation. An 
input-oriented model holds the current level of output constant and minimizes inputs, whereas an 
output-oriented model maximizes output keeping the amount of inputs constant. Farrell [21] did not 
specify a formal definition of the contemporary “Farrell measure” of the technical efficiency of 
production and did not standardize the two different measures of technical efficiency [17]. As he was 
originally considering CRS, the difference between input and output orientation was irrelevant. Deprins 
and Simar [13] defined input technical efficiency as a measure between zero and one, whereas the 
inverse of output technical efficiency is a measure greater than one.  
 
In our study, we adopt an output-oriented model to determine the overall efficiency measure as the 
input levels used in healthcare production is usually determined externally and highly influenced by the 
political system: Thus, it is much more plausible to argue the system should try to maximize its output 
levels, given the input levels it is provided. Therefore, the output-oriented efficiency of firm s: 
 
)
  1
1
( )y,(x TE
s
ss 
 , where ))1(,(:)(maxs ss yx   ∈ T {3} 
 
An important distinction in healthcare efficiency should be made between technical and cost 
(allocative) efficiency, which additionally requires price data to assess scale efficiency [21, 33]. While 
technical efficiency measures the efficiency level with the given bundle only, cost efficiency analysis 
additionally investigates whether the optimum was also chosen given the input prices, allowing for 
substitution between inputs. In this study, we only focus on the technical efficiency side. This decision 
is necessitated both by theoretical and data considerations, as consistent international hospital cost 
statistics needed for the estimation of cost efficiency are not available. 
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4 Data 
 
Data used in this study are mainly obtained from the Organization for Economic Cooperation and 
Development (OECD) Health Data 2013 [27], which is the broadest source of comparable statistics on 
diverse health systems across OECD countries. The sources and methods of data collection are 
described in detail in the OECD documentation [71]. The dataset consists of 34 OECD countries and 12 
years between 2000 and 2011 for a total of 408 firms. The only non-OECD data are the BMI figures 
acquired from the World Health Organization as a patient-risk characteristic. The inclusion of multiple 
(12) years also serves to give a better picture of each country, rather than a one-year snapshot.  
 
Using panel data has several advantages compared to the use of cross-sectional data. Comparing the 
same unit with itself as well as others and creating a richer sample of observed units over multiple years 
provide additional insights and a further check on validity and data accuracy. For pooled analysis, such 
a comparison may allow for increased discrimination among efficient units and the inclusion of 
additional variables.  
 
Each yearly data point for each country is treated as a separate decision making unit (DMU); e.g. the 
year 2000 data point for the US is an entirely different DMU than the US data point for 2011. We are 
assuming non-regressive technology, which implies that a currently available technology will also be 
available to all future DMUs, but was not available to the past ones. This assumption requires control 
for technological progress over time and can be done by the in/exclusion of the relevant DMUs. 
 
The variables used in the analysis: Resources, health Services, health outcomes, quality of outputs, 
healthcare per capita expenditures, patient risk characteristics, inequality of access to healthcare (See 
the table below). We have only included the control variables that have direct effects on healthcare, in 
order to avoid diluting the results, although there are other variables that are also commonly included in 
the literature, such as education, income, and to a lesser extent, homicide and suicide rates.  
While the existence of an “education gradient” on health outcomes is accepted in the literature [11], as 
Lochner (2011) [37] suggested, the literature has produced mixed results, and most studies fail to 
address the endogeneity of education and health behaviors in regressions. Basically we attempt to 
control for all channels, through which education can affect the data. Simply put, individuals with 
better education also tend to be richer (poverty rates), behave better and take better care of themselves 
(risk factors), and spend more money on healthcare (per capita health expenditure). 
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Variables Used In the Analysis 
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Abstract 
 
This paper measures the technical efficiency of healthcare production and estimates the 
impact of technical change on healthcare across OECD Countries between 2000 and 2011, 
based on a 12 year, 34 country panel data set, extending the study by Fare et al. (1997). We 
adopt a DEA (Data Envelopment Analysis) based output-oriented efficiency measure to 
obtain the productive efficiency of each country for all given years, and use the Malmquist 
Index to determine the productivity growth and decompose the technical change from 
efficiency changes over the years. 
 
We find that the inefficiency in OECD healthcare systems has slightly increased over time, 
from 12% to 13%, while the production frontier shifted up around 0.8% annually between 
2000 and 2011, with a cumulative 8.5% technical and 7.2% productivity increase over the 
period. Technological progress seems to be stable over time, while most of the fluctuations in 
productivity growth come from changes in efficiency due to utilization of new technologies.  
 
 
Keywords: Healthcare, Efficiency, DEA, Technical Change, Productivity Growth, OECD 
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1 Introduction 
 
In most developed countries, the state devotes a considerable share of resources to healthcare [7], and 
healthcare costs have been steadily increasing, to current levels, over 10% of GDP globally [78, 60], 
with few signs of slowing down in the future [55, 75]. 
 
To explain this trend, many studies [3, 9, 48, 49, 63, 67, 84, 98, 108] have tried to diagnose the 
underlying factors such as an ageing population, increased social expectations, broader insurance 
coverage, supplier induced demand and relative prices that may affect the utilization and costs of 
healthcare services. Efficiency and productivity of the healthcare systems, as well as technological 
change and productivity growth in healthcare have also been claimed to have a major impact on 
healthcare costs [3, 37, 62, 74].  
 
Technological advances in healthcare, notably hospital care, have been dramatic over the last four 
decades [33], but they have often been blamed for mounting costs of hospital care, especially in the 
United States. Various analysts (Aaron, (1991) [1]; Newhouse, (1993) [71]; and Schwartz and 
Mendelson, (1994) [91]) have argued that technological change generates the underlying growth in 
expenditures.  
 
On the other hand, many studies in the literature [11, 12, 41, 66, 80, 90] identify technical change as 
the main source of healthcare improvements. Fare et al. [31], for example, find widespread and rapid 
productivity growth for a sample of OECD countries from 1974 to 1989, especially for Denmark and 
the USA. Likewise, Moscone et al. [66] find a significant relationship between scientific research and 
the growth in healthcare productivity. Although technical change is found to constitute about a quarter 
of the healthcare expenditure growth, it also constitutes a large portion of the outcome growth. In this 
study, we find a similar increase in technical change, and identify it as the main source of healthcare 
improvements.  
 
Another possibility is that increasing inefficiency in the hospital industry is causing real expenditure 
growth; a World Bank Health, Nutrition and Population Paper by Wang, et al. (1999) [103] and a 
WHO study (2000) [105] made early attempts to measure global healthcare efficiency using different 
performance indicators, showing enormous variance in health outcomes, despite similar income and 
education levels. This generated considerable interest in the measurement of healthcare efficiency. 
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Among the seminal healthcare studies at the system level are Hollingsworth and Wildman (2002) 
[46], Jamison et al. (2001) [50], Salomon et al. (2001) [92], and Evans et al. (2001) [25]. 
 
Schwartz and Mendelson [91] argue that almost a quarter of the real expenditure growth could be 
eliminated if inefficiency was curbed. Greene [42] argues that the main problems in the US are the 
access to healthcare and phenomenally high medical prices, rather than the quality of healthcare. 
Similarly recent studies suggest that if increases in healthcare costs are inevitable, the focus should 
shift from cost reduction to improving healthcare quality [97]. It is then much more plausible to argue 
the system should try to maximize its output levels given the input it is provided, as the resources and 
expenditure levels used in healthcare production are usually determined externally. This is why we 
adopt an output-oriented efficiency measure in our study. 
 
A healthcare provider (e.g., hospital, physician, healthcare system) is efficient if it maximizes output 
for a given bundle of inputs or minimizes inputs used to produce a given output. The measured inputs 
and outputs are assumed to be homogeneous across units. We can talk about technological progress if 
the production frontier has shifted up over time, meaning the same input bundle can now produce 
more due to technological progress.  
 
Although the initial Farrell analysis  [36] is static, changes in efficiency can be measured over time, 
i.e. the frontier may shift due to technological advances. Productivity is defined as the ratio of an 
index of output to an index of input usage. Change of this measure over time is productivity change, 
which was initially attributed to technological changes, i.e. shifts of the production or cost frontier. 
However, it became increasingly recognized after Nishimuzu and Page (1982) [72]  that productivity 
change can also be caused by changes in efficiency, that is, firms can move closer to the theoretical 
frontier over time, rather than showing genuine technological progress (shifts in the actual production 
frontier). 
 
The Malmquist index [56], introduced in 1953 by the Swedish economist, Sten Malmquist, is a 
summary measure of the change in productivity of a given unit over time. Initially, Caves et. al. 
(1982) [13] adapted this index in order to evaluate productivity movements between different 
production units. Later, Fare et al. (1989) [26]  derived the Malmquist productivity index as a 
geometric mean of the technologies of two periods of Caves et al.’s output productivity indices, and 
decomposed it into efficiency change and technological change components. Fare and Grosskopf 
(1992) [28] then generalized their non-parametric approach to eliminate assumptions on optimizing 
behavior, efficiency, and the need for price data, unlike previous studies such as Nishimizu and Page 
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(1982) [72]  and Bauer (1990) [8], which required specification of a functional form for technology. 
Fare et al. (1997) [33] later used the technique to measure the productivity growth in healthcare across 
10 OECD countries between 1974 and 1989. 
 
Fa¨re et al. (1994) [31] operationalized and further the decomposed the approach to include scale 
changes, maintaining the constant returns to scale (CRS) assumption. However, the internal 
inconsistency of the approach, attempting to explain the scale changes under CRS, which requires the 
assumption of variable returns to scale (VRS) was criticized by Ray and Desli (1997) [82] who found 
significantly different results under VRS. Färe et al. (1997) [34] acknowledge the criticism and 
suggest that the CRS and VRS should be considered as the upper (long run) and lower (short run) 
boundaries of the production frontier of a given technology. Lovell et al. (1994) [54] also showed that 
the Malmquist productivity index can be expressed as the product of a Malmquist productivity index 
and a Malmquist scale index, as well as the ratio of a Malmquist output quantity index to a Malmquist 
input quantity index 
 
Fa¨re et al. (1995) [32], who regard quality as an input in the production process, further extended the 
Malmquist index by incorporating quality ‘attributes’ into the technology of medical services and 
decomposing the index into three components: quality change, technical change and efficiency 
change. Maniadakis et al. (1999) [58] and Chen (2006) [15] use this method to evaluate the reform of 
the national health services and the implementation of the national health insurance program in the 
UK, respectively. Alternatively, Thanassoulis et al. (1995) [96] treat quality as an output in 
determining the performance of the district level health authorities in providing pre-natal care in the 
UK. Dismuke and Sena (2001) [24] define quality as the reduction in undesirable outputs and utilize 
the Malmquist-Luenberger productivity index developed by Chung et al. (1997) [21]. 
 
Other studies in the healthcare literature include, but are not limited to, Burgess and Wilson (1995) 
[10] who allow variable returns to scale (unlike Fare et al. (1994b) [30] who used CRS). McCallion G 
et. al. (2000) [61] use the input-based version of the Fare et al. (1994) [31] distance function 
approach, more suited to an input-oriented efficiency analysis. Sommersguter-Reichmann (2000) [95] 
follows Fa¨re et al. (1994) [31] and further decomposes the Malmquist index to scale efficiency 
changes in addition to the changes in technical efficiency and improvements in technology. Quellette 
and Vierstraete (2004) [79] generalize the Fare et al. (1994) [31] approach to incorporate quasi-fixed 
inputs. Some other noteworthy studies that used the Malmquist Index include Magnussen (1996) [57]; 
Lee and Wang (1998) [51]; Linna (1998) [52]; and Simar and Wilson (1999) [94]. 
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2 Objectives  
Färe and Grosskopf (2000) [35] introduced a multistage DEA (Data Envelopment analysis) model 
that later came to be known as network DEA. Following their paradigm, we devise a multi-stage 
healthcare system analysis where production takes place at the first stage and resources produce 
health services, which are, as intermediate goods, then transformed to health outcomes at the second 
(provision) stage. Additionally, non-discretionary inputs, which affect both the production and 
provision stages by shifting the frontiers, need to be controlled for.  
In this paper, we focus on the production stage and investigate the efficiency and technical changes in 
production as the initial step of a more comprehensive efficiency analysis of the two-stage healthcare 
system. This will enable us to pinpoint where exactly the inefficiencies occur and to determine the 
role of technology in this process. The three objectives of this paper:  
 
a) To measure productive efficiency levels of all 34 OECD countries and monitor their progress over 
time.  
b) To obtain the efficient output quantities which will be used as alternative inputs in the second stage 
of multi-stage efficiency analysis in the following chapter. 
c) To measure the productivity growth and decompose it to technical change and efficiency change, 
and see if the technological growth still persists, as shown by Fare et al. (1997) [33] for the 1974-
1989 period.  
 
Although there are numerous studies of the technical changes of the OECD healthcare systems [10, 
15, 24, 30, 33, 40, 61, 79, 95, 106], the relationship between the technical changes in production and 
provision is not well established. The technological growth in production also leads to growth in 
outcomes, which further needs to be investigated in a multi-stage analysis. 
 
As a part of multi-stage analysis, this paper’s main contribution will be to obtain the technical 
changes solely on the production side of a coherent multiple-stage framework, while a following study 
will analyze the subsequent impacts on the provision side, revealing either higher quantity or quality 
of services due to advancing technology.  
 
We mainly use OECD data [75], which are, for the most part, standardized across fairly similar 
countries; so the quality of the variable measurements, although spotty at times, is relatively good. 
The only non-OECD data are the BMI figures acquired from the World Health Organization as a 
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patient-risk characteristic. Inclusion of multiple (12) years also serves to give a better picture of each 
country, rather than a one-year snapshot. 
Following the standard procedure, we are using additional variables to control for non-discretionary 
inputs and the quality of outputs, which will be further investigated in the following pages. We aim to 
measure inefficiency levels, identify the sources of inefficiency, and measure the productivity growth 
and decompose the technical change from the changes in technical efficiency.  
3 Methodology 
3.1 Literature 
Two methodologies are most common in the literature: DEA (Data Envelopment Analysis) and SFA 
(Stochastic Frontier Analysis) [45]. Both approaches use “frontier analyses” for measuring efficiency. 
Frontier analysis compares a firm’s (e.g., hospital, physician practice) use of actual inputs and outputs 
to efficient combinations of multiple inputs and/or outputs. Although the two methods use different 
approaches to calculate the ‘‘frontier’’ of efficient combinations used for comparison, they are 
constructed using similar types of inputs and outputs, typically those in publicly available data. Both 
DEA and SFA require appropriate conceptualization of the relationship between the measured inputs 
and outputs. 
DEA is a nonparametric approach that can simultaneously handle multiple inputs and outputs while 
SFA is confined to a single output and requires specification of a functional form. On the other hand, 
SFA is better suited to situations where the functional form is known and policy deductions may be 
done with the included variables [65]. Banker, Gadh and Gorr (1993) [6] show that DEA is favoured 
when measurement error is unlikely, while SFA better deals with severe measurement errors.  
SFA was independently developed by Aigner et al. (1977) [2] and Meeusen and van den Broeck 
(1977) [64]. The purpose of SFA is to decompose variations from the best practice cost frontier into a 
random error and a deterministic error, which is assumed to represent cost inefficiency. SFA results 
could be sensitive to variable specification as shown by Folland and Hofler (2001) [38], who 
indicated that frontier analysis can have a production or cost orientation (allowing only one dependent 
variable). The first healthcare application of SFA was published by Wagstaff (1989) [101], who 
examined 49 Spanish hospitals, followed by an increasing number of studies conducted in the United 
States [17-20, 59, 62, 86-88, 100, 107] and in Europe [52, 83, 102]. The literature tends to concentrate 
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on the cost effıciency analysis where the prices are known and the cost is fused into one dependent 
variable [47]. 
DEA was first introduced by Charnes, Cooper, and Rhodes in 1978 [14] and further formalized by 
Banker, Charnes and Cooper in 1984 [4] based on Farrell’s (1959) [36] simple measure of firm 
efficiency that accounted for multiple inputs. The first application of DEA to health issues is an 
unpublished work from 1979 regarding family planning centers in Costa Rica and Guatemala (Ray 
2004, p. xi) [83]. Nunamaker and Lewin (1983) [73] is the first published work applying DEA to 
healthcare, whereas Sherman (1984) [93] was the first author to use DEA to evaluate overall hospital 
efficiency. Today there is a very extensive literature surveyed by O’Neill et al. (2008) [76], who 
emphasize national differences in hospital efficiency research, and Ozcan (2008) [78] who considers 
many aspects of healthcare delivery, as well as providing an overview of existing techniques. 
Hollingsworth (2008) [47] classifies 317 published papers into various subcategories and offers 
comments as to their practical usefulness.  
 
Recent healthcare studies that concentrate on OECD countries include Retzlaff-Roberts et al. 
(2004) [85], who find that countries with less stellar results can also be relatively efficient; Varabyova 
et al. (2013) [99] who use a panel data set and compare parametric and non parametric methods for a 
robustness check; and Cheng and Zervopoulos (2014) [16], who extend their study to 171 countries 
and use a directional distance function to incorporate undesirable outputs as well.  
 
A variety of other DEA based OECD healthcare studies at the national level include Moscone et al 
(2013) [66], who find a positive impact of scientific research on healthcare based on a large set of 
panel data spanning from 1960 to 2008. Or et al. [77] also find a positive impact of doctors on infant 
mortality, applying a multilevel analysis. Davies et al. [22] evaluate hospital performance in three 
dimensions (efficiency, effectiveness, equity), while Gholami [39] and Nayar et al. [70] question if 
the tradeoff between efficiency and quality is really inevitable. 
3.2 Output-oriented Radial Model 
As we are using panel data in this study, each yearly data point for each country is treated as a 
separate decision making unit (DMU); e.g. the year 2000 data point for the US is an entirely different 
DMU than the US data point for 2011. We are assuming non-regressive technology, which implies 
that a currently available technology will also be available to all future DMUs, but was not available 
to the past ones. This assumption requires control for technological progress over time and can be 
done by the in/exclusion of the relevant DMUs. 
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In our study, we adopt an output-oriented radial model with equiproportional changes in output to 
determine the overall efficiency measure as the input levels used in healthcare production is usually 
determined externally and highly influenced by the political system: Thus, it is much more plausible 
to argue the system should try to maximize its output levels, given the input levels it is provided. The 
implied inefficiencies in output levels are the least that all outputs should be increased to attain 
efficiency. In this study, we only focus on the technical efficiency side of the equation. This decision 
is necessitated both by theoretical and data considerations, as consistent international hospital cost 
statistics needed for the estimation of cost efficiency are not available. 
3.3 Model Specification 
In this study, we focus on the production side of a multi-stage healthcare model. DEA relies on a 
number of fairly weak assumptions to construct the production technology but avoids any explicit 
functional relationship between the inputs and outputs through a production function [23]. These 
assumptions are summarized below. Let Ψ be the feasible set: 
 
a) all observed input-output combinations are possible; (x1, y1) ∈ Ψ. 
b) the production possibility set is convex; Let α ∈ [0, 1]; If (x1, y1), (x2, y2) ∈ Ψ, then (x, y) = 
α(x1, y1) + (1−α)(x2, y2) ∈ Ψ. 
c) inputs and outputs are freely disposable; Let x2 ≥ x1, and y2 ≤ y1. If (x1, y1) ∈ Ψ then (x2, y1) ∈ 
Ψ and (x1, y2) ∈ Ψ 
Let (xi, yi) represent the input-output bundle of a firm i, assuming input-output bundle observed for N 
firms. Then given the aforementioned assumptions, the CRS production possibility set is  
)},....,3,2,1(;0; y; x y); {(x, T ic Niyx i
N
i
ii
N
i
ii     {i} 
By measuring the radial (equiproportional) efficiency levels of production under constant returns to 
scale (CRS), we obtain the efficient services (y*) that should have been produced. However, the 
convexity and the scalability of the control variables need to be addressed, because the quality (or 
risk) does not scale like the actual outputs, and these controls are subject to VRS by definition, which 
further requires the condition 1
N
i
i  for controls, where qik  is the control k for DMU i. The 
output-oriented radial efficiency of a DMU s:  
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The standard DEA LP problem solved to estimate the efficiency of DMU s, relative to 
contemporaneous CRS frontier is 
Objective: Max β,    subject to   {iii} 
 ∑λi xij ≤ x0j        j = 1…3     (Input constraint) (1) 
 ∑λiyik ≥ (1 + β) y0k          k = 1…3    (Output constraint) (2) 
 ∑λi qi1  ≤  qs1                    (Quality constraint with undesirable outcome)        (3) 
 ∑λi qi2  ≥  qs2                    (Risk factors fused into one variable)   (4a) 
 ∑λi qi3  ≥  qs3                    (Control for inequality) (4b) 
 λi ≥ 0                                (Reference Selection)                           (5) 
 β : Radial Output inefficiency 
 
In the maximization problem above (Max β), constraints (1), (2), and (5) ensure that the benchmark 
unit created from the convex combination of actually observed data points does not use any more 
inputs (resources) than the comparison unit while producing β* y0k more outputs (services), where β 
is the radial inefficiency rate for all outputs. If β equals 0, then the unit appears efficient in producing 
at least at one output, given the observed data. The inclusion of undesirable output (3) in the first 
stage, first popularized by FGLP89 [27] and FGLY93  [29], acts like a control variable and ensures 
that the benchmark unit created from the convex combination of reference DMUs, which produce β* 
y0k more output, has at least the same quality of healthcare.  
Among the various ways to incorporate environmental variables into the DEA framework, we use 
Ruggiero’s 3-stage method [89] to incorporate multiple risk factors into one risk variable (4a), as it 
performed best in virtually all scenarios, being the only model robust to sample size and the number 
of nondiscretionary variables [69], when compared to the other common methods such as Ray (1991) 
[81], Muñiz (2002) [68] and Banker and Morey [5]. The original DEA model without the risk factors 
(4a) is solved and the second-stage regression on the risk factors is performed. Let β̂ be the 
estimated inefficiency regressed on the risk factors: 
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β̂ = qi2 = α + γ1 r1 + γ2 r2+ γ3 r3+ ε    {iv} 
 
After construction of qi2 (the combined patient-risk control) from estimating the first inefficiency, the 
model {iii} is solved again. Finally, inequality of access to healthcare enters the problem as yet 
another environmental variable that needs to be controlled for in the model. This is represented in the 
equation (4b), in a similar fashion to the risk factors, but introduced separately.    
 
3.4 Malmquist Index and measuring technical change 
The assumption of “non-regressive technology” allows us to include all current and past observations 
in the calculation of inefficiency for a certain DMU. However, the observations of the succeeding 
years have to be dropped to control for the technology that was not available to the DMU in question 
at the time. 
Let the calculated inefficiency of the input-output bundle of a country i with respect to technology… 
…in year t = βit,t , and in year t+1 = βit,t+1 
βit,t+1 ≥ βit,t implies that the measured inefficiency of a DMU through time will tend to increase. The 
inclusion of new observations due to additional years will inevitably bring in more efficient DMUs, 
shifting up the constructed production frontier, causing past DMUs to appear more inefficient, due to 
two possible reasons: 
a) The actual production frontier shifts up (technological progress), 
b) The constructed frontier moves closer to the actual frontier (increase in efficiency). 
Although this may not be clear from the calculation of inefficiency for a single country, using 
longitudinal data, calculation of an average inefficiency path for all countries through time 
will be much more representative of technological progress. Let the average OECD 
inefficiency in year t measured in year t = n
n
/
1
i
tt  
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n
n
/
1
i
1tt   ≥ n
n
/
1
i
tt  implies that the measured average inefficiency for a certain year will 
tend to increase over time, inevitably shifting up the production frontier. This fact must be 
invariant to the base year “t”, and thus n
n
/
1
i
11t-t   ≥ n
n
/
1
i
1t-t  must also hold.  
In other words, the measured inefficiency changes due to technological progress between two 
years must be equal, regardless of the base year it is based on. The discrepancies in the 
measurement are likely because of the changes in efficiency rather than technological 
progress. Therefore multiple year comparisons are necessary for a better assessment of the 
technological trend over the years. 
In order to measure the productivity growth, we need to convert the inefficiency (β) values 
obtained in the DEA process to efficiency values (D) as in )1/(1 itt
i
tt D . Then, following 
Färe et al. (1992) [28], we obtain the Malmquist productivity values and decompose them 
into technical change and efficiency change in the following way: 
 
4 Data 
Data used in this study are obtained from the Organization for Economic Cooperation and 
Development (OECD) Health Data 2013 [110], which is the broadest source of comparable statistics 
on diverse health systems across OECD countries. The sources and methods of data collection are 
described in detail in the OECD documentation [43]. 
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Because countries are not uniform in their reporting practices and not all variables are recorded each 
year, a slight adjustment of OECD data is unavoidable and common in OECD studies [85, 110]. 
Similarly, in this study, linear interpolation is applied to impute missing values in the time-series for 
particular countries, meaning some of the gaps are filled with average estimates (5-10% of the data 
points).  
The dataset consists of 34 OECD countries and 12 years between 2000 and 2011 for a total of 408 
decision making units (DMUs). However, the number of included DMUs in the measurements varies 
by year from a minimum of 5 years (170 DMUs) up to 11 years (378 DMUs) in order to control for 
technical change through time. 
Variables  
The variables used to determine efficiency include: Inputs (resources), outputs (health 
services), quality of outputs (PYLL), patient risk characteristics, and inequality with access 
to healthcare (see Table 1). 
Table 1 – Variables 
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4.1 Resources (Inputs): The inclusion of physicians, nurses and hospital beds is standard across 
most healthcare studies [47, 76-78] and there is significant homogeneity in the data as well.  
4.2 Health Services (Outputs): We use three of the most commonly used hospital services, 
namely doctor consultations, hospital discharge rates, and patient days, as the intermediate goods 
[47, 76-78], or in other words, the outputs of the first stage, later to be used as inputs of second stage. 
Because their homogeneity varies and effectiveness on health status depends on environmental 
variables, we control for per capita healthcare expenditure as a proxy for capital intensity, in addition 
to risk factors, and inequality. 
4.3 Quality of Health Services (Control): We are using Potential years of life lost (PYLL)1 as a 
proxy for service quality at the first stage. It is defined as “a summary measure of premature mortality 
which provides an explicit way of weighting deaths occurring at younger ages, which are, a priori, 
preventable” [111].  
4.4 Patient-risk characteristics (Control): There are three highly standardized and commonly used 
risk characteristics defined in the OECD data set, namely tobacco and alcohol consumption, and 
obesity. Data regarding tobacco and alcohol consumption have been obtained from the OECD web 
site, while the BMI figures, as a proxy for overweight population, were obtained from the WHO data 
set [109]. 
4.5 Inequality in access to healthcare (Control): We use the Gini coefficient and alternatively 
poverty rates for each country as a proxy for inequality of access to healthcare. Although not a perfect 
match, the Gini is a sufficient indicator of healthcare inequality. There are various studies in the 
literature that show clear negative correlations between socioeconomic inequality and access to 
healthcare, both globally [104] and within a country [44]. We find that this correlation is stronger in 
privately oriented healthcare systems. 
                                            
1 The calculations for PYLL involve adding up deaths occurring at each age and multiplying this with the number of remaining years to live 
up to a selected age limit. The limit of 70 years has been chosen for the calculations in OECD Health Data.  
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5 Results 
5.1 Inefficiency across time 
The results in Graph and Table 2 indicate that the OECD radial productive inefficiency has slightly 
increased between 2000 and 2011, from about 12% to 13%. Individual outputs roughly agree with the 
radial results that the inefficiency has indeed increased.  We see little difference with poverty rates 
when used as a proxy measure for inequality instead of the Gini. 
Relative stability over time, however, does not necessarily imply there are no fluctuations. 
Socioeconomic variables obviously impact the utilization and efficiency of healthcare production, but 
those impacts do not seem to be permanent. The system tends to revert to the original path in the long 
run. Nevertheless this does not mean that resources do not become more productive and produce more 
over time, they actually do. However, it seems from the results that the increase in the production is 
similar to the shifts in production frontier; therefore the gap between the frontier and the actual 
production (output inefficiency) remains rather stable. 
Graph 1 – OECD Inefficiency over the Years 
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Table 2 – OECD Inefficiency over the Years 
 
 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Average 
Efficiency -gini 11.77% 12.79% 13.19% 13.26% 12.02% 12.42% 12.09% 10.91% 11.31% 12.20% 13.11% 12.21% 
Effic. -poverty 12.41% 12.84% 12.58% 12.78% 12.25% 12.75% 12.19% 10.63% 12.20% 13.24% 14.16% 13.20% 
Doctor consult. 14.32% 17.12% 21.47% 21.92% 22.30% 22.38% 20.87% 21.23% 25.73% 24.16% 27.16% 25.68% 
Hospital disc. 11.82% 13.14% 14.29% 14.06% 12.86% 13.80% 13.90% 13.10% 14.23% 15.25% 15.74% 15.07% 
Patient days  18.84% 22.86% 27.13% 28.43% 26.51% 29.47% 31.30% 31.11% 32.55% 31.46% 32.68% 32.23% 
5.2 Inefficiency level by country  
The average inefficiency between 2001 and 2011 is 12.21%.  There are 
six countries (Sweden, Israel, Turkey, Korea, Greece, and Italy) that 
are found to be radially efficient in production. There is no clear 
economic or development pattern associated with those countries, 
other than that they are either resource-scarce or service-abundant, 
with relatively high productivity (output / input) levels based on the 
OECD data. 
There are eleven countries with higher inefficiency rates than average. 
The least efficient countries are Portugal, Poland, Netherlands, 
Mexico, France, and the US. Again we do not see a clear pattern 
among these countries other than that they either have resource slacks, 
and/or do under-produce services, with relatively low productivity 
(output / input) levels. 
However, the measured inefficiency of production may be misleading, 
as part of the inefficiency in production may be a result of this trade-
off between quality and quantity as well as outputs not included in the 
analysis. Countries like France, Poland, and Belgium have relatively 
high health outcomes, with and a good chunk of their production 
inefficiency is likely due to this trade-off; which will further be 
investigated in the second stage of the analysis. 
Other countries such as Germany and the UK have reasonable amounts 
of inefficiency while those like Spain, Chile and Japan are found to 
have very little inefficiency in production, if at all. 
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5.3 Sources of inefficiency 
Employment of a radial (equiproportional) approach in the measurement of output inefficiency 
assumes no substitution or trade-off between the outputs, yielding rather conservative results 
assuring a minimum necessary increase in all outputs to reach efficiency. Nonetheless this 
does not prevent us from tracking the outputs and inputs slacks. 
 
Table 3 – Sources of Inefficiency 
  
Doctor 
Consultations 
Hospital 
Discharges 
Patient 
Days Nurses 
US 109.2% 39.1% 39.1% -70.5% 
OECD 15.5% 11.5% 19.4% -8.0% 
 
It is clear from the results that “Doctor Consultations” is the most under-produced health service in 
the US with 109.2% inefficiency (less than half of the efficient figure), while OECD generally suffers 
inefficiency in producing “patient days”, at 19.4%. Increasing the number of doctor consultations, 
in addition to more patient days, especially in US should help boost all other outputs2.  
Even though this study does not focus on the input efficiency, the huge slacks in the utilization of 
“nurses”, exaggerated by, but not exclusive to, the US. There are other countries which suffer similar 
but smaller slacks in nurse utilization, such as Belgium, Denmark, Ireland, and Netherlands, creating 
a 10% slack (overuse) of nurses on average. Although this is most likely due to different use and 
allocation of resources (with respect to the substitutability of physicians and nurses), it is very 
unlikely that the huge slack in nurse utilization can only be attributed to that. 
5.4 Productivity and Technical Change 
 
The inclusion of the future observations inevitably increases the measured inefficiency for each year’s 
OECD average. As argued earlier, this is either because of technological progress, which is a shift in 
production frontier, or DMUs moving closer to the actual frontier and helping us construct a more 
realistic one. As we discussed above, the measured efficiency across time is fairly stable in the long 
run; therefore the bulk of technical change in the long run largely reflects technological progress. 
                                            
2 The reason for identical numbers for the US Hospital Discharges and the Patient Days is the fact that the US Average Length of Stay is a 
binding constraint and much shorter than the OECD average. 
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When we look at the measured inefficiency figures for any base year (2001 to 2011), we find similar 
results which seem to be consistent and robust over time. In each of the cases, the evaluated year 
appears increasingly more inefficient due to the shifting frontier, albeit at slightly different levels 
(0.74% - 0.92%) due to short-run efficiency fluctuations as well as measurement issues with respect 
to the observed data. Long run averages, however, seem to agree with each other, at around 0.82%.  
Graph 2 – Productivity Growth and Inefficiency Path over the Years 
 
Table 4 – Inefficiency of Year i (left) with respect to the Technology of Year j (top) 
OECD 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Annual 
2011 4.31% 4.59% 5.31% 5.64% 6.30% 7.45% 8.25% 9.76% 11.65% 12.12% 13.11% 0.80% 
2010 4.56% 4.84% 5.68% 5.99% 6.91% 8.39% 9.15% 10.30% 11.83% 12.20% 13.42% 0.81% 
2009 5.08% 5.38% 6.52% 6.96% 7.74% 8.84% 9.27% 10.08% 11.31% 12.07% 13.18% 0.74% 
2008 5.83% 6.23% 7.43% 8.36% 8.92% 9.76% 10.25% 10.91% 12.48% 13.04% 13.87% 0.73% 
2007 6.64% 7.08% 8.54% 9.14% 10.54% 11.35% 12.09% 13.51% 14.80% 15.64% 16.25% 0.87% 
2006 7.38% 7.67% 9.40% 10.59% 11.68% 12.42% 13.49% 14.48% 15.59% 16.11% 17.50% 0.92% 
2005 8.27% 8.70% 9.85% 10.46% 12.02% 13.14% 14.01% 14.87% 15.74% 16.50% 17.33% 0.82% 
2004 10.13% 10.39% 11.52% 13.26% 14.10% 15.28% 16.12% 16.94% 18.07% 18.47% 19.08% 0.81% 
2003 10.94% 11.47% 13.19% 14.17% 14.81% 15.92% 16.83% 17.54% 18.40% 18.80% 19.73% 0.80% 
2002 11.06% 12.79% 14.14% 15.24% 16.05% 17.04% 17.43% 18.27% 19.31% 19.86% 20.76% 0.88% 
2001 11.77% 13.29% 14.83% 15.77% 16.56% 17.55% 17.88% 18.47% 19.52% 20.12% 20.85% 0.82% 
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Table 5 – Decomposition of Productivity Growth, Technical and Efficiency Changes 
 
Cumulative productivity growth between 
2001 and 2011 is 7.2% on average, somewhat 
less than the technical change at 8.5%, due to 
a slight decrease in technical efficiency, by 
around 1.2%. It is then plausible to assume 
that fluctuations are mostly due to short run 
changes in efficiency although the long run 
efficiency patterns seem to be relatively 
stable, as shown in the following graph 3. 
 
 
Graph 3 – Decomposition of Productivity Growth, Technical and Efficiency Changes 
 
 
OECD Tech.Chng Eff.Chng Prod.Chng 
Average 8.46% -1.18% 7.18% 
2001 1.46% -0.90% 0.54% 
2002 1.37% -0.35% 1.02% 
2003 1.21% -0.07% 1.14% 
2004 1.07% 1.11% 2.20% 
2005 0.83% -0.36% 0.47% 
2006 0.81% 0.29% 1.11% 
2007 0.93% 1.06% 2.00% 
2008 1.26% -0.36% 0.90% 
2009 0.51% -0.79% -0.29% 
2010 0.98% -0.80% 0.17% 
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Annual efficiency changes clearly take time to adjust. Whenever there is a significant change in 
technology, it leads to a disruption in the system and a temporary decrease in efficiency, which is then 
followed by a sequential increase and so on. In the long run, however, those fluctuations tend to 
smooth out. Productivity growth, integrating the inefficiency changes, clearly demonstrates these 
fluctuations, having a much greater variance than technical change, and sometimes going negative. 
Technical change however, is always positive (being non-regressive) and relatively stable (between 
0.51% - 1.46%) though we see a slight decreasing trend. Considering the measurement errors in 
individual years, the fluctuations in technical change are likely even smaller, and from our study, it is 
not clear whether the technical change is increasing or decreasing. 
Countries with the highest technical change between 
2001 and 2011 are mostly those which spend the most on 
healthcare and invest in technology. However, there are a 
few unexpected entries among the top countries such as 
Mexico and Slovak Republic, which seem to be rapidly 
catching up to their more developed neighbours. We 
should also note that all those countries also suffer from 
high inefficiency; none of the relatively efficient 
countries are among the top countries. This implies the technical change for relatively more 
efficient countries is underestimated in the analysis. 
5.5 Limitations of the Study 
a) Radial efficiency analysis tends to underestimate the inefficiency:  The radial efficiency 
approach assumes no substitution or trade-off between outputs and adopts a conservative way 
to determine the efficiency levels. The results should be evaluated with the slacks in mind. 
The countries with no slacks are usually in much better shape than those with large slacks.   
 
b) Frontier analysis tends to underestimate technical changes: There are two reasons for this:  
1) technical changes for the efficient countries on the production frontier are inherently 
underestimated, and 2) technical spill-overs between countries do not shift the frontier but 
increase the efficiency through catch-up, which underestimates the role of technical change. 
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c) Production efficiency is just one part of the healthcare efficiency and only partially addresses 
the overall of the healthcare sector. Efficiency in provision as well as losses due to non-
discretionary inputs (such as inequality) and lack of sufficient spending need to be 
considered. Some countries which excel at one particular stage often fail in another, and it is 
crucial to identify the exact sources of inefficiency. 
6 Conclusion and Discussion 
 
In this study, we have found that the OECD healthcare productive inefficiency has slightly 
increased from 12% to 13% between 2001 and 2011, which is also supported by the 
decomposition of individual outputs. However, this is not really surprising given the “catch-
up” trend of the efficiency. According to our findings, whenever there is a larger technical 
change, efficiency levels tend to decrease, only to catch up in the subsequent periods. In other 
words, it takes time to adjust to the new technology, and efficiency will decrease when 
productivity increases do not keep up with the technical change.  
In the literature, healthcare inefficiency often refers to “input based cost inefficiency”, 
assuming the outputs are reasonably good, and the whole problem revolves around 
phenomenally high costs associated with inefficiency. Although the US has its fair share of 
input inefficiency, this is largely a “pricing issue” [43] rather than a cost efficiency issue, With 
a vastly different healthcare system, dominated by private oligopolistic firms, without 
sufficient government leverage and consumer-friendly bargaining power, the US is a special 
case. Our study, supporting this point, finds that there are substantial inefficiencies on the 
output side, resulting in severe under-production of health services, high prices and a very 
inefficient market for the delivery of the services. 
Following the steps of Fare et al. (1997) [33], who examined the technical change in OECD 
countries in the 1974 - 1989 period and found a cumulative 33% growth with only 10 developed 
countries,  we investigated whether the technological progress still persists in the modern era, and 
found supporting results. Unlike the bulk of the literature, we were able to include all 34 OECD 
countries, and found about 8.5% cumulative technical change and 7.2% productivity growth between 
2001 and 2011, while technical inefficiency has increased by 1.2%. The technical change has slightly 
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speeded up in the recent years and most of the fluctuations seem to be due to the efficiency changes as 
a result of the catch-up process.  
Given the aforementioned limitations of the methodology, the technical change is likely to be 
underestimated. Concentrating on the more developed countries boosts the annual technical change 
from 0.82% to around 1.2%.  Therefore, it is plausible to assume a 1% annual technical change, 
which would accumulate to 16% in 15 years. Limiting the results to relatively more developed 
nations, on the other hand, as in Fare et al [33], would imply about 20% of cumulative change at the 
same time frame. The more comprehensive nature of our study and the spillover effects that are not 
typically detected in the analysis imply even larger technical change. 
Although investment in technology is partially responsible for increasing healthcare costs, it 
more than pays back as it is also the main driver of the productivity increases. This study, 
however, only deals with the production side of the story and calculates the technical change 
for health services, which are intermediate goods in the healthcare system. The ultimate goal 
of the healthcare system, however, is to produce the best health outcomes.  
We will devise a more coherent multi-stage framework in subsequent studies to further 
investigate and establish a clear link between output and outcome productivity growth and 
technical changes. This will also help us to better analyse the impact of technical changes on 
health outcomes, and whether the inefficiencies in the production of services reveal 
themselves as inefficiencies in health outcomes.  
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7 Appendix 
Table 6 – Radial Inefficiency Levels between 2001 and 2011 
 
 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Average 
Australia 0.00% 0.00% 3.23% 3.31% 0.56% 0.43% 5.10% 5.48% 6.34% 6.02% 9.11% 3.60% 
Austria 0.12% 0.00% 0.99% 0.00% 0.39% 0.11% 0.11% 0.16% 4.54% 6.55% 6.84% 1.80% 
Belgium 30.62% 26.48% 33.76% 33.44% 25.59% 21.92% 21.92% 16.75% 12.43% 11.14% 14.86% 22.63% 
Canada 0.00% 1.62% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.47% 2.54% 0.60% 
Chile 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.34% 0.00% 1.04% 0.13% 
Czech R. 0.60% 0.50% 0.37% 0.36% 0.11% 0.73% 0.57% 3.22% 2.69% 3.32% 1.46% 1.27% 
Denmark 0.50% 3.55% 21.91% 24.12% 16.62% 25.19% 24.02% 24.05% 20.11% 21.56% 17.35% 18.09% 
Estonia 31.97% 31.65% 29.25% 17.55% 25.73% 29.11% 25.10% 30.32% 33.25% 32.65% 33.92% 29.14% 
Finland 0.00% 0.00% 1.05% 3.80% 5.88% 4.83% 5.31% 8.11% 4.59% 12.97% 11.50% 5.28% 
France 0.00% 30.94% 34.04% 35.35% 36.86% 37.69% 34.02% 35.93% 34.46% 32.19% 33.10% 31.32% 
Germany 21.74% 21.73% 7.15% 6.93% 3.82% 1.59% 0.62% 2.82% 2.63% 3.00% 3.24% 6.84% 
Greece 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Hungary 0.00% 0.60% 0.49% 0.65% 0.00% 3.90% 11.46% 8.21% 6.62% 13.70% 8.46% 4.92% 
Iceland 0.00% 0.00% 0.00% 6.47% 0.00% 8.13% 4.84% 0.00% 1.13% 0.00% 0.00% 1.87% 
Ireland 41.11% 42.12% 37.49% 36.68% 32.12% 24.94% 16.08% 15.54% 1.42% 1.12% 1.14% 22.71% 
Israel 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Italy 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Japan 0.00% 0.00% 0.07% 0.00% 0.22% 0.00% 0.00% 0.00% 0.00% 0.00% 3.57% 0.35% 
Korea 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Luxembourg 2.90% 0.81% 0.00% 0.00% 0.00% 7.49% 0.00% 0.00% 2.97% 12.09% 13.76% 3.64% 
Mexico 20.71% 18.81% 23.98% 34.17% 25.79% 27.68% 33.53% 35.33% 42.50% 52.04% 71.63% 35.11% 
Netherlands 40.42% 45.86% 45.67% 40.38% 40.71% 34.04% 34.75% 35.58% 36.92% 22.87% 22.21% 36.31% 
N. Zealand 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8.21% 10.46% 1.70% 
Norway 16.29% 18.64% 11.35% 14.93% 8.66% 12.21% 8.98% 1.81% 7.61% 9.17% 11.52% 11.01% 
Poland 65.86% 62.74% 60.63% 55.83% 38.07% 33.89% 35.48% 32.32% 20.16% 17.83% 14.79% 39.78% 
Portugal 79.37% 73.17% 76.68% 80.80% 80.61% 70.27% 71.65% 60.01% 70.51% 65.95% 66.32% 72.30% 
Slovak R. 13.33% 6.53% 7.79% 13.39% 17.67% 25.46% 29.20% 21.94% 26.41% 31.25% 32.61% 20.51% 
Slovenia 0.00% 19.50% 17.37% 6.95% 8.18% 3.70% 1.96% 0.06% 0.00% 0.00% 0.00% 5.25% 
Spain 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.54% 0.05% 
Sweden 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Switzerland 0.47% 0.51% 0.98% 0.23% 0.00% 0.00% 0.00% 0.00% 2.00% 0.00% 0.00% 0.38% 
Turkey 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
UK 2.37% 1.87% 7.04% 7.85% 13.34% 20.69% 16.73% 6.02% 14.27% 10.85% 10.24% 10.12% 
USA 31.90% 27.27% 27.00% 27.78% 27.62% 28.25% 29.59% 27.34% 30.70% 37.95% 43.57% 30.82% 
Average 11.77% 12.79% 13.19% 13.26% 12.02% 12.42% 12.09% 10.91% 11.31% 12.20% 13.11% 12.21% 
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Table 7 – Doctor Consultations Inefficiency Levels between 2001 and 2011 
 
 
 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Average 
Australia 0.00% 0.00% 3.23% 3.31% 0.56% 0.43% 5.10% 5.48% 6.34% 6.02% 9.11% 3.60% 
Austria 2.43% 27.56% 21.44% 31.12% 45.81% 20.77% 27.20% 32.62% 31.25% 37.32% 45.47% 29.36% 
Belgium 30.62% 26.48% 33.76% 33.44% 25.59% 21.92% 21.92% 16.75% 12.43% 11.14% 14.86% 22.63% 
Canada 0.00% 1.62% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.47% 2.54% 0.60% 
Chile 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.34% 0.80% 1.04% 0.20% 
Czech R. 0.60% 0.50% 0.37% 0.36% 0.11% 0.73% 0.57% 3.22% 2.69% 4.07% 1.46% 1.33% 
Denmark 4.26% 13.75% 40.68% 44.86% 40.67% 43.37% 38.80% 32.11% 50.24% 41.08% 32.53% 34.76% 
Estonia 53.87% 40.50% 29.25% 17.55% 25.73% 32.02% 25.10% 30.80% 38.62% 58.00% 52.14% 36.69% 
Finland 0.00% 6.17% 6.99% 11.21% 6.30% 30.05% 12.54% 64.76% 150.44% 130.15% 138.96% 50.69% 
France 0.00% 30.94% 34.04% 35.35% 36.86% 37.69% 34.02% 35.93% 34.46% 32.19% 33.10% 31.32% 
Germany 21.74% 21.73% 7.15% 15.60% 5.93% 30.90% 26.73% 33.15% 26.54% 17.49% 18.15% 20.46% 
Greece 0.00% 21.52% 21.79% 50.38% 55.25% 64.40% 64.38% 70.55% 24.22% 22.66% 72.21% 42.49% 
Hungary 0.00% 0.60% 0.49% 0.65% 0.00% 3.90% 11.46% 8.21% 6.62% 13.70% 8.46% 4.92% 
Iceland 0.00% 0.00% 0.00% 6.47% 0.00% 8.13% 4.84% 0.00% 1.13% 0.00% 0.00% 1.87% 
Ireland 98.85% 107.18% 99.19% 93.92% 119.45% 96.14% 66.74% 53.46% 68.60% 13.26% 13.37% 75.47% 
Israel 0.00% 0.12% 0.00% 0.00% 2.29% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.22% 
Italy 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Japan 0.00% 0.00% 0.07% 0.00% 0.22% 0.00% 0.00% 1.52% 1.81% 0.80% 3.57% 0.73% 
Korea 0.00% 0.00% 0.00% 0.00% 3.65% 2.44% 0.00% 0.37% 1.88% 9.69% 5.81% 2.17% 
Luxembourg 2.90% 0.81% 0.00% 0.50% 0.00% 7.49% 0.00% 0.00% 2.97% 12.09% 13.76% 3.68% 
Mexico 20.71% 18.81% 23.98% 34.17% 25.79% 27.68% 33.53% 35.33% 42.50% 52.04% 71.63% 35.11% 
Netherlands 40.42% 45.86% 45.67% 40.38% 40.71% 34.04% 34.75% 35.58% 36.92% 22.87% 22.21% 36.31% 
N. Zealand 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 18.60% 20.24% 3.53% 
Norway 16.29% 22.01% 21.26% 25.96% 18.33% 17.79% 8.98% 1.81% 12.26% 13.51% 17.15% 15.94% 
Poland 65.86% 62.74% 60.63% 55.83% 38.07% 33.89% 35.48% 32.32% 51.56% 47.08% 43.74% 47.93% 
Portugal 79.37% 73.17% 76.68% 80.80% 80.61% 70.27% 71.65% 60.01% 75.84% 66.19% 66.32% 72.81% 
Slovak R. 13.33% 6.53% 7.79% 13.39% 17.67% 25.46% 29.20% 21.94% 26.41% 31.25% 32.61% 20.51% 
Slovenia 0.00% 19.50% 17.37% 6.95% 8.18% 3.70% 1.96% 0.06% 0.00% 1.51% 1.38% 5.51% 
Spain 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.54% 0.05% 
Sweden 0.00% 0.00% 17.63% 21.94% 79.94% 69.82% 42.05% 43.35% 49.28% 46.38% 63.22% 39.42% 
Switzerland 1.23% 4.95% 125.34% 81.08% 39.59% 24.24% 66.15% 7.71% 8.18% 9.46% 11.10% 34.46% 
Turkey 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.57% 0.00% 0.23% 
UK 2.37% 1.87% 7.04% 7.85% 13.34% 20.69% 16.73% 6.02% 14.27% 10.85% 10.24% 10.12% 
USA 31.90% 27.27% 28.11% 32.15% 27.62% 32.88% 29.59% 88.87% 97.02% 86.16% 96.58% 52.56% 
Average 14.32% 17.12% 21.47% 21.92% 22.30% 22.38% 20.87% 21.23% 25.73% 24.16% 27.16% 25.68% 
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Table 8 – Hospital Discharges Inefficiency Levels between 2001 and 2011 
 
 
 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Average 
Australia 0.00% 0.00% 3.23% 3.31% 0.56% 0.43% 5.10% 5.48% 6.34% 6.02% 9.11% 3.60% 
Austria 0.12% 0.00% 0.99% 0.00% 0.39% 0.11% 0.11% 0.16% 4.54% 6.55% 6.84% 1.80% 
Belgium 30.62% 26.48% 33.76% 33.44% 25.59% 21.92% 21.92% 16.75% 12.43% 11.14% 14.86% 22.63% 
Canada 0.00% 4.78% 3.90% 10.30% 8.62% 32.26% 36.63% 23.12% 26.89% 36.93% 41.66% 20.46% 
Chile 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.34% 0.00% 1.04% 0.13% 
Czech R. 0.60% 0.50% 0.37% 0.36% 1.86% 0.73% 0.57% 3.22% 7.18% 3.32% 1.46% 1.83% 
Denmark 0.50% 3.55% 21.91% 24.12% 16.62% 25.19% 24.02% 24.05% 20.11% 21.56% 17.35% 18.09% 
Estonia 31.97% 31.65% 29.25% 17.55% 25.73% 29.11% 25.10% 30.32% 33.25% 32.65% 33.92% 29.14% 
Finland 0.00% 2.96% 3.10% 5.51% 6.10% 8.10% 12.66% 11.37% 11.53% 15.21% 13.90% 8.22% 
France 0.00% 30.94% 34.04% 35.35% 36.86% 37.69% 34.02% 35.93% 34.46% 32.19% 33.10% 31.32% 
Germany 21.74% 21.73% 7.15% 6.93% 3.82% 1.59% 1.00% 2.82% 2.63% 3.00% 3.24% 6.88% 
Greece 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Hungary 0.00% 0.78% 2.52% 3.18% 3.55% 6.35% 11.46% 8.21% 6.62% 13.70% 8.46% 5.89% 
Iceland 0.00% 0.00% 0.00% 6.47% 0.00% 8.13% 9.61% 0.00% 1.13% 1.95% 0.00% 2.48% 
Ireland 41.11% 42.12% 37.49% 36.68% 32.12% 24.94% 16.08% 15.54% 1.42% 1.12% 1.14% 22.71% 
Israel 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Italy 0.00% 0.00% 0.00% 0.00% 0.00% 0.78% 0.00% 3.23% 3.28% 11.18% 2.91% 1.94% 
Japan 0.00% 0.00% 0.07% 3.35% 0.22% 0.35% 0.92% 1.49% 1.62% 8.44% 3.57% 1.82% 
Korea 0.00% 0.00% 0.00% 0.31% 0.06% 0.00% 0.00% 0.00% 10.04% 7.08% 4.57% 2.01% 
Luxembourg 2.90% 3.19% 0.00% 0.00% 0.00% 7.49% 0.10% 0.00% 2.97% 12.09% 13.76% 3.86% 
Mexico 20.71% 18.81% 23.98% 34.17% 25.79% 27.68% 33.53% 60.50% 76.91% 81.92% 90.66% 44.97% 
Netherlands 40.42% 45.86% 45.67% 40.38% 40.71% 34.04% 34.75% 35.58% 36.92% 22.87% 22.21% 36.31% 
N. Zealand 0.00% 0.00% 0.00% 0.70% 0.00% 4.52% 0.00% 0.00% 0.00% 8.21% 10.46% 2.17% 
Norway 16.29% 18.64% 11.35% 14.93% 8.66% 12.21% 8.98% 1.81% 7.61% 9.17% 11.52% 11.01% 
Poland 65.86% 62.74% 60.63% 55.83% 38.07% 33.89% 35.48% 32.32% 20.16% 17.83% 14.79% 39.78% 
Portugal 79.37% 73.17% 76.68% 80.80% 80.61% 70.27% 71.65% 60.01% 70.51% 65.95% 66.32% 72.30% 
Slovak R. 13.33% 6.53% 7.79% 13.39% 17.67% 25.46% 29.20% 21.94% 26.41% 35.87% 35.71% 21.21% 
Slovenia 0.00% 19.50% 17.37% 6.95% 8.18% 3.70% 1.96% 0.06% 0.00% 0.00% 0.00% 5.25% 
Spain 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.86% 16.63% 11.62% 0.00% 14.73% 4.17% 
Sweden 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Switzerland 2.00% 3.85% 30.46% 8.51% 14.51% 3.35% 8.73% 1.45% 2.00% 3.74% 4.01% 7.51% 
Turkey 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
UK 2.37% 1.87% 7.04% 7.85% 13.34% 20.69% 16.73% 6.02% 14.27% 10.85% 10.24% 10.12% 
USA 31.90% 27.27% 27.00% 27.78% 27.62% 28.25% 29.59% 27.34% 30.70% 37.95% 43.57% 30.82% 
Average 11.82% 13.14% 14.29% 14.06% 12.86% 13.80% 13.90% 13.10% 14.23% 15.25% 15.74% 15.07% 
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Table 9 – Hospital Discharges Inefficiency Levels between 2001 and 2011 
 
 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Average 
Australia 0.00% 0.00% 24.85% 28.50% 28.48% 25.39% 25.17% 45.61% 39.78% 38.69% 43.22% 27.24% 
Austria 0.12% 0.00% 0.99% 0.00% 0.39% 1.05% 0.11% 0.16% 4.54% 6.55% 6.84% 1.89% 
Belgium 30.62% 26.48% 33.76% 33.44% 25.59% 21.92% 21.92% 16.75% 12.43% 11.14% 17.99% 22.91% 
Canada 0.00% 3.34% 4.34% 7.88% 2.36% 12.77% 14.15% 7.88% 11.59% 2.47% 8.07% 6.80% 
Chile 0.00% 0.00% 0.00% 2.56% 1.91% 2.68% 1.04% 1.51% 1.07% 1.40% 4.98% 1.56% 
Czech R. 0.60% 0.50% 0.37% 0.36% 0.11% 0.73% 0.57% 3.22% 2.69% 3.32% 1.46% 1.27% 
Denmark 0.50% 3.55% 92.90% 107.18% 95.17% 111.10% 135.82% 141.05% 123.69% 110.86% 94.94% 92.43% 
Estonia 31.97% 31.65% 29.25% 17.55% 25.73% 29.11% 25.10% 30.32% 33.25% 32.65% 33.92% 29.14% 
Finland 0.00% 0.00% 1.05% 3.80% 5.88% 4.83% 5.31% 8.11% 4.59% 12.97% 11.50% 5.28% 
France 0.00% 63.83% 73.87% 72.06% 78.13% 80.42% 98.90% 79.17% 98.61% 75.94% 97.55% 74.41% 
Germany 21.74% 21.73% 7.15% 6.93% 3.82% 1.59% 0.62% 2.82% 2.63% 3.00% 3.24% 6.84% 
Greece 0.00% 0.00% 0.00% 6.55% 5.49% 8.48% 5.21% 0.00% 7.67% 10.78% 5.87% 4.55% 
Hungary 0.00% 0.60% 1.13% 0.65% 1.03% 4.17% 11.46% 8.21% 6.62% 13.70% 8.46% 5.09% 
Iceland 0.00% 10.48% 1.79% 18.91% 5.46% 16.21% 15.91% 1.79% 1.13% 0.00% 0.19% 6.53% 
Ireland 67.65% 77.95% 80.70% 85.08% 75.06% 69.03% 56.26% 48.65% 48.25% 32.35% 33.65% 61.33% 
Israel 0.00% 0.00% 2.24% 3.37% 1.55% 0.00% 2.34% 4.34% 2.39% 14.74% 4.87% 3.26% 
Italy 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Japan 0.00% 0.00% 0.66% 0.00% 0.22% 0.00% 0.00% 1.26% 6.07% 0.17% 4.83% 1.20% 
Korea 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.77% 0.00% 0.00% 0.98% 
Luxembourg 5.18% 0.81% 0.00% 0.00% 0.00% 7.49% 0.00% 0.00% 2.97% 12.09% 13.76% 3.84% 
Mexico 69.95% 67.83% 83.53% 101.56% 97.13% 90.15% 86.12% 100.63% 113.07% 120.57% 114.06% 94.96% 
Netherlands 40.42% 45.86% 45.67% 40.38% 40.71% 34.04% 65.82% 82.67% 99.59% 98.42% 106.36% 63.63% 
N. Zealand 0.00% 0.00% 1.78% 0.00% 2.69% 0.00% 5.54% 7.86% 0.00% 8.21% 10.46% 3.32% 
Norway 51.80% 51.26% 33.76% 64.69% 54.09% 74.05% 56.34% 48.90% 76.39% 63.06% 66.00% 58.21% 
Poland 75.05% 72.23% 75.21% 78.80% 41.92% 41.24% 50.58% 43.85% 27.97% 24.91% 25.60% 50.67% 
Portugal 79.37% 73.17% 76.68% 80.80% 80.61% 125.28% 124.47% 109.01% 97.07% 99.68% 99.51% 95.06% 
Slovak R. 13.33% 6.53% 7.79% 13.39% 17.67% 25.46% 29.20% 30.85% 31.95% 34.68% 34.03% 22.26% 
Slovenia 0.00% 73.46% 81.94% 6.95% 8.18% 3.70% 1.96% 9.31% 4.45% 4.37% 8.22% 18.41% 
Spain 0.00% 0.00% 0.00% 13.01% 14.77% 19.05% 10.22% 13.54% 23.87% 12.17% 25.92% 12.05% 
Sweden 0.00% 0.00% 14.26% 18.98% 22.19% 20.60% 33.94% 38.91% 48.25% 57.92% 62.57% 28.87% 
Switzerland 0.47% 0.51% 0.98% 0.23% 0.00% 0.00% 0.00% 0.00% 2.00% 0.00% 0.00% 0.38% 
Turkey 0.00% 0.00% 0.00% 0.00% 1.17% 2.18% 5.38% 19.10% 2.59% 6.38% 6.57% 3.94% 
UK 2.37% 1.87% 7.04% 7.85% 13.34% 20.69% 16.73% 6.02% 14.27% 10.85% 10.24% 10.12% 
USA 149.28% 143.60% 138.78% 145.17% 150.68% 148.60% 158.18% 146.22% 144.39% 145.59% 146.12% 146.96% 
Average 18.84% 22.86% 27.13% 28.43% 26.51% 29.47% 31.30% 31.11% 32.55% 31.46% 32.68% 32.23% 
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Abstract 
This paper measures the technical efficiency of healthcare systems and estimates the impact 
of technical change on health outcomes across OECD Countries between 2000 and 2011, 
based on a 12 year, 34 country panel dataset, extending our previous study of productive 
efficiency in OECD as a part of a multi-stage analysis. We adopt a DEA (Data Envelopment 
Analysis) based output-oriented efficiency methodology to obtain the productive efficiency 
of each country for all given years, and use the Malmquist Index to determine the 
productivity growth and decompose the technical change from efficiency changes over the 
years. 
 
We find that the inefficiency in OECD health outcomes has slightly increased over time, 
from 2.8% to 3.1%, while the production frontier shifted up around 2% between 2000 and 
2010. Technical change alone explains 30-50% of the improvement in health outcomes 
(6.4%) in the given period. 1% technical change in production leads to a 0.2% change in 
health outcomes, and technological progress seems to be fairly stable over time while most of 
the fluctuations in productivity growth come from changes in efficiency due to utilization of 
new technologies. 
 
Keywords: Healthcare, Efficiency, DEA, Technical Change, Productivity Growth, OECD 
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1 Introduction 
 
In most developed countries, the state devotes a considerable share of resources to healthcare [6], and 
healthcare costs have been steadily increasing to current levels, over 10% of GDP globally [76, 61], 
with few signs of slowing down in the future [58, 74]. 
 
To explain this trend, many studies [3, 8, 39, 49, 50, 64, 68, 82, 103] have tried to diagnose the 
underlying factors such as an ageing population, increased social expectations, broader insurance 
coverage, supplier induced demand and relative prices that may affect the utilization and costs of 
healthcare services. Efficiency and productivity of the healthcare systems, as well as technological 
change and productivity growth in healthcare have also been claimed to have a major impact on 
healthcare costs [3, 38, 63, 73].  
 
Technological advances in healthcare, notably hospital care, have been dramatic over the last four 
decades [34], but they have often been blamed for the mounting costs of hospital care, especially in 
the United States. Various analysts (Aaron, (1991) [1]; Newhouse, (1993) [69]; and Schwartz and 
Mendelson, (1994) [88]) have argued that technological change generates the underlying growth in 
expenditures.  
 
On the other hand, many studies in the literature [12, 13, 40, 65, 78, 86] identify technical change as 
the main source of healthcare improvements. Fare et al. [31], for example, find widespread and rapid 
productivity growth for a sample of OECD countries from 1974 to 1989, especially for Denmark and 
the USA. Likewise, Francesco Moscone et al. [65] find a significant relationship between scientific 
research and the growth in healthcare productivity. Although technical change is found to constitute 
about a quarter of the healthcare expenditure growth, it also constitutes a large portion of the outcome 
growth. In this study, we find a similar increase in technical change, and identify it as the main source 
of healthcare improvements.  
 
Another possibility is that increasing inefficiency in the hospital industry is causing real expenditure 
growth; a World Bank Health, Nutrition and Population Paper by Wang, et al. (1999) [98] and a 
WHO study (2000) [100] made early attempts to measure global healthcare efficiency using different 
performance indicators, showing enormous variance in health outcomes, despite similar income and 
education levels. This generated considerable interest in the measurement of healthcare efficiency. 
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Among the seminal healthcare studies at the system level are Hollingsworth and Wildman (2002) 
[47], Jamison et al. (2001) [52], Salomon et al. (2001) [87], and Evans et al. (2001) [28]. 
 
Schwartz and Mendelson [88] argue that almost a quarter of the real expenditure growth could be 
eliminated if inefficiency was curbed. Greene [41] argues that the main problems in the US are the 
access to healthcare and phenomenally high medical prices, rather than the quality of healthcare. 
Similarly recent studies suggest that if increases in healthcare costs are inevitable, the focus should 
shift from cost reduction to improving healthcare quality [95]. It is then much more plausible to argue 
the system should try to maximize its output levels given the input it is provided, as the resources and 
expenditure levels used in healthcare production are usually determined externally. This is why we 
adopt an output-oriented efficiency measure in our study. 
 
A healthcare provider (e.g., hospital, physician, healthcare system) is efficient if it maximizes 
output for a given bundle of inputs or minimizes inputs used to produce a given output. The measured 
inputs and outputs are assumed to be homogeneous across units. Data Envelopment Analysis (DEA) is 
a nonparametric approach which constructs a theoretical best-practice frontier from the observed data 
points to measure the efficiency of any observed point. The method can simultaneously handle 
multiple inputs and outputs, originally developed to measure the efficiency of a DMU as a whole unit, 
without considering its internal structure. Within this black box, inputs are supplied to produce 
outputs, generally with a positive correlation between the two, which is not always the case [25, 97]. 
It is often necessary to study the internal structure of a system so that the cause of any inefficiency 
can be identified. 
 
The first study using this approach is probably Charnes et al. (1986) [18], who observes two stages 
in army recruitment; the first one is creating awareness through advertisements, and the second one is 
creating contracts. Separating large operations into multiple stages helps identify the real impact of 
input factors. The simplest case is to separate the whole operation into two stages, as in Charnes et al. 
(1986) and Wang et al. (1997)  [97] studies. There are more complicated cases with more than two 
stages and in different structural forms such as series structure, a parallel structure, or a mixture of 
these, which are overall called “network structures”, and the DEA technique to measure the efficiency 
of systems with a network structure is called network DEA after (Färe & Grosskopf, 2000) [36]. 
 
Another issue is that an overall system may be efficient, even when all of its stages are not [53]. 
Although a DMU which is efficient in all stages is also efficient overall, there are cases in which a 
DMU is less efficient in all stages than another DMU, and yet the former still has better system 
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efficiency [54]. Similarly, in healthcare production, a DMU inefficient at production can still appear 
efficient in overall outcomes. This is because a) in the case of overuse of health resources, the 
inefficiency in production does not automatically lead to inefficiency in health outcomes; b) constant 
returns in production is often linked with rapidly diminishing returns in provision, so a fairly large 
efficiency loss in production will not always result in similar losses in outcomes. 
 
Measuring efficiency in healthcare directly from resources to outcomes ignores the inefficiencies in 
production. Although the system may be efficient overall, the inefficiencies within the system are still 
costly and should be eliminated. We show in this study that the inefficiency in production also leads 
to decreases in productivity growth, which remains underestimated or undetected without a multi-
stage analysis. These findings indicate that a network DEA model is required to produce correct 
results when measuring efficiencies. 
 
Countless studies that discuss network DEA have been published since Charnes et al. (1986). Cook, 
Liang, and Zhu (2010) [24] reviewed a number of models for the basic two-stage systems, connected 
in series, where the second stage only consumes all the outputs from the first production. Castelli, 
Pesenti, and Ukovich (2010)  [15] reviewed shared-flow, multilevel, and some network models. The 
network models they reviewed are of the general network DEA form developed by Färe and 
Grosskopf (2000) [36], leaving many others untouched.  
 
Our study falls under “General two stage-structure”, which is an extended form of basic two stage 
models, allowing both stages to consume exogenous inputs supplied from outside and to produce final 
outputs. Examples include Simon, Simon, and Arias (2011)  [90] who analysed the productivity 
growth of 34 Spanish university libraries using an MPI, or Löthgren and Tambour (1999)  [57] who 
included customer satisfaction in studying the performance of 31 Swedish pharmacies. 
2 Objectives  
As stressed by Jacobs et al. (2006) [51], efficiency analysis should be based on outcomes of care. 
However researchers are often forced to study efficiency on the basis of measured services like 
patients treated or hospital discharges. Many of the published studies use health services as outputs [2, 
27, 85], but some studies include health outcomes as outputs [14, 26, 55, 91], and a few include 
quality, either explicitly [43] or as an explanatory variable [102]. Either way is problematic, since 
health services as intermediate goods do not tell us whether the patient’s health has improved, while 
the outcomes are not the direct products of the inputs used but of intermediate goods in conjunction 
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with other non-discretionary inputs. This critique was summarized in Newhouse (1994) [70] and fully 
discussed in Jacobs et al. (2006) [51], who conclude by suggesting the use of multivariate models and 
multi-stage models [44], where the objectives may include quality.  
Färe and Grosskopf (2000) [36] introduced a multistage DEA (Data Envelopment analysis) model 
that later came to be known as network DEA. Following their paradigm, we devise a multi-stage 
healthcare system analysis where production takes place at the first stage and resources produce 
health services, which are, as intermediate goods, then transformed to health outcomes at the second 
(provision) stage. Additionally, non-discretionary inputs, which affect both the production and 
provision stages by shifting the frontiers, need to be controlled for.  
 
Although there are numerous studies in the literature examining the technical changes of the OECD 
healthcare systems [11, 19, 27, 31, 34, 42, 62, 77, 92, 101], the focus is on the production side, with 
little emphasis of the technical change on provision (the actual health outcomes), and the relationship 
between the technical changes on production and provision is not well established.  
 
Fare et al. (1997) paper [34] for example, calculates the technical change for both health services and 
outcomes at one stage and from resources. However, health outcomes are a product of health services, 
rather than directly of resources, and skipping the production stage leads to underestimation of not 
only inefficiency but also the productivity growth of outcomes. 
In this paper, we do not only investigate the second (provision) stage but also combine the results 
obtained from our previous study [9] which investigated the first (production) stage. This will enable 
us to pinpoint where exactly the inefficiencies occur and what is the role of technology in all of this.  
As part of a multi-stage analysis, this paper’s main contribution will be to analyze the subsequent 
impact of productivity growth and technical inefficiency of production on the provision side, as a 
follow up to our previous study investigating the production stage. The purpose of this paper can be 
expressed in three parts: 
 
a) To measure the outcome efficiency levels of all 34 OECD Countries, by discriminating between 
production and provision inefficiencies, and monitor their progress over time.  
 
b) To measure the technical change and productivity growth between 2000 and 2010, and to gauge the 
impact of productive inefficiency on the technical change of outcomes. 
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c) To gauge the impact of technical change in production on technical change in provision. 
 
We mainly use OECD data [74], which are, for the most part, standardized across fairly similar 
countries; so the quality of the variable measurements, although spotty at times, is relatively good. 
The only non-OECD data are the BMI figures acquired from the World Health Organization as a 
patient risk characteristic. Inclusion of multiple (12) years also serves to give a better picture of each 
country, rather than a one-year snapshot. 
Following the standard procedure, we are using additional variables to control for non-discretionary 
inputs and the quality of outputs, which will be further investigated in the following pages. We aim to 
measure inefficiency levels, identify the sources of inefficiency, and measure the productivity growth 
and decompose the technical change from the changes in technical efficiency. 
3 Methodology 
3.1 Literature 
DEA was first introduced by Charnes, Cooper, and Rhodes in 1978 [17] and further formalized by 
Banker, Charnes and Cooper in 1984 [4] based on Farrell’s (1959) [37] simple measure of firm 
efficiency that accounted for multiple inputs. The first application of DEA to health issues is an 
unpublished work from 1979 regarding family planning centers in Costa Rica and Guatemala (Ray 
2004, p. xi) [81]. Nunamaker and Lewin (1983) [72] is the first published work applying DEA to 
healthcare, whereas Sherman (1984) [89] was the first author to use DEA to evaluate overall hospital 
efficiency. Today there is a very extensive literature surveyed by O’Neill et al. (2008) [75], who 
emphasize national differences in hospital efficiency research, and Ozcan (2008) [76] who 
encompasses many aspects of healthcare delivery, as well as providing an overview of existing 
techniques, while Hollingsworth (2008) [48] classifies 317 published papers into various 
subcategories and offers comments as to their practical usefulness.  
 
Recent healthcare studies that concentrate on OECD countries include Retzlaff-Roberts et al. 
(2004) [83], who find that countries with less stellar results can also be relatively efficient; Varabyova 
et al. (2013) [96] who use a panel data set and compare parametric and non parametric methods for a 
robustness check; and Cheng and Zervopoulos (2014) [23], who extend their study to 171 countries 
and use a directional distance function to incorporate undesirable outputs as well.  
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Although the initial Farrell analysis  [37] is static, changes in efficiency can be measured over time, 
i.e. the frontier may shift due to technological advances. Productivity is defined as the ratio of an 
index of output to an index of input usage. Change of this measure over time is productivity change, 
which was initially attributed to technological changes, i.e. shifts of the production or cost frontier. 
However, it became increasingly recognized after Nishimuzu and Page (1982) [71]  that productivity 
change can also be caused by changes in efficiency, that is, firms move closer to the theoretical 
frontier over time, rather than show genuine technological progress (shifts in the actual production 
frontier). 
 
The Malmquist index [59], introduced in 1953 by the Swedish economist, Sten Malmquist, is a 
summary measure of the change in productivity of a given unit over time. Initially, Caves et. al. 
(1982) [16] adapted this index in order to evaluate productivity movements between different 
production units. Later, Fare et al. (1989) [29]  derived the Malmquist productivity index as a 
geometric mean of the technologies of two periods of Caves et al.’s output productivity indices, and 
decomposed it into efficiency change and technological change components. Fare and Grosskopf 
(1992) [30] then generalized their non-parametric approach to eliminate assumptions on optimizing 
behavior, efficiency, and the need for price data, unlike previous studies such as Nishimizu and Page 
(1982) [71]  and Bauer (1990) [7], which required specification of a functional form for technology. 
Fare et al. (1997) [34] later used the technique to measure the productivity growth in healthcare across 
10 OECD countries between 1974 and 1989. 
 
Fa¨re et al. (1994) [31] operationalized and further the decomposed the approach to include scale 
changes, maintaining the constant returns to scale (CRS) assumption. However, the internal 
inconsistency of the approach, attempting to explain the scale changes under CRS, which requires the 
assumption of variable returns to scale (VRS) was criticized by Ray and Desli (1997) [80] who found 
significantly different results under VRS. Färe et al. (1997) [35] acknowledge the criticism and 
suggest that the CRS and VRS should be considered as the upper (long run) and lower (short run) 
boundaries of the production frontier of a given technology. Lovell et al. (1994) [56] also showed that 
the Malmquist productivity index can be expressed as the product of a Malmquist productivity index 
and a Malmquist scale index, as well as the ratio of a Malmquist output quantity index to a Malmquist 
input quantity index 
 
Fa¨re et al. (1995) [33], who regard quality as an input in the production process, further extended the 
Malmquist index by incorporating quality ‘attributes’ into the technology of medical services and 
decomposing the index into three components: quality change, technical change and efficiency 
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change. Maniadakis et al. (1999) [60] and Chen (2006) [19] use this method to evaluate the reform of 
the national health services and the implementation of the national health insurance program in the 
UK, respectively. 
 
Alternatively, Thanassoulis et al. (1995) [94] treat quality as an output in determining the 
performance of the district level health authorities in providing pre-natal care in the UK. Dismuke and 
Sena (2001) [27] define quality as the reduction in undesirable outputs and utilize the Malmquist-
Luenberger productivity index developed by Chung et al. (1997) [21]. 
3.2 Output-oriented two-stage Model 
Graph 1 – Multi-Stage Healthcare System 
 
As we are using panel data in this study, each yearly data point for each country is treated as a 
separate decision making unit (DMU); e.g. the year 2000 data point for the US is an entirely different 
DMU than the US data point for 2011. We are assuming non-regressive technology, which implies 
that a currently available technology will also be available to all future DMUs, but was not available 
to the past ones. This assumption requires control for technological progress over time and can be 
done by the in/exclusion of the relevant DMUs. 
Although it is generally accepted that the production stage exhibits CRS, the provision of health 
services demonstrates VRS, and most OECD countries operate at a sharply diminishing returns 
region. In other words, although doubling of all resources will lead to doubling of health services 
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(CRS), this will not necessarily lead to a similar increase in health outcomes (VRS). Therefore, the 
OECD healthcare system exhibits CRS in production but VRS in the provision stage and as a whole. 
The model consists of two output-oriented stages. In this paper, however, we concentrate on the 
second stage, where we measure the non-radial efficiency levels of provision under VRS with 
desirable and undesirable health outcomes. This stage alternatively uses the actual (y) and efficient 
(y*) quantities of services (obtained in the previous chapter) as inputs to measure the second stage 
(β2), and overall (β) inefficiency levels respectively, which allows us to also derive the first stage 
inefficiency (β1) in terms of health outcomes. 
Weights are adjusted to be proportional to their impacts on the outcomes in terms of years of life lost 
and normalized to have equal impacts for comparable changes. For example, a 1% change in life 
expectancy at birth of an 80 year average is equivalent to a 4% change in life expectancy at age 65 of 
a 20 year average, which requires a relative weight of 4 to 1 (80 to 20) respectively.  
3.3 Model Specification 
DEA relies on a number of fairly weak assumptions to construct the production technology but avoids 
any explicit functional relationship between the inputs and outputs through a production function 
[22]. These assumptions are summarized below. Let Ψ be the feasible set: 
 
a) all observed input-output combinations are possible; (x1, y1) ∈ Ψ. 
b) the production possibility set is convex; Let α ∈ [0, 1]; If (x1, y1), (x2, y2) ∈ Ψ, then (x, y) = 
α(x1, y1) + (1−α)(x2, y2) ∈ Ψ. 
c) inputs and outputs are freely disposable; Let x2 ≥ x1, and y2 ≤ y1. If (x1, y1) ∈ Ψ then (x2, y1) ∈ 
Ψ and (x1, y2) ∈ Ψ 
Let (yi, zi) represent the input-output bundle of a firm i, assuming input-output bundle observed for N 
firms. Then given the aforementioned assumptions, the VRS production possibility set is  
)},....,3,2,1(;0;1; z;y  z); {(y, T iv Nizy i
N
i
i
N
i
ii
N
i
ii     {i} 
By measuring the non-radial efficiency levels of production under variable returns to scale (VRS), we 
obtain the efficient outcomes (z*) that should have been produced. The output-oriented non-radial 
efficiency of a DMU s:  
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The standard DEA LP problem solved to estimate the efficiency of DMU s, relative to 
contemporaneous VRS frontier is 
Objective: Max β = ∑wk* βk,   (β: weighted non-radial outcome inefficiency) 
 subject to   {iii} 
 ∑λi*yij ≤ y0j         j = 1…3     (Input constraint) (1) 
 ∑λi*zik ≥ (1 + βk) * zsk     k = 1, 2      (Desirable Output constraint) (2a) 
 ∑λi*zik ≤ (1 - βk) * zsk      k = 3           (Undesirable Output constraint) (2b) 
 ∑λi*qi1  ≤  qs1                                       (Per capita health expenditure)        (3) 
 ∑λi*qi2 ≥  qs2                                        (Risk factors fused into one variable)   (4a) 
 ∑λi*qi3 ≥  qs3                                        (Control for inequality) (4b) 
 λi ≥ 0,     ∑λi = 1                                   (Variable Returns to Scale) (5) 
 
In the maximization problem above (Max β), constraints (1), (2a), (2b), and (5) ensure that the 
benchmark unit created from the convex combination of actually observed data points does not use 
any more inputs (services) than the comparison unit while producing βk* z0k more of desirable and 
less of undesirable outputs, where wk is the weight of output k, βk is the non-radial inefficiency rate 
for output k, and β = ∑wk* βk is the weighted non-radial outcome inefficiency. If βk equals 0 then the 
unit appears efficient at that specific individual output given the observed data. However, this does 
not mean the unit produces the best possible amount for all outputs, as β = ∑wk* βk may still be 
greater than zero, implying inefficiency in other outputs. The inclusion of healthcare expenditures (3) 
ensures that the benchmark unit is not any more capital intensive than the evaluated unit, which is 
also a proxy for its technological level.  
Among the various ways to incorporate environmental variables into the DEA framework, we use 
Ruggiero’s 3-stage method [84] to incorporate multiple risk factors into one risk variable (4a), as it 
performed best in virtually all scenarios, being the only model robust to sample size and the number 
of nondiscretionary variables [67], when compared to the other common methods such as Ray (1991) 
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[79], Muñiz (2002) [66] and Banker and Morey [5]. The original DEA model without the risk factors 
(4a) is solved and the second-stage regression on the risk factors is performed. Let β̂ be the 
estimated inefficiency regressed on the risk factors: 
β̂ = qi2 = α + γ1 r1 + γ2 r2+ γ3 r3+ ε    {iv} 
 
After construction of qi2 (the combined patient-risk control) from estimating the first inefficiency, the 
model {iii} is solved again. Finally, inequality of access to healthcare enters the problem as yet 
another environmental variable that needs to be controlled for in the model. This is represented in the 
equation (4b), in a similar fashion to the risk factors, but introduced separately.    
 
In the model, we initially decompose β (outcome inefficiency) into two parts. As in Chen, Cook, and 
Zhu (2010)  [20], the overall efficiency is the product of efficiencies in two consecutive stages. Let “1 
+ β = (1 + β1) * (1 + β2)” where,  
β1: Outcome inefficiency of production,            β2: Outcome inefficiency of provision 
Using the actual health services as given in the model implicitly assumes the first stage production is 
fully efficient and will only yield β2, the outcome inefficiency of provision. Using the efficient health 
services obtained from our previous study as the input, on the other hand, implies no such assumption, 
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and yields the total outcome inefficiency (β) from which, β1 can easily be derived. This 
decomposition will allow us to not only distinguish between the first and second stage inefficiencies, 
but also gauge the impact of production inefficiency on technical change. 
3.5 Malmquist Index and measuring technical change 
The assumption of “non-regressive technology” allows us to include all current and past observations 
in the calculation of inefficiency for a certain DMU. However, the observations of the succeeding 
years have to be dropped to control for the technology that was not available to the DMU in question 
at the time. 
Let the calculated inefficiency of the input-output bundle of a country i with respect to technology… 
…in year t = βit,t , and in year t+1 = βit,t+1 
βit,t+1 ≥ βit,t implies that the measured inefficiency of a DMU through time will tend to increase. The 
inclusion of new observations due to additional years will inevitably bring in more efficient DMUs, 
shifting up the constructed frontier, causing past DMUs to appear more inefficient, due to two 
possible reasons: 
a) The actual production frontier shifts up (technological progress), 
b) The constructed frontier moves closer to the actual frontier (increase in efficiency). 
Although this may not be clear from the calculation of inefficiency for a single country, using 
longitudinal data, calculation of an average inefficiency path for all countries through time 
will be much more representative of technological progress. Let the average OECD 
inefficiency in year t measured in year t = n
n
/
1
i
tt  
n
n
/
1
i
1tt   ≥ n
n
/
1
i
tt  implies that the measured average inefficiency for a certain year will 
tend to increase over time, inevitably shifting up the production frontier. This fact must be 
invariant to the base year “t”, and thus n
n
/
1
i
11t-t   ≥ n
n
/
1
i
1t-t   must also hold.  
In other words, the measured inefficiency changes due to technological progress between two 
years must be equal, regardless of the base year it is based on. The discrepancies in the 
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measurement are likely due to the changes in efficiency rather than technological progress. 
Therefore multiple year comparisons are necessary for a better assessment of the 
technological trend over the years. 
In order to measure the productivity growth, we convert the inefficiency (β) values obtained 
in the DEA process to efficiency values (D) as in )1/(1 itt
i
tt D . Then, following Färe et al. 
(1994) [32], we obtain the Malmquist productivity values and decompose them into technical 
change and efficiency change in the following way: 
 
4 Data 
Data used in this study are obtained from the Organization for Economic Cooperation and 
Development (OECD) Health Data 2013 [105], which is the broadest source of comparable statistics 
on diverse health systems across OECD countries. The sources and methods of data collection are 
described in detail in the OECD documentation [45]. 
Because countries are not uniform in their reporting practices and not all variables are recorded each 
year, a slight adjustment of OECD data is unavoidable and common in OECD studies [83, 105]. 
Similarly, in this study, linear interpolation is applied to impute missing values in the time-series for 
particular countries, meaning some of the gaps are filled with average estimates (5-10% of the data 
points).  
The dataset consists of 34 OECD countries and 12 years between 2000 and 2011 for a total of 408 
decision making units (DMUs). However, the number of included DMUs in the measurements varies 
by year, from a minimum of 5 years (170 DMUs) up to 11 years (378 DMUs), in order to control for 
technical change through time. 
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Variables  
The variables used to determine efficiency include: Inputs (health services), outputs (health 
outcomes), per capita health expenditure, patient risk characteristics, and inequality of access to 
healthcare (see Table 1). 
Table 1- Variables 
 
4.1 Health Services (Inputs of the Provision Stage): We use three of the most commonly used 
hospital services [48, 75, 76] as the inputs of the provision stage, and intermediary products between 
first and second stages. Because their homogeneity varies and effectiveness on health status depends 
on environmental variables, we control for per capita healthcare expenditure as a proxy for capital 
intensity, in addition to risk factors, and inequality. 
4.2 Health Outcomes (Final Outputs): We use three of the most commonly used health outcomes as 
our outputs of the provision stage [48, 75, 76]. Life expectancy at birth is a good proxy for general 
healthcare, and life expectancy at age 65 is a better proxy for senior and chronic healthcare, while 
infant mortality is particularly useful to measure more basic and youth healthcare efficiency. 
4.3 Per capita Health Expenditures (Control): We use healthcare expenditure per capita at the 
second stage, as a proxy for capital intensity and technology level. Both total and public health 
expenditures are employed for robustness checks.  
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4.4 Patient-risk characteristics (General Control): There are three highly standardized and 
commonly used risk characteristics defined in the OECD data set, namely tobacco and alcohol 
consumption, and obesity. Data regarding tobacco and alcohol consumption have been obtained from 
the OECD web site, while the BMI figures, as a proxy for overweight population, were obtained from 
the WHO data set [104]. 
4.5 Inequality in access to healthcare (General Control): We use the Gini coefficient and 
alternatively poverty rates for each country as a proxy for inequality of access to healthcare. Although 
not a perfect match, the Gini is a sufficient indicator of healthcare inequality. There are various 
studies in the literature that show clear negative correlations between socioeconomic inequality and 
access to healthcare, both globally [99] and within a country [46]. We find that this correlation is 
stronger in privately oriented healthcare systems. 
 
5 Results 
5.1 Inefficiency across time 
Table 2 – OECD Health Outcome Inefficiency over the Years 
 The results in Table 2 and Graph 3 indicate that 
the OECD health outcome inefficiency is 
mostly stable around 3% over time. Our 
baseline control with total per capita health 
expenditure and gini for inequality indicates a 
slight increase in inefficiency by 0.28%, which 
is replicated with the use of poverty rates 
instead, yielding a similar 0.44 increase in 
inefficiency and almost identical trend over the 
years. Using public healthcare expenditures, on 
the other hand, produced somewhat different 
results. The average inefficiency is slightly greater at around 3.3%, and indicates a decrease in 
inefficiency by 0.35% instead, although the general trend is virtually the same.  
 
  Inefficiency over the years 
OECD 
Total HC 
Exp. & Gini 
Total HC Exp. 
& Poverty 
Public HC Exp. 
& Gini 
2011 3.08% 3.12% 3.14% 
2010 2.96% 3.00% 3.04% 
2009 3.09% 3.13% 3.28% 
2008 2.98% 2.99% 3.04% 
2007 3.11% 3.09% 3.25% 
2006 2.91% 2.94% 3.11% 
2005 2.97% 3.00% 3.19% 
2004 3.06% 2.99% 3.36% 
2003 3.42% 3.38% 3.87% 
2002 3.17% 3.02% 3.62% 
2001 2.79% 2.67% 3.50% 
Average 3.05% 3.03% 3.31% 
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Graph 3 – OECD Inefficiency over the Years 
 
This result may reflect the increasing share of public expenditures in healthcare [45], as public 
expenditure is often found to be more efficient than private in the literature [39]. This is likely why 
the trend is reversed with the inclusion of the relatively less efficient private expenditures.  
However, the change in inefficiency levels is not homogenous across the board. Some countries such 
as Estonia, Ireland, and Portugal have seen remarkable improvements in their healthcare efficiencies 
while some others such as Finland, Slovak Republic, and Turkey became less efficient, probably 
because these countries had a hard time adjusting to the drastic changes in the healthcare sector [10, 
93]. 
5.2 Decomposition of Inefficiency  
Both life expectancy at birth and at 65 replicate the overall trend, albeit at different levels. 
Inefficiency levels for life expectancy at birth hover around 1.8% regardless of gini or the poverty 
rates for control. Using public expenditures, however, leads to a noticeable rise in average 
inefficiency. Life expectancy at 65 yields around 5% inefficiency across the board, also resulting in a 
similar rise in inefficiency with the use of public expenditures for control. In both cases, control for 
total expenditure shows a fairly stable trend while public expenditures show a slight decrease in 
inefficiency.  
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Table 3 & 4 – OECD Inefficiency Life Expectancy at Birth & 65 
 
 Table 3 
Inefficiency in Life 
Expectancy at Birth    Table 4 
Inefficiency in Life 
Expectancy at 65 
OECD 
Total HC 
Exp. & 
Gini 
Total HC 
Exp. & 
Poverty 
Public 
HC Exp. 
& Gini   OECD 
Total HC 
Exp. & 
Gini 
Total HC 
Exp. & 
Poverty 
Public 
HC Exp. 
& Gini 
2011 1.71% 1.71% 1.84%   2011 4.76% 4.72% 4.95% 
2010 1.79% 1.80% 1.92%   2010 4.99% 5.00% 5.25% 
2009 1.74% 1.74% 1.92%   2009 4.74% 4.70% 4.97% 
2008 1.74% 1.72% 1.78%   2008 4.62% 4.59% 4.56% 
2007 1.77% 1.74% 1.90%   2007 4.87% 4.83% 5.08% 
2006 1.61% 1.63% 1.75%   2006 4.50% 4.56% 4.78% 
2005 1.74% 1.75% 1.94%   2005 4.94% 4.97% 5.25% 
2004 1.82% 1.80% 2.06%   2004 4.99% 4.90% 5.58% 
2003 2.02% 2.01% 2.34%   2003 6.28% 6.15% 6.86% 
2002 1.83% 1.80% 2.15%   2002 5.78% 5.61% 6.50% 
2001 1.62% 1.57% 2.13%   2001 4.59% 4.37% 5.99% 
Average 1.76% 1.75% 1.97%   Average 5.01% 4.95% 5.43% 
Graph 4 – OECD Inefficiency Rates for Life Expectancy at Birth 
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Graph 5 – OECD Inefficiency Rates for Life Expectancy at 65 
 
 
The results show that it is the infant mortality that 
actually leads to a rise in the overall inefficiency, 
with consistency across different controls. We are 
using the actual number of deaths here, rather than 
percentages to avoid distortion on the relative 
magnitudes. 
 
The infant mortality inefficiency increases from 
around 0.8 to over 1 death (per 1000) between 2001 
and 2011. The results show that although technology 
has rapidly increased, healthcare systems are still 
trying to catch up to the new frontiers, resulting in 
lower efficiency rates, which is expected given the rapid developments in this field. This is a classic 
example of rising productivity with diminishing efficiency. 
 
 
Table 5 
Inefficiency in Infant Mortality 
(number of deaths) 
OECD 
Total HC 
Exp. & 
Gini 
Total HC 
Exp. & 
Poverty 
Public 
HC Exp. 
& Gini 
2001 0.78 0.72 0.85 
2002 0.82 0.73 0.89 
2003 0.86 0.84 0.97 
2004 0.87 0.81 0.97 
2005 0.85 0.86 0.89 
2006 0.97 0.97 1.01 
2007 1.00 0.99 1.03 
2008 0.93 0.90 0.96 
2009 1.06 1.06 1.09 
2010 1.00 1.00 0.97 
2011 1.04 1.10 0.98 
Average 0.93 0.91 0.96 
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Graph 6 – OECD Inefficiency Rates for Infant Mortality 
 
5.3 Production vs. Provision Inefficiency 
 
The major advantage of a multi-stage efficiency 
analysis is to be able to see the contribution of each 
stage on inefficiency. Our analysis reveals that the 
lion’s share of inefficiency is in provision; with 
about 79% of the efficiency loss occurs at the 
provision stage, leaving 21% for the production 
inefficiency, though not every country is affected 
the same way. More than 60% of US’s inefficiency, 
for example, comes from production, which is in 
stark contrast to the OECD trend. Additionally 
production inefficiency has a serious negative 
effect on technical change and productivity growth of health outcomes as well, which we will discuss 
more in detail shortly. 
 
 Table 6 Inefficiency over the years 
OECD β1 + β2 β1 β2 
2011 3.08% 0.69% 2.37% 
2010 2.96% 0.76% 2.19% 
2009 3.09% 0.76% 2.32% 
2008 2.98% 0.62% 2.35% 
2007 3.11% 0.63% 2.47% 
2006 2.91% 0.52% 2.38% 
2005 2.97% 0.47% 2.49% 
2004 3.06% 0.56% 2.48% 
2003 3.42% 0.63% 2.77% 
2002 3.17% 0.72% 2.44% 
2001 2.79% 0.69% 2.09% 
Average 3.05% 0.65% 2.39% 
Share of Inefficiency 21.31% 78.69% 
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5.4 Productivity Growth and Technical Change 
The inclusion of the future observations gradually increases the measured inefficiency for 
each year’s OECD average. This is either because of technological progress, which is a shift 
in production frontiers, or DMUs moving closer to the actual frontier and helping us 
construct a more realistic one. As we discussed earlier, in the long run, healthcare efficiency 
is largely stable albeit slightly down. Therefore the bulk of technical change in the long run 
largely reflects technological progress. 
Relative stability over time, however, does not necessarily mean no fluctuations in the short 
run. Socioeconomic variables obviously impact the healthcare utilization and efficiency but 
those impacts do not seem to be permanent. The system tends to go back to the original path 
in the long run that it seems to deviate from. This, however, does not imply that resources do 
not become more productive and produce more over time, they actually do. The study reveals 
that the outcome growth is similar to the shifts in production frontier; therefore the gap 
between the frontier and the actual outcome (outcome inefficiency) remains largely the same. 
Graph 7 – Health Outcomes Productivity Growth and Inefficiency Path over the Years 
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Table 7 – Inefficiency Path and Productivity Growth of Year i (left) and Annual Change (right) 
We find similar results with different base years between 2001 and 2011, which seem to be 
consistent and robust over time. In each of these cases, the evaluated year appears 
increasingly more inefficient due to the shifting frontier, albeit at slightly different levels 
(0.15% - 0.21%) due to short-run efficiency fluctuations as well as measurement issues with 
respect to the observed data. Long run averages, however, seem to agree with each other, at 
around 0.19%. 
Table 8 – Decomposition of Productivity Growth, Technical and Efficiency Changes 
 
The cumulative technical change between 2001 and 
2011 is 1.84%, and efficiency change is -0.28%, 
leading to a smaller productivity growth at 1.56%. 
These figures are 2.05%, 0.35%, and 2.41% when 
only the public expenditures are used for control 
instead. Note that the technical change is robust to 
the type of control used. Therefore fluctuations are 
mostly due to short run changes and technical 
change has a much lower variance, as shown in 
graph 6. 
Technical changes in health outcomes have a greater 
variance compared to the technical changes in production only [9], which is expected due to the 
various stochastic environmental effects. Still, technical change, mostly ranging around 0.2 – 0.4%, 
has a much smaller variance than both productivity growth and efficiency changes, which clearly take 
time to adjust. Whenever there is a significant change in technology, it leads to a disruption in the 
  Inefficiency of Year i (left) with respect to the Technology of Year j (top) 
OECD 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Annual 
2011 1.40% 1.58% 1.66% 1.78% 2.00% 2.29% 2.32% 2.35% 2.50% 2.66% 3.08% 0.15% 
2010 1.56% 1.80% 1.89% 1.98% 2.22% 2.59% 2.61% 2.65% 2.80% 2.96% 3.62% 0.19% 
2009 1.78% 2.00% 2.05% 2.14% 2.41% 2.79% 2.83% 2.94% 3.09% 3.34% 3.95% 0.20% 
2008 1.91% 2.12% 2.19% 2.28% 2.47% 2.80% 2.88% 2.98% 3.28% 3.50% 4.01% 0.19% 
2007 2.04% 2.24% 2.33% 2.41% 2.62% 3.01% 3.11% 3.29% 3.47% 3.68% 4.16% 0.19% 
2006 1.99% 2.25% 2.29% 2.37% 2.57% 2.91% 3.02% 3.21% 3.39% 3.56% 4.03% 0.19% 
2005 2.19% 2.51% 2.60% 2.70% 2.97% 3.44% 3.52% 3.68% 3.88% 4.06% 4.49% 0.21% 
2004 2.48% 2.69% 2.77% 3.06% 3.41% 3.80% 3.91% 4.02% 4.16% 4.31% 4.67% 0.20% 
2003 2.95% 3.32% 3.42% 3.70% 4.00% 4.39% 4.45% 4.55% 4.68% 4.83% 5.13% 0.20% 
2002 2.86% 3.17% 3.30% 3.51% 3.76% 4.13% 4.21% 4.32% 4.46% 4.63% 4.83% 0.18% 
2001 2.79% 3.07% 3.21% 3.39% 3.58% 3.85% 3.92% 4.01% 4.14% 4.30% 4.46% 0.15% 
                        0.19% 
OECD Tech Eff Prod 
Average 1.84% -0.28% 1.56% 
2001 0.29% -0.37% -0.08% 
2002 0.11% -0.24% -0.13% 
2003 0.27% 0.35% 0.63% 
2004 0.30% 0.08% 0.38% 
2005 0.40% 0.05% 0.45% 
2006 0.10% -0.19% -0.09% 
2007 0.13% 0.13% 0.26% 
2008 0.22% -0.10% 0.11% 
2009 0.20% 0.13% 0.33% 
2010 0.52% -0.12% 0.41% 
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system and a temporary decrease in efficiency, which is then followed by a sequential increase and so 
on. In the long run, however, those fluctuations tend to smooth out. Productivity growth has a much 
greater variance than technical change and even occasionally goes negative due to the fluctuations in 
efficiency integrated in its composition.  
Graph 8 – Decomposition of Productivity Growth, Technical and Efficiency Changes 
 
5.5 Single vs. Multi-Stage Technical Change 
 
As mentioned earlier, inefficiency in production 
does not only negatively affect outcome 
inefficiency but also leads to underestimation of 
the technical change in a single stage efficiency 
analyses.  Measuring technical change in a 
single stage, by using either resources or health 
services as inputs reveals a mere 1.55% 
technical change between 2001 and 2010. A 
multi stage analysis, however, raises this figure 
to 1.84%. Controlling for public healthcare expenditures yield 1.78% and 2.04% respectively, 
Table 9 - Technical Change 
OECD Single Stage Multi-Stage  Ratio 
Total 1.55% 1.84% 118.6% 
2001 0.29% 0.29% 101.4% 
2002 0.11% 0.15% 135.3% 
2003 0.27% 0.29% 107.6% 
2004 0.30% 0.27% 88.4% 
2005 0.40% 0.41% 104.4% 
2006 0.10% 0.09% 86.8% 
2007 0.13% 0.12% 87.0% 
2008 0.27% 0.22% 126.3% 
2009 0.20% 0.29% 145.7% 
2010 0.52% 0.58% 111.0% 
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producing a very similar gap. In other words, a single stage analysis leads to 19% under-estimation of 
technical change, which is already a conservative estimate based due to the limitations of our study. 
Graph 9 – Technical Change with Single or Multi-Stage Analysis 
 
Considering the share of 
the production 
inefficiency, which is 
found to be 20% earlier in 
the study, this figure seems 
logical. Under-supply of 
health services due to 
inefficiency also leads to a 
diminishing impact of 
technical change on health 
outcomes. 
 
 
5.6 Share of Technical Change on Improvement of Healthcare 
 
  Table 10 - Share of Technical Change 
  Explanation 
LE Total 
population at 
birth 
LE Total 
Population 
at 65 
Infant 
mortality 
rate 
Average 
Change 
  2010 79.8 19.1 4.2   
  2000 77.1 17.3 6.7   
  Average 78.5 18.2 5.3   
  Total Change 3.48% 10.15% 37.01% 6.42% 
           
Total Exp & 
Gini 
Tech Change (1) 1.01% 2.73% 18.12% 2.21% 
Share (1) 29.03% 26.89% 48.96% 29.69% 
Total Exp & 
Poverty 
Tech Change (2) 1.22% 3.19% 17.32% 2.41% 
Share (2) 35.06% 31.46% 46.80% 35.03% 
Public Exp 
& Gini 
Tech Change (3) 1.10% 2.83% 19.69% 2.38% 
Share (3) 31.47% 27.89% 53.20% 31.97% 
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Our study shows that technical change alone is responsible for at least 30-35% of the total 
improvement in healthcare development between 2000 and 2010. The same amount of resources and 
health services result in an average of 2.2 - 2.4 % better outcome by the virtue of technical change 
alone. This translates to approximately 1 year increase in life expectancy at birth and 65, and a 20% 
reduction in infant mortality, while the rest of the improvement comes from employment of more 
resources, and higher healthcare spending among others. However, there are two fundamental reasons 
that cause significant underestimation of technical change in the analysis: 
 
a) Technical changes for the efficient 
countries on the production frontier are 
inherently underestimated,  
b) Technical spill-over between countries 
do not shift the frontier but increase 
the efficiency through catch-up, which 
underestimates the role of technical 
change. 
Focusing on developed but relatively less 
efficient countries paints a highly different 
picture. The average technical change of select OECD Countries on table 11 reveals over 55% 
contribution of technical change on healthcare development, double the overall average.  
This implies that, technical change in relatively more developed OECD Countries has a higher 
contribution than relatively less developed ones, which tend to use the readily available technologies 
to catch up with the rest, rather than produce new ones.  
5.7 Production Inefficiency and Its Impact on Health Outcomes 
The productive efficiency figures obtained in our previous study and their impact on health outcomes 
will be different and not necessarily homogenous.  The average inefficiency rate of the US between 
2000 and 2011 e.g. is 30.8%, while the outcome inefficiency of the production stage is 3.7%. This 
means US health services are under-produced by 30.8% causing a 3.7% drop in health outcomes. 
However, the above relationship is not automatic and affects some countries more seriously than 
others. There are two major reasons for this: 
Table 11 - Technical Change for Select Countries 
Country 
Total 
Exp. 
Total 
Exp. 
Public 
Exp. 
Gini Poverty Gini 
Finland 4.56% 4.48% 4.56% 
Austria 4.10% 4.10% 4.10% 
Germany 3.72% 3.72% 3.76% 
Netherlands 3.66% 3.66% 3.77% 
Denmark 3.50% 3.50% 3.50% 
Belgium 3.34% 3.34% 3.77% 
USA 3.34% 3.34% 4.00% 
N. Zealand 3.16% 3.32% 3.34% 
Norway 3.03% 3.03% 2.97% 
UK 2.88% 3.02% 3.50% 
Average 3.53% 3.55% 3.73% 
Share 54.96% 55.30% 58.03% 
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a) Standardized measurements may not cover all services produced by diverse healthcare systems 
combined with highly different environmental conditions. Non-standard services such as extensive 
home care and family physician services may cause production inefficiencies to be overestimated. 
b) Potential tradeoffs between quantity and quality of services are likely to be registered as productive 
inefficiency, which leads to an overestimation of the inefficiency of services. 
 
Countries like Ireland, Mexico, 
Netherlands, Portugal, and US suffer 
high degrees of production inefficiency 
which also has clear dire effects on 
health outcomes. 61% of US healthcare 
inefficiency is a direct result of 
production for instance. That figure is 
even higher for Netherlands (85%), 
Portugal (99%), and Mexico (100%). 
Basically those countries have primarily 
a production inefficiency problem.  
Countries like France, Slovak Republic, or Poland, on the other hand, appear somewhat 
inefficient in their production with minimal impact on health outcomes. They are either 
producing other health services not counted in the analysis due to diversity of healthcare 
systems (such as unaccounted family physician services), or their production deficits do not 
lead to a significant loss on outcome due to increasing quality of services that positively 
affect health outcomes. 
 
 
 
Table 12 - 
Country 
Production 
Inefficiency 
Decrease 
in Outcome 
Share of 
Inefficiency 
Belgium 22.63% 0.02% 0.43% 
Denmark 18.09% 1.17% 20.29% 
Estonia 29.14% 0.43% 11.87% 
France 31.32% 0.00% 0.00% 
Ireland 22.71% 1.98% 82.01% 
Mexico 35.11% 2.71% 100.00% 
Netherlands 36.31% 4.24% 85.21% 
Norway 11.01% 1.16% 42.69% 
Poland 39.78% 0.23% 4.72% 
Portugal 72.30% 3.26% 99.36% 
Slovak Rep. 20.51% 0.18% 1.81% 
UK 10.12% 0.42% 11.97% 
USA 30.82% 3.70% 61.23% 
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5.8 Limitations of the Study 
Well known limitations of the study are; 
a) Nonparametric frontier analyses tend to underestimate the inefficiency and productivity 
growth. Due to its general construction, the firms on the frontier are assumed to be efficient in 
the analysis and the productivity growth of the DMUs which are on or close to the frontier 
will also be underestimated since they will eventually appear efficient compared to older data 
set only having access to older technology. Concentrating on relatively more inefficient 
DMUs avoid this problem but leads to bias in the analysis.  
b) Country level aggregate data is far from precise but it can still present profound insights, 
especially when applied at multiple stages and with different controls for robustness check. A 
single-stage efficiency analysis based on only health services or health outcome is inherently 
inferior to a multi-stage analysis that combines production and provision.  
c) Healthcare system efficiency is just part of the problem. We observe in our study that further 
outcome losses stem from inadequate healthcare spending and environmental conditions like 
inequality and risk factors. To have a more complete understanding of the issue, the impact of 
those external variables and their interaction with the system efficiency must also be tackled  
6 Conclusion and Discussion 
 
In this study, we have found that the OECD health outcome inefficiency has slightly increased from 
2.8% to 3.1% between 2001 and 2011, although, controlling for public expenditures only finds a 
slight decrease instead. This roughly translates to “1.4 years of life expectancy at birth, 1 year at 65, 
and 1 infant death”. Decreased inefficiency with respect to public resources is obviously dominated 
by the increase in total expenditures, which is most likely aided by the increasing share of private and 
especially out of pocket expenditures in OECD countries [45]. Despite the short run fluctuations, 
efficiency appears to have a fairly stable trend in the long run. 
On a closer look, we find that “infant mortality” is the main reason behind the diverging results and 
most of the fluctuations. Although drastic improvements in hospital care and infant mortality rates 
have significantly increased productivity rates, hospitals are still lagging to adjust to the new 
technologies resulting in lower overall efficiency levels. 
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On average, 79% of the healthcare inefficiency comes from the provision side, leaving merely 21% to 
the production. This does not bode the same way for all countries though. Countries like the US, 
Netherlands, Ireland and Portugal suffer primarily from production inefficiency with rates in excess 
of 60%. Interestingly production inefficiency does not only negatively affect outcomes, but is also 
detrimental to productivity growth and technical change. We find that technical change is 
underestimated by 19% solely because of the production inefficiency. 
Following the steps of Fare et al. (1997) [34], who examined the technical change in OECD countries 
in the 1974 – 1989 period, we investigated whether the technological progress still persists in the 
modern era, and found a similar result. Unlike the bulk of the literature, we were able to include all 34 
countries in OECD, devise a more coherent multi-stage framework, and establish a clear distinction 
between output and outcome productivity growth and technical change.  
In our previous study [9], we had found similar results to Fare et al., around 8.5% cumulative and 
0.8% annual technical change in production for a 10 year period, which is matched with our current 
results, namely about a 2% cumulative and 0.2% annual change in provision, which is robust to 
different controls for healthcare expenditure or inequality. Technical change has slightly speeded up 
in the recent years and most of the fluctuations seem to be due to the efficiency changes as a result of 
the catch up process.  
2% technical change alone, which is a highly conservative figure given the limitations of our analysis, 
means that at least 30-35% of the total improvement in healthcare development between 2001 and 
2010 (6.4%) comes from technical change. This translates to approximately 1 year increase in life 
expectancy at birth and 65, and a 20% reduction in infant mortality. Focusing on developed but 
relatively less efficient countries, however, raises the cumulative technical change to 3.6% and its 
contribution to over 55%. Technical change in relatively more developed OECD Countries is found to 
have a higher contribution than relatively less developed ones, which tend to use the readily available 
technologies to catch up with the rest, rather than produce new ones.  
Finally we conclude that healthcare system efficiency is just part of the problem. Further outcome 
losses stem from inadequate healthcare spending and environmental conditions like inequality and 
risk factors. To have a more complete understanding of the issue, the impact of those external 
variables and their interaction with the system efficiency must also be tackled. This will not only help 
identify the exact points of inefficiency but also form a contiguous and robust relationship between 
resources and health outcomes through health services. 
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7 Appendix 
Table 13 – Non-Radial Inefficiency Levels between 2001 and 2011 
 
   
 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Average 
Australia 2.16% 2.04% 2.19% 1.31% 2.30% 1.80% 1.25% 1.72% 1.36% 2.36% 2.83% 1.94% 
Austria 4.03% 3.85% 3.91% 3.48% 3.66% 3.80% 4.59% 4.35% 5.17% 4.44% 5.07% 4.21% 
Belgium 4.97% 4.35% 4.49% 4.99% 4.64% 5.65% 5.43% 4.88% 6.43% 6.51% 6.30% 5.33% 
Canada 0.68% 0.40% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.31% 0.00% 0.13% 
Chile 1.76% 0.00% 0.25% 0.33% 1.42% 0.00% 0.00% 0.20% 0.25% 0.00% 0.00% 0.38% 
Czech R. 2.44% 1.29% 3.22% 1.31% 1.35% 1.45% 1.73% 2.79% 5.15% 3.43% 1.40% 2.32% 
Denmark 6.58% 6.26% 6.58% 6.56% 6.89% 6.37% 5.24% 5.40% 4.54% 5.40% 4.21% 5.82% 
Estonia 0.45% 0.80% 1.55% 8.22% 6.39% 1.03% 3.47% 6.71% 7.60% 1.13% 2.67% 3.64% 
Finland 4.43% 3.19% 3.76% 3.62% 2.19% 2.57% 1.81% 1.72% 1.35% 0.69% 0.65% 2.36% 
France 1.80% 1.90% 1.46% 1.33% 1.34% 1.35% 1.71% 1.64% 3.67% 2.83% 2.96% 2.00% 
Germany 4.17% 4.10% 4.11% 3.84% 4.02% 4.00% 4.17% 3.99% 5.10% 4.89% 4.76% 4.29% 
Greece 0.46% 0.48% 1.01% 0.41% 0.68% 0.63% 0.73% 0.67% 0.73% 1.01% 0.92% 0.70% 
Hungary 10.42% 10.98% 10.34% 10.76% 11.35% 11.90% 12.75% 12.02% 13.37% 11.60% 10.21% 11.43% 
Iceland 0.00% 0.00% 0.01% 0.18% 0.27% 0.00% 0.00% 0.52% 0.00% 0.00% 0.00% 0.09% 
Ireland 0.65% 0.29% 0.39% 0.83% 1.48% 1.83% 2.30% 3.25% 4.40% 5.00% 6.25% 2.42% 
Israel 0.48% 0.50% 0.47% 0.44% 0.57% 0.28% 0.51% 0.85% 1.09% 2.16% 1.95% 0.85% 
Italy 0.48% 0.21% 1.44% 0.30% 0.71% 0.82% 1.32% 1.34% 1.32% 0.88% 1.08% 0.90% 
Japan 0.50% 0.00% 0.00% 0.00% 0.00% 0.00% 0.17% 0.00% 0.00% 0.00% 0.00% 0.06% 
Korea 1.91% 2.33% 0.68% 1.55% 1.53% 1.11% 0.84% 0.50% 0.62% 0.47% 0.77% 1.12% 
Luxembourg 4.09% 3.14% 1.67% 0.52% 1.96% 2.02% 1.37% 0.91% 4.08% 3.47% 4.81% 2.55% 
Mexico 4.67% 4.85% 4.70% 4.01% 2.24% 1.83% 1.62% 2.10% 1.48% 1.17% 1.13% 2.71% 
Netherlands 4.35% 3.95% 4.08% 4.35% 4.85% 5.38% 5.55% 4.82% 5.94% 6.04% 5.72% 5.00% 
N. Zealand 3.05% 2.80% 0.86% 0.79% 0.50% 0.82% 0.32% 0.69% 0.78% 1.35% 0.93% 1.17% 
Norway 1.76% 2.25% 2.85% 0.48% 3.54% 3.62% 1.28% 2.52% 3.58% 4.05% 4.26% 2.74% 
Poland 4.35% 5.09% 6.41% 5.60% 4.88% 3.73% 4.03% 4.51% 4.63% 5.45% 4.03% 4.79% 
Portugal 2.28% 2.90% 4.37% 3.48% 3.30% 2.70% 2.88% 2.45% 3.11% 4.56% 4.02% 3.28% 
Slovak R. 10.93% 13.34% 13.15% 13.32% 12.38% 10.96% 9.99% 8.99% 8.28% 7.54% 2.06% 10.09% 
Slovenia 2.58% 0.84% 1.74% 1.23% 1.22% 3.27% 5.47% 4.50% 6.72% 5.55% 3.73% 3.35% 
Spain 0.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.21% 0.00% 0.03% 
Sweden 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Switzerland 0.00% 0.00% 0.09% 0.00% 0.00% 0.00% 0.00% 0.43% 1.12% 0.07% 0.06% 0.16% 
Turkey 9.17% 9.24% 10.23% 8.92% 10.32% 10.40% 10.74% 9.25% 4.55% 4.90% 2.55% 8.21% 
UK 2.56% 2.88% 3.06% 3.56% 3.69% 3.89% 3.72% 3.63% 4.07% 4.05% 3.35% 3.50% 
USA 6.38% 6.31% 5.97% 5.68% 6.19% 5.88% 6.00% 6.56% 5.85% 6.40% 6.21% 6.13% 
Average 3.08% 2.96% 3.09% 2.98% 3.11% 2.91% 2.97% 3.06% 3.42% 3.17% 2.79% 3.05% 
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Table 14 – Life Expectancy at Birth Inefficiency Levels between 2001 and 2011 
 
 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Average 
Australia 0.45% 0.69% 0.38% 0.13% 0.07% 0.00% 0.28% 0.27% 0.28% 0.29% 0.70% 0.32% 
Austria 1.60% 1.91% 1.63% 0.87% 1.25% 1.35% 1.92% 1.91% 2.51% 2.32% 2.40% 1.79% 
Belgium 2.36% 2.71% 1.94% 2.11% 1.80% 2.47% 2.87% 2.72% 3.49% 3.30% 3.40% 2.65% 
Canada 0.30% 0.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.08% 0.00% 0.05% 
Chile 0.99% 0.00% 0.02% 0.43% 0.65% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.19% 
Czech R. 1.30% 0.88% 2.25% 0.94% 0.97% 1.04% 1.18% 1.92% 3.60% 2.38% 0.93% 1.58% 
Denmark 3.34% 3.31% 3.34% 3.10% 3.37% 3.20% 2.81% 3.27% 2.98% 3.51% 2.73% 3.18% 
Estonia 0.39% 0.67% 1.39% 7.13% 5.85% 0.96% 3.30% 6.27% 6.78% 1.16% 2.43% 3.30% 
Finland 2.23% 2.53% 2.58% 2.00% 1.45% 1.83% 1.79% 1.62% 1.29% 0.58% 0.56% 1.68% 
France 0.14% 0.32% 0.28% 0.19% 0.15% 0.23% 0.82% 0.96% 1.96% 1.42% 1.46% 0.72% 
Germany 2.14% 2.49% 2.41% 1.48% 1.50% 1.75% 1.75% 2.07% 2.61% 2.54% 2.49% 2.11% 
Greece 0.14% 0.25% 0.54% 0.23% 0.42% 0.16% 0.34% 0.25% 0.32% 0.33% 0.35% 0.30% 
Hungary 7.33% 7.60% 7.66% 7.77% 8.33% 8.66% 9.10% 8.69% 9.21% 8.59% 7.56% 8.23% 
Iceland 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Ireland 0.44% 0.04% 0.19% 0.24% 0.91% 0.39% 0.82% 1.49% 2.29% 2.75% 3.35% 1.17% 
Israel 0.05% 0.03% 0.00% 0.03% 0.06% 0.05% 0.11% 0.07% 0.19% 0.61% 0.60% 0.16% 
Italy 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.09% 0.00% 0.45% 0.00% 0.02% 0.05% 
Japan 0.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.11% 0.00% 0.00% 0.00% 0.00% 0.03% 
Korea 1.09% 1.45% 0.37% 1.02% 0.99% 0.63% 0.52% 0.32% 0.41% 0.28% 0.37% 0.68% 
Luxembourg 1.64% 1.69% 0.53% 0.19% 1.43% 1.41% 1.10% 0.45% 2.11% 2.18% 2.62% 1.40% 
Mexico 3.86% 3.93% 3.78% 3.02% 1.61% 1.33% 1.15% 1.41% 0.95% 0.76% 0.72% 2.05% 
Netherlands 1.46% 1.79% 1.02% 1.21% 1.34% 1.76% 2.21% 2.14% 2.62% 2.61% 2.51% 1.88% 
N. Zealand 0.97% 0.93% 0.27% 0.23% 0.21% 0.19% 0.08% 0.18% 0.14% 0.24% 0.32% 0.34% 
Norway 0.48% 0.71% 0.54% 0.00% 0.92% 0.91% 0.49% 1.13% 1.76% 2.13% 2.22% 1.03% 
Poland 3.73% 4.26% 5.04% 4.70% 4.18% 3.39% 3.45% 3.71% 3.63% 4.15% 3.20% 3.95% 
Portugal 1.62% 2.27% 2.33% 2.53% 2.28% 2.20% 2.15% 1.92% 2.39% 3.29% 3.15% 2.38% 
Slovak R. 6.73% 8.02% 8.02% 8.17% 7.90% 7.03% 6.44% 6.09% 5.53% 5.27% 1.58% 6.43% 
Slovenia 1.96% 0.69% 1.34% 1.01% 1.02% 2.49% 3.58% 3.41% 4.79% 4.30% 2.65% 2.48% 
Spain 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Sweden 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Switzerland 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01% 0.01% 0.00% 
Turkey 5.73% 5.89% 5.95% 4.85% 5.51% 5.39% 4.97% 3.79% 0.78% 1.12% 0.88% 4.08% 
UK 1.28% 1.67% 1.71% 1.86% 1.77% 1.82% 1.76% 1.73% 2.04% 2.11% 1.73% 1.77% 
USA 4.21% 3.99% 3.79% 3.57% 4.10% 4.03% 4.06% 4.16% 3.74% 4.04% 4.03% 3.97% 
Average 1.71% 1.79% 1.74% 1.74% 1.77% 1.61% 1.74% 1.82% 2.02% 1.83% 1.62% 1.76% 
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Table 15 – Life Expectancy at Birth Inefficiency Levels (in Years of Life Lost) 
 
 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Average 
Australia 0.37 0.56 0.31 0.10 0.05 0.00 0.22 0.22 0.22 0.23 0.56 0.26 
Austria 1.30 1.54 1.31 0.70 1.00 1.08 1.53 1.51 1.98 1.83 1.89 1.42 
Belgium 1.90 2.18 1.55 1.69 1.44 1.96 2.27 2.15 2.73 2.58 2.66 2.10 
Canada 0.25 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.00 0.04 
Chile 0.77 0.00 0.01 0.34 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.15 
Czech R. 1.01 0.68 1.74 0.72 0.75 0.80 0.90 1.46 2.71 1.79 0.70 1.21 
Denmark 2.67 2.63 2.64 2.44 2.64 2.51 2.20 2.54 2.30 2.71 2.10 2.49 
Estonia 0.30 0.50 1.04 5.29 4.27 0.70 2.40 4.52 4.85 0.82 1.72 2.40 
Finland 1.80 2.03 2.06 1.60 1.16 1.46 1.41 1.28 1.01 0.46 0.44 1.34 
France 0.12 0.26 0.23 0.15 0.13 0.19 0.65 0.77 1.55 1.12 1.15 0.57 
Germany 1.73 2.01 1.94 1.18 1.20 1.40 1.39 1.64 2.05 1.99 1.95 1.68 
Greece 0.11 0.20 0.43 0.19 0.33 0.13 0.27 0.19 0.25 0.26 0.28 0.24 
Hungary 5.49 5.68 5.70 5.77 6.13 6.36 6.65 6.34 6.69 6.23 5.48 6.05 
Iceland 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Ireland 0.36 0.03 0.15 0.19 0.73 0.31 0.65 1.17 1.79 2.14 2.59 0.92 
Israel 0.04 0.02 0.00 0.02 0.05 0.04 0.09 0.06 0.15 0.49 0.48 0.13 
Italy 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.00 0.36 0.00 0.02 0.04 
Japan 0.20 0.00 0.00 0.00 0.00 0.00 0.09 0.00 0.00 0.00 0.00 0.03 
Korea 0.88 1.17 0.30 0.82 0.79 0.50 0.41 0.25 0.32 0.21 0.28 0.54 
Luxembourg 1.33 1.36 0.43 0.15 1.13 1.12 0.88 0.36 1.64 1.70 2.04 1.10 
Mexico 2.86 2.91 2.80 2.24 1.20 0.99 0.85 1.04 0.70 0.56 0.53 1.52 
Netherlands 1.18 1.45 0.83 0.97 1.07 1.41 1.75 1.70 2.06 2.04 1.97 1.49 
N. Zealand 0.79 0.75 0.22 0.19 0.17 0.16 0.06 0.14 0.11 0.19 0.25 0.27 
Norway 0.39 0.58 0.44 0.00 0.74 0.74 0.40 0.91 1.40 1.68 1.75 0.82 
Poland 2.87 3.25 3.82 3.56 3.15 2.55 2.59 2.78 2.71 3.10 2.38 2.98 
Portugal 1.31 1.81 1.86 2.01 1.80 1.73 1.68 1.50 1.85 2.54 2.43 1.87 
Slovak R. 5.12 6.06 6.04 6.12 5.89 5.23 4.78 4.52 4.08 3.89 1.16 4.81 
Slovenia 1.57 0.55 1.06 0.80 0.80 1.95 2.77 2.64 3.66 3.30 2.02 1.92 
Spain 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Sweden 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Switzerland 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 
Turkey 4.28 4.38 4.41 3.59 4.06 3.96 3.63 2.76 0.56 0.81 0.63 3.01 
UK 1.04 1.35 1.37 1.49 1.41 1.45 1.39 1.36 1.60 1.65 1.35 1.41 
USA 3.31 3.14 2.98 2.79 3.19 3.13 3.14 3.22 2.88 3.11 3.09 3.09 
Average 1.33 1.39 1.34 1.33 1.35 1.23 1.33 1.38 1.54 1.40 1.23 1.35 
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Table 16 – Life Expectancy at 65 Inefficiency Levels between 2001 and 2011 
 
 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Average 
Australia 0.51% 1.57% 0.28% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.13% 0.97% 0.31% 
Austria 2.87% 4.47% 3.72% 1.59% 2.34% 2.93% 3.65% 4.21% 6.70% 6.63% 5.95% 4.10% 
Belgium 5.37% 6.90% 4.25% 4.28% 2.72% 4.47% 6.63% 7.40% 8.97% 9.32% 8.63% 6.27% 
Canada 0.42% 0.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.17% 0.00% 0.08% 
Chile 4.91% 0.00% 0.00% 0.00% 3.23% 0.00% 0.00% 0.85% 0.44% 0.00% 0.00% 0.86% 
Czech R. 7.80% 6.20% 10.47% 5.63% 7.73% 8.28% 10.03% 7.61% 13.83% 9.32% 4.01% 8.26% 
Denmark 12.10% 8.98% 9.37% 8.08% 9.44% 9.14% 7.78% 7.73% 8.68% 11.10% 8.39% 9.16% 
Estonia 0.82% 1.56% 2.63% 15.88% 11.12% 1.66% 5.39% 10.99% 13.98% 1.41% 3.60% 6.28% 
Finland 4.17% 6.05% 6.51% 1.27% 0.45% 1.44% 0.67% 1.29% 2.08% 1.41% 1.29% 2.42% 
France 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.23% 0.22% 0.00% 0.13% 
Germany 6.49% 8.30% 8.07% 3.92% 3.80% 5.02% 4.70% 5.32% 7.84% 7.43% 7.05% 6.18% 
Greece 0.20% 0.41% 0.64% 0.53% 1.03% 0.71% 0.91% 1.08% 1.99% 1.84% 1.24% 0.96% 
Hungary 19.82% 20.41% 19.76% 20.07% 20.99% 21.93% 24.39% 22.51% 25.51% 22.50% 19.68% 21.60% 
Iceland 0.00% 0.00% 0.04% 1.03% 0.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.13% 
Ireland 1.69% 0.04% 0.35% 1.64% 3.40% 2.23% 4.37% 6.63% 9.53% 11.25% 12.62% 4.89% 
Israel 0.00% 0.04% 0.00% 0.03% 1.20% 0.09% 0.24% 0.18% 1.76% 2.30% 3.41% 0.84% 
Italy 0.00% 0.00% 1.23% 0.00% 0.02% 0.00% 0.49% 0.00% 2.97% 1.10% 0.63% 0.59% 
Japan 0.31% 0.00% 0.00% 0.00% 0.00% 0.00% 0.42% 0.00% 0.00% 0.00% 0.00% 0.07% 
Korea 5.03% 5.43% 2.98% 4.22% 4.40% 3.63% 2.57% 1.46% 1.80% 1.48% 1.88% 3.17% 
Luxembourg 5.62% 4.53% 0.12% 0.53% 4.90% 2.71% 3.05% 0.74% 8.07% 5.45% 6.50% 3.84% 
Mexico 4.28% 4.13% 3.84% 2.86% 1.68% 1.21% 1.18% 1.44% 1.04% 0.47% 0.00% 2.01% 
Netherlands 5.48% 7.12% 4.03% 4.26% 4.82% 6.89% 7.67% 7.07% 9.26% 10.47% 9.53% 6.96% 
N. Zealand 0.00% 0.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.03% 
Norway 1.46% 2.42% 0.53% 0.15% 2.27% 1.51% 0.53% 2.66% 3.68% 7.25% 6.93% 2.67% 
Poland 8.29% 10.39% 12.69% 11.50% 9.65% 6.48% 7.94% 9.60% 10.72% 13.04% 9.23% 9.96% 
Portugal 1.98% 6.11% 5.77% 6.84% 6.07% 5.72% 7.04% 5.63% 7.42% 8.88% 7.92% 6.31% 
Slovak R. 22.13% 26.53% 25.47% 25.90% 26.21% 25.46% 23.68% 22.65% 20.54% 19.76% 4.97% 22.12% 
Slovenia 5.48% 1.67% 3.87% 2.52% 2.47% 6.65% 10.60% 9.66% 15.28% 13.10% 9.91% 7.38% 
Spain 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.27% 0.00% 0.02% 
Sweden 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Switzerland 0.00% 0.00% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.09% 0.00% 0.00% 0.01% 
Turkey 23.85% 23.99% 23.77% 22.60% 23.15% 21.84% 20.54% 18.90% 14.75% 13.71% 7.51% 19.51% 
UK 2.75% 3.97% 4.17% 5.49% 4.63% 4.85% 6.16% 5.65% 7.51% 7.33% 5.88% 5.31% 
USA 7.84% 7.88% 6.55% 6.33% 7.48% 8.19% 7.41% 8.48% 7.89% 8.99% 8.45% 7.77% 
Average 4.76% 4.99% 4.74% 4.62% 4.87% 4.50% 4.94% 4.99% 6.28% 5.78% 4.59% 5.01% 
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Table 17 – Life Expectancy at 65 Inefficiency Levels (in Years of Life Lost) 
 
 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Average 
Australia 0.10 0.32 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.18 0.06 
Austria 0.57 0.88 0.72 0.31 0.45 0.56 0.68 0.78 1.21 1.20 1.08 0.77 
Belgium 1.06 1.34 0.82 0.82 0.52 0.84 1.22 1.36 1.59 1.65 1.54 1.16 
Canada 0.09 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.02 
Chile 0.89 0.00 0.00 0.00 0.58 0.00 0.00 0.15 0.08 0.00 0.00 0.15 
Czech R. 1.36 1.07 1.78 0.96 1.30 1.37 1.61 1.21 2.14 1.45 0.63 1.35 
Denmark 2.25 1.65 1.70 1.46 1.69 1.62 1.37 1.35 1.48 1.86 1.41 1.62 
Estonia 0.14 0.26 0.44 2.58 1.76 0.26 0.84 1.69 2.10 0.21 0.54 0.98 
Finland 0.82 1.18 1.26 0.25 0.09 0.27 0.13 0.24 0.38 0.25 0.23 0.46 
France 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.23 0.04 0.00 0.03 
Germany 1.28 1.61 1.55 0.75 0.72 0.95 0.87 0.98 1.40 1.33 1.27 1.15 
Greece 0.04 0.08 0.12 0.10 0.19 0.13 0.16 0.19 0.35 0.32 0.22 0.17 
Hungary 3.23 3.30 3.18 3.21 3.31 3.43 3.72 3.46 3.81 3.40 2.97 3.36 
Iceland 0.00 0.00 0.01 0.20 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.03 
Ireland 0.33 0.01 0.07 0.30 0.63 0.41 0.80 1.19 1.66 1.93 2.11 0.86 
Israel 0.00 0.01 0.00 0.01 0.23 0.02 0.05 0.03 0.33 0.43 0.63 0.16 
Italy 0.00 0.00 0.25 0.00 0.00 0.00 0.10 0.00 0.55 0.21 0.12 0.11 
Japan 0.06 0.00 0.00 0.00 0.00 0.00 0.09 0.00 0.00 0.00 0.00 0.01 
Korea 0.99 1.05 0.58 0.79 0.81 0.66 0.46 0.25 0.31 0.25 0.31 0.59 
Luxembourg 1.11 0.88 0.02 0.10 0.90 0.51 0.57 0.14 1.38 0.98 1.16 0.70 
Mexico 0.75 0.72 0.67 0.50 0.30 0.21 0.21 0.25 0.18 0.08 0.00 0.35 
Netherlands 1.08 1.38 0.78 0.81 0.91 1.28 1.40 1.28 1.63 1.83 1.67 1.28 
N. Zealand 0.00 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 
Norway 0.29 0.47 0.10 0.03 0.43 0.29 0.10 0.50 0.68 1.30 1.25 0.50 
Poland 1.46 1.80 2.16 1.95 1.62 1.08 1.30 1.56 1.71 2.08 1.45 1.65 
Portugal 0.39 1.15 1.08 1.27 1.12 1.05 1.25 1.01 1.29 1.55 1.38 1.14 
Slovak R. 3.64 4.25 4.09 4.09 4.08 3.90 3.60 3.44 3.09 2.97 0.74 3.44 
Slovenia 1.04 0.32 0.71 0.46 0.45 1.19 1.83 1.66 2.52 2.19 1.66 1.28 
Spain 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.00 
Sweden 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Switzerland 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 
Turkey 3.60 3.60 3.55 3.37 3.43 3.23 3.03 2.77 2.15 1.98 1.08 2.89 
UK 0.55 0.78 0.81 1.04 0.87 0.91 1.13 1.03 1.33 1.30 1.04 0.98 
USA 1.50 1.50 1.24 1.18 1.39 1.50 1.34 1.54 1.41 1.59 1.49 1.42 
Average 0.84 0.87 0.82 0.78 0.82 0.75 0.82 0.83 1.03 0.96 0.77 0.84 
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Table 18 – Infant Mortality (in Number of preventable deaths) 
 
 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Average 
Australia 1.33 1.31 1.48 1.02 1.56 1.34 0.90 1.17 1.01 1.70 1.75 1.33 
Austria 2.00 2.21 2.01 2.04 1.63 1.48 1.80 1.73 1.71 0.98 1.65 1.75 
Belgium 1.97 2.18 2.03 2.23 2.17 2.35 1.42 1.53 1.70 1.79 1.59 1.91 
Canada 0.42 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.19 0.00 0.08 
Chile 0.38 0.00 0.36 0.00 0.68 0.00 0.00 0.07 0.21 0.00 0.00 0.15 
Czech R. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Denmark 2.28 2.00 1.60 2.29 2.23 1.63 1.32 1.13 0.56 0.56 0.52 1.46 
Estonia 0.00 0.00 0.00 0.38 0.00 0.00 0.00 0.00 0.00 0.00 0.27 0.06 
Finland 1.23 0.90 1.20 1.12 0.54 0.58 0.17 0.16 0.00 0.00 0.00 0.54 
France 1.02 1.11 0.91 0.82 0.82 0.81 0.79 0.60 1.53 1.27 1.32 1.00 
Germany 1.68 1.87 1.42 1.43 1.69 1.35 1.38 1.33 1.37 1.27 1.10 1.44 
Greece 0.24 0.25 0.32 0.08 0.24 0.25 0.21 0.20 0.18 0.35 0.35 0.24 
Hungary 1.23 1.55 1.12 1.45 1.34 1.48 1.61 1.56 2.23 1.31 1.33 1.47 
Iceland 0.00 0.00 0.00 0.00 0.08 0.00 0.00 0.24 0.00 0.00 0.00 0.03 
Ireland 0.00 0.22 0.13 0.34 0.47 0.75 0.91 0.76 0.94 0.84 1.34 0.61 
Israel 0.30 0.29 0.28 0.26 0.35 0.16 0.35 0.61 0.50 1.11 0.72 0.45 
Italy 0.30 0.15 1.03 0.20 0.48 0.54 0.79 0.82 0.29 0.51 0.65 0.52 
Japan 0.16 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01 
Korea 0.15 0.21 0.05 0.02 0.00 0.01 0.18 0.00 0.06 0.06 0.14 0.08 
Luxembourg 2.22 1.77 0.76 0.10 0.10 0.39 0.05 0.28 0.89 0.73 1.55 0.80 
Mexico 3.19 3.77 3.93 3.81 2.28 1.77 1.76 2.33 1.92 1.56 1.80 2.56 
Netherlands 2.08 2.08 2.36 2.15 2.31 2.26 2.14 1.42 1.82 1.83 1.82 2.02 
N. Zealand 2.98 2.52 0.73 0.63 0.32 0.63 0.23 0.53 0.65 1.15 0.60 1.00 
Norway 0.63 1.23 1.55 0.25 1.52 1.68 0.43 0.88 0.99 0.69 0.84 0.97 
Poland 1.80 0.42 0.41 0.14 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.25 
Portugal 0.51 0.02 1.19 0.40 0.32 0.00 0.00 0.00 0.00 0.41 0.20 0.28 
Slovak R. 1.60 2.53 2.47 2.50 2.02 1.26 1.12 0.44 0.63 0.12 0.00 1.33 
Slovenia 0.25 0.00 0.00 0.00 0.00 0.17 0.63 0.13 0.27 0.16 0.00 0.15 
Spain 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.00 0.01 
Sweden 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Switzerland 0.00 0.00 0.07 0.00 0.00 0.00 0.00 0.55 0.75 0.04 0.04 0.13 
Turkey 1.16 0.62 2.80 2.78 5.25 7.49 11.55 12.54 6.38 8.23 2.61 5.58 
UK 1.07 1.11 1.84 1.79 2.06 1.50 1.36 1.11 1.05 0.96 0.87 1.34 
USA 2.62 2.71 2.94 2.98 2.24 1.67 1.94 2.14 1.86 1.95 1.81 2.26 
Average 1.02 0.98 1.03 0.92 0.96 0.93 0.97 1.01 0.87 0.88 0.73 0.94 
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Table 19 – Life Expectancy at Birth Productivity Growth and Inefficiency Path over the Years 
 Inefficiency - Measured in year t 
OECD 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Annual 
2011 0.79% 0.87% 0.89% 0.92% 1.07% 1.11% 1.13% 1.19% 1.33% 1.58% 1.71% 0.08% 
2010 0.88% 0.97% 1.02% 1.07% 1.23% 1.29% 1.31% 1.37% 1.54% 1.79% 2.00% 0.10% 
2009 0.95% 1.05% 1.11% 1.15% 1.34% 1.44% 1.49% 1.59% 1.74% 2.08% 2.31% 0.12% 
2008 1.16% 1.26% 1.32% 1.37% 1.50% 1.59% 1.65% 1.74% 1.95% 2.21% 2.42% 0.12% 
2007 1.16% 1.26% 1.34% 1.40% 1.51% 1.65% 1.77% 1.87% 2.06% 2.36% 2.53% 0.13% 
2006 1.13% 1.25% 1.28% 1.35% 1.47% 1.61% 1.69% 1.79% 1.98% 2.22% 2.42% 0.12% 
2005 1.24% 1.45% 1.53% 1.61% 1.74% 1.92% 1.97% 2.08% 2.30% 2.56% 2.68% 0.13% 
2004 1.51% 1.62% 1.69% 1.82% 1.97% 2.09% 2.15% 2.27% 2.49% 2.66% 2.78% 0.12% 
2003 1.76% 1.93% 2.02% 2.21% 2.34% 2.48% 2.56% 2.66% 2.85% 3.01% 3.13% 0.13% 
2002 1.64% 1.83% 1.91% 2.06% 2.14% 2.31% 2.39% 2.49% 2.69% 2.88% 2.96% 0.12% 
2001 1.62% 1.77% 1.84% 1.97% 2.05% 2.21% 2.28% 2.36% 2.55% 2.72% 2.81% 0.11% 
                        0.12% 
Table 20 – Life Expectancy at 65 Productivity Growth and Inefficiency Path over the Years 
 Inefficiency - Measured in year t 
OECD 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Annual 
2011 2.17% 2.47% 2.49% 2.64% 2.87% 3.05% 3.06% 3.24% 3.76% 4.51% 4.76% 0.23% 
2010 2.48% 2.77% 2.85% 2.99% 3.20% 3.47% 3.57% 3.70% 4.25% 4.99% 5.48% 0.27% 
2009 2.81% 3.11% 3.20% 3.33% 3.55% 3.81% 3.97% 4.14% 4.74% 5.77% 6.29% 0.32% 
2008 3.16% 3.46% 3.47% 3.66% 3.90% 4.26% 4.43% 4.62% 5.34% 6.10% 6.66% 0.32% 
2007 3.32% 3.61% 3.62% 3.82% 4.00% 4.63% 4.87% 5.22% 5.74% 6.67% 7.17% 0.35% 
2006 3.46% 3.77% 3.77% 4.02% 4.14% 4.50% 4.71% 5.03% 5.56% 6.37% 6.89% 0.31% 
2005 3.93% 4.42% 4.43% 4.76% 4.94% 5.56% 5.69% 6.08% 6.74% 7.66% 8.10% 0.38% 
2004 4.26% 4.61% 4.63% 4.99% 5.32% 5.76% 5.92% 6.37% 7.12% 7.86% 8.30% 0.37% 
2003 5.69% 6.22% 6.28% 6.94% 7.25% 7.81% 8.08% 8.49% 9.13% 9.84% 10.34% 0.42% 
2002 5.23% 5.78% 5.86% 6.34% 6.58% 7.24% 7.57% 7.92% 8.54% 9.25% 9.58% 0.40% 
2001 4.59% 5.10% 5.26% 5.67% 5.90% 6.62% 6.89% 7.20% 7.78% 8.41% 8.79% 0.38% 
                        0.34% 
Table 21 – Infant Mortality Productivity Growth and Inefficiency Path over the Years 
 Inefficiency - Measured in year t 
OECD 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Annual 
2011 0.43 0.51 0.57 0.66 0.72 0.98 0.97 0.93 0.93 0.92 1.04 0.06 
2010 0.47 0.61 0.65 0.68 0.74 1.06 1.03 1.02 1.02 1.00 1.26 0.07 
2009 0.58 0.70 0.71 0.73 0.79 1.13 1.11 1.08 1.06 1.08 1.23 0.06 
2008 0.49 0.62 0.63 0.65 0.68 0.89 0.92 0.93 0.99 0.97 1.07 0.05 
2007 0.59 0.70 0.74 0.74 0.79 0.98 1.00 1.01 1.01 0.98 1.06 0.04 
2006 0.54 0.71 0.72 0.71 0.78 0.97 0.97 1.04 1.02 1.00 1.06 0.05 
2005 0.58 0.69 0.72 0.72 0.85 1.09 1.11 1.09 1.09 1.04 1.11 0.05 
2004 0.60 0.71 0.73 0.87 1.03 1.25 1.26 1.22 1.17 1.12 1.17 0.05 
2003 0.64 0.84 0.86 0.92 1.05 1.25 1.20 1.14 1.09 1.04 1.04 0.04 
2002 0.71 0.82 0.90 0.95 1.08 1.22 1.19 1.15 1.10 1.05 1.04 0.03 
2001 0.78 0.86 0.93 0.97 1.07 1.16 1.12 1.08 1.03 0.99 0.96 0.02 
                        0.05 
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Table 22 – Technical Change, Efficiency Change, and Productivity Growth by Country  
 
 2001-2010 Tech Eff Prod 
1 Australia 0.27% 0.66% 0.93% 
2 Austria 4.10% 1.00% 5.14% 
3 Belgium 3.34% 1.27% 4.66% 
4 Canada 0.78% -0.67% 0.10% 
5 Chile 0.88% -1.73% -0.87% 
6 Czech Republic 1.81% -1.01% 0.78% 
7 Denmark 3.50% -2.22% 1.20% 
8 Estonia 1.51% 2.21% 3.74% 
9 Finland 4.56% -3.62% 0.77% 
10 France 1.12% 1.14% 2.27% 
11 Germany 3.72% 0.56% 4.30% 
12 Greece 0.51% 0.46% 0.97% 
13 Hungary 0.01% -0.18% -0.17% 
14 Iceland 1.57% 0.00% 1.57% 
15 Ireland 0.54% 5.56% 6.12% 
16 Israel 0.00% 1.46% 1.46% 
17 Italy 1.13% 0.60% 1.73% 
18 Japan 0.25% -0.50% -0.25% 
19 Korea 1.04% -1.12% -0.09% 
20 Luxembourg 4.03% 0.69% 4.75% 
21 Mexico 2.32% -3.38% -1.14% 
22 Netherlands 3.66% 1.32% 5.03% 
23 New Zealand 3.16% -2.05% 1.04% 
24 Norway 3.03% 2.46% 5.57% 
25 Poland 0.32% -0.30% 0.03% 
26 Portugal 2.37% 1.70% 4.11% 
27 Slovak R. 0.75% -8.00% -7.30% 
28 Slovenia 2.27% 1.12% 3.42% 
29 Spain 0.03% -0.07% -0.03% 
30 Sweden 0.51% 0.00% 0.51% 
31 Switzerland 0.23% 0.06% 0.29% 
32 Turkey 3.15% -6.06% -3.10% 
33 UK 2.88% 0.77% 3.68% 
34 United States 3.34% -0.16% 3.17% 
 OECD 1.84% -0.28% 1.56% 
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Abstract 
This paper measures the multi-stage technical efficiency of healthcare systems, the impact of 
environmental variables, and the expenditure levels across OECD countries between 2000 and 2011, 
based on a 12 year, 34 country panel data. We adopt an output-oriented DEA (Data Envelopment 
Analysis) methodology to obtain the technical efficiencies in production and provision. We find 
3.05% overall inefficiency across OECD countries, which translates into a loss of 1.38 years of life 
expectancy at birth and additional 0.75 infant deaths per 1000 live births. There are further outcome 
losses, however, from environmental variables (0.54%), and inadequate healthcare spending (1.94%), 
almost doubling the total OECD outcome loss to 5.65%, or 2.4 years of life expectancy and 1.5 infant 
deaths per 1000 live births. 
 
The inefficiency is split 21%-79% between production and provision. While provision is generally the 
main source of inefficiency, other countries like the US, suffer heavily from production inefficiency 
(61%). Although most countries are inefficient in one way or another, the type of inefficiencies they 
suffer and the solutions to those issues as well as the policy implications might be very different. 
 
Keywords: Healthcare, Efficiency, Network DEA, OECD, Environmental Variables 
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1 Introduction 
 
Governments in most developed countries allocate a significant share of public resources to 
healthcare [11]. This share has been steadily increasing to its current level of over 10% of global GDP 
[85, 109]. Although there are some signs of slowdown [81], the latest OECD data show a bounce 
back in expenditure growth [104]. 
 
Many studies [66, 67, 98] have tried to explain this trend by laying out the main culprits of the 
expenditure growth. “Proximity to death” [139] accounts for about 1/6 of the expenditure growth 
while the rise in medical service prices is found to be the main driver of rising expenditures, primarily 
due to wage increases in the medical sector exceeding productivity growth [118]. This is mainly a 
supply-side problem, as predicted by Baumol’s unbalanced growth model [12], which identifies the 
medical sector as a high-skilled labor intensive non-progressive sector. However, these increases can 
be significantly curbed by monopsonistic payers, especially the public sector and large insurers [7, 88, 
118].  
 
Increased social expectations and use of medical services due to rising incomes, especially among less 
developed countries, are also major contributing factors. The high income-elasticity of healthcare 
[118, 49] implies that an increasing share of national income will be allocated to healthcare as 
nations get richer. Similarly, increasing use of technological equipment [46, 86, 103], investment in 
technology [7], and inefficiency of healthcare systems are other major reasons for increasing 
healthcare costs.  
 
Technological advances in healthcare, notably hospital care, have been dramatic over the last four 
decades [43], but they have often been blamed for the mounting costs of hospital care, especially in 
the United States. Various analysts (Aaron, (1991) [1]; Newhouse, (1993) [100]; and Schwartz and 
Mendelson, (1994) [122]) have argued that technological change generates the underlying growth in 
expenditures, without providing in-depth empirical analysis.  
 
On the other hand, many studies in the literature [18, 19, 52, 93, 112, 121] identify technical change 
as the main source of healthcare improvements. Fare et al. [40], for example, find widespread and 
rapid productivity growth for a sample of OECD countries from 1974 to 1989, especially for 
Denmark and the USA. Likewise, Moscone et al. [93] find a significant relationship between 
scientific research and the growth in healthcare productivity. Although technical change is found to 
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constitute about a quarter of the healthcare expenditure growth, it also constitutes a large portion of 
the outcome growth. Our working papers [13, 14], which include data for all OECD Countries 
between 2000 and 2011, finds a similar increase in technical change, and identify this as the main 
source of healthcare improvements.  
 
Even though Europe and the US experience similar levels of technological improvement over the long 
haul [94], healthcare costs remain substantially different. The main reason for such a phenomenally 
high cost differential between the US and other OECD countries is the relative price levels [53, 60], 
due to very different market structure and medical systems. Average physician income in the US, for 
instance, is nearly three times the OECD average ($200,000 vs. $70,000) and the ratio of physician 
income / average income in the US is 5.5, but only 3.4 in Germany, 3.2 in Canada, 1.9 in France, and 
1.4 in the UK [118]. Similarly Koechlin et al. [76] find US medical service prices to be 73% higher 
than in a selected group of OECD countries. The main reasons for such high prices in the US [81] can 
be summarized as, 
 
a) more intense use of health-related technologies, [22, 126]  
b) low productivity, [56, 58, 75]  
c) decentralized price negotiations and fragmentation in the insurance market, [87, 90, 92]  
d) high level of provider concentration and less monopsonist power than OECD [15, 133]   
e) high administrative costs. [36, 118]  
 
Therefore the reasons for the current high levels of healthcare costs in the US should not be confused 
with the reasons for the growth in costs, which can only partially be attributed to investment in 
technology.  
 
Another possibility is that increasing inefficiency in the hospital industry is causing real expenditure 
growth; a World Bank Health, Nutrition and Population Paper by Wang, et al. [132] and a WHO 
study (2000) [136] made early attempts to measure global healthcare efficiency using different 
performance indicators, showing enormous variance in health outcomes, despite similar income and 
education levels. This generated considerable interest in the measurement of healthcare efficiency. 
Among the seminal healthcare studies at the system level are Hollingsworth and Wildman (2002) 
[63], Jamison et al. (2001) [69], Salomon et al. (2001) [120], and Evans et al. (2001) [37]. 
Schwartz and Mendelson [122] argue that almost a quarter of the real expenditure growth could be 
eliminated if inefficiency was curbed. Similarly recent studies suggest that if increases in healthcare 
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costs are inevitable, the focus should shift from cost reduction to improving healthcare quality [129]. 
It is then much more plausible to argue the system should try to maximize its output levels given the 
input it is provided, as the resources and expenditure levels used in healthcare production are usually 
determined externally. This is why we adopt an output-oriented efficiency measure in our study. 
 
A healthcare provider (e.g., hospital, physician, healthcare system) is efficient if it maximizes 
output for a given bundle of inputs or minimizes inputs used to produce a given output. Data 
Envelopment Analysis (DEA) is a nonparametric approach which constructs a theoretical best-practice 
frontier from the observed data points to measure the efficiency of any observed point. The method 
can simultaneously handle multiple inputs and outputs, which are assumed to be homogeneous across 
units. The first application of DEA to health issues is an unpublished work from 1979 regarding 
family planning centers in Costa Rica and Guatemala (Ray 2004, p. xi) [114]. Nunamaker and Lewin 
(1983) [102] is the first published work applying DEA to healthcare, whereas Sherman (1984) [123] 
was the first author to use DEA to evaluate overall hospital efficiency. 
 
The technique was first introduced by Charnes, Cooper, and Rhodes in 1978 [23] and further 
formalized by Banker, Charnes and Cooper in 1984 [9] based on Farrell’s (1959) [45] simple measure 
of firm efficiency that accounted for multiple inputs. Today there is a very extensive DEA literature 
surveyed by O’Neill et al. (2008) [106], who emphasize national differences in hospital efficiency 
research, and Ozcan (2008) [109] who considers many aspects of healthcare delivery, as well as 
providing an overview of existing techniques. Hollingsworth (2008) [64] classifies 317 published 
papers into various subcategories, including parametric techniques such as stochastic frontier 
analysis, and offers comments as to their practical usefulness.  
 
Recent healthcare studies that concentrate on OECD countries include Retzlaff-Roberts et al. 
(2004) [119], who find that countries with less stellar results can also be relatively efficient; 
Varabyova et al. (2013) [131], who use a panel data set and compare parametric and non parametric 
methods for a robustness check; and Cheng and Zervopoulos (2014) [48], who extend their study to 
171 countries and use a directional distance function to incorporate undesirable outputs as well.  
 
A variety of other OECD based studies at the national level include Moscone et al (2013) [121], 
who find a positive impact of scientific research on healthcare, based on a large set of panel data 
spanning from 1960 to 2008. Or et al. [108] also find a positive impact of doctors on infant mortality, 
applying a multilevel analysis. Davies et al. [34] evaluate three dimensions (efficiency, effectiveness, 
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equity) of hospital performance, while Gholami [51] and Nayar et al. [99] question if the tradeoff 
between efficiency and quality is really inevitable. 
 
Many of the other studies focus on the relative performance of health status and the determinants of 
health and healthcare expenditures of the different OECD countries [4-7, 29, 50, 66, 82, 91, 105, 118, 
119]. Lorenzoni [81] elaborates and presents an executive summary of the earlier studies to highlight 
the major differences between the US healthcare system and other OECD countries. Gerdtham et al 
[49] find the income elasticity of healthcare to be greater than 1, resulting in an increased share of 
medical expenditures with rising incomes. 
2 Objectives  
As stressed by Jacobs et al. (2006) [68], efficiency analysis should be based on outcomes of 
healthcare. However, researchers are often forced to study efficiency on the basis of measured 
services like patients treated or hospital discharges. Many of the published studies use health services 
as outputs [8, 35, 117] but some studies include health outcomes as outputs [20, 33, 74, 125], and a 
few include quality, either explicitly [57] or as an explanatory variable [138]. Either approach is 
problematic; since health services as intermediate goods do not tell us whether the patient’s health has 
improved, while the outcomes are not the direct products of the inputs used but of intermediate goods 
in conjunction with other non-discretionary inputs. This critique was summarized in Newhouse 
(1994) [101] and fully discussed in Jacobs et al. (2006) [68], who conclude by suggesting the use of 
multivariate models and multi-stage models [59], where objectives may include quality.  
 
Much of the literature finds diverse results with respect to healthcare efficiency. While there are 
studies that find countries like Turkey with relatively poor health outcomes to be efficient [34, 108] 
others find the opposite results [17, 127]. The problem obviously stems from the output choice 
(services vs. outcomes) and the lack of consistent and reliable quality measurements. Additionally, 
measuring the impact of the environmental factors is also the goal of a growing body of studies with 
diverse implications [16, 62, 84, 107], though they often fail to explain why those inefficiencies occur 
and how to cure them. Our study not only measures but also depicts how much environmental 
variables impact healthcare and shift the production frontier. 
 
Most countries, regardless of their level of development, are inefficient in producing healthcare to 
some degree. However, the kinds of inefficiencies they suffer vary greatly by level of development 
and market structure. Pinpointing the precise type of such inefficiencies with composite effects has 
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important political implications. Also, the conflicting results due to the choice of outputs necessitates 
a more comprehensive multi-stage efficiency analysis, where both health services and health 
outcomes are included in separate stages, controlling for other factors. 
 
Following the seminal model of Färe and Grosskopf (2000) [44], we devise a multi-stage healthcare 
system analysis where first-stage production uses resources to produce health services, which are, as 
intermediate goods, then transformed to health outcomes at the second (provision) stage. 
Additionally, non-discretionary inputs affect both the production and provision stages by shifting the 
frontiers, and therefore need to be measured and controlled for.  
 
There is no study in the literature, to our knowledge, that covers all 34 OECD Countries, in a multi-
stage analysis using national panel data, which also measures the impact of environmental variables 
on health outcomes. As part of this multi-stage analysis, this paper’s main contribution will be to 
pinpoint where exactly and what type of inefficiencies occur, what is the impact of environmental 
variables on health outcomes, and which policies might be used to improve efficiency and health 
outcomes. 
 
Using panel data has several advantages compared to the use of cross-sectional data. Comparing the 
same unit with itself as well as others and creating a richer sample of observed units over multiple 
years provide additional insights and a further check on validity and data accuracy. For pooled 
analysis, such a comparison may allow for increased discrimination among efficient units and the 
inclusion of additional variables.  
 
We are mainly using OECD data [104], which are, for the most part, standardized across fairly similar 
countries; so the quality of the variable measurements, although spotty at times, is relatively good. 
The only non-OECD data are the BMI figures acquired from the World Health Organization as an 
environmental variable. The inclusion of multiple (12) years also serves to give a better picture of 
each country, rather than a one-year snapshot. 
Following the standard procedure, we are using additional variables to control for risk factors, 
outcome quality, and capital intensity, which will be further investigated in the following pages.  In 
order to achieve our goal, we control for non-discretionary inputs, healthcare expenditures, and the 
quality of outputs; and aim to measure inefficiency levels, identify the sources of inefficiency, and 
measure the impacts of environmental variables and healthcare expenditures. 
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3 Methodology 
3.1 Literature 
 
DEA was originally developed to measure the efficiency of a DMU (decision making unit) as a whole 
unit, without considering its internal structure, which was treated as a black box. Within the system, 
inputs are supplied to produce outputs, generally with a positive correlation between the two, but this 
is not always the case [30, 130]. It is often necessary to study the internal structure of a system to 
identify the cause of any inefficiency. 
 
Another issue is that an overall system may be efficient, even when all of its stages are not [70]. 
Although a DMU which is efficient in all stages is also efficient overall, there are cases in which a 
DMU is less efficient in all stages than another DMU, and yet the former still has better system 
efficiency [71]. Similarly, in healthcare production, a DMU inefficient at production can still appear 
efficient in overall outcomes. This is because a) in the case of overuse of health resources, the 
inefficiency in production does not automatically lead to inefficiency in provision; b) constant returns 
in production is often linked with diminishing returns in provision, so a fairly large efficiency loss in 
production will not always result in similar losses in outcomes. 
 
Measuring efficiency in healthcare directly from resources to outcomes does not capture the 
inefficiencies in production. We show in this study that the inefficiency in production remains 
underestimated or simply undetected without a multi-stage analysis, and a network DEA model is 
required to produce correct results when measuring efficiencies. 
 
The first study using this approach is probably Charnes et al. (1986) [24], who observe two stages 
in army recruitment: creating awareness and creating contracts. Separating large operations into 
multiple stages helps identify the real impact of input factors. The simplest case is to separate the 
whole operation into two stages, as in Charnes et al. (1986) and Wang et al. (1997)  [130].  
 
Countless studies that discuss network DEA have been published since Charnes et al. (1986). 
Cook, Liang, and Zhu (2010) [28] reviewed a number of models for the basic two-stage systems, 
connected in series, where the second stage only consumes all the outputs from the first production. 
Castelli, Pesenti, and Ukovich (2010)  [21] reviewed shared-flow, multilevel, and some network 
models. The network models they reviewed are of the general network DEA form developed by Färe 
and Grosskopf (2000) [44], leaving many others untouched. 
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Some examples of basic two stage structure include Yang (2006)  [137] who used the CCR-concept 
model to measure the production and inventory efficiencies of 72 life and health insurance companies 
in Canada. Chen and Zhu (2004)  [26] used a process distance measure model to find the input 
efficiency of process one and the output efficiency of process two, composing a system efficiency 
with the given weights. This idea is widely discussed in the literature. Chen, Cook, and Zhu (2010)  
[27] applied a system distance measure model to measure the system efficiency of a basic two-stage 
system. The paper is also able to project the efficient intermediate product, which is also what we do 
in the first stage of our analysis. 
 
Kao and Hwang (2011)  [72] use a BCC input model [9] to measure the scale efficiency of the first 
process and an output model to measure efficiency for the second process, decomposing the system 
efficiency into the product of the technical and scale efficiencies. Kao and Hwang (2013) [73], on the 
other hand,  study the performance changes of a basic two-stage system by using the relational model. 
They show that the Malmquist productivity index [MPI, 83] of the system is the product of those two 
processes. Chen, Cook, Li, and Zhu (2009)  [25] set weights for each of the processes in a two stage 
structure, resulting in an aggregate efficiency measure, which is called an additive model in the 
literature. 
 
Our study is best described as a “General two stage-structure”, which is an extended form of basic 
two stage models, allowing both stages to consume exogenous inputs supplied from outside and to 
produce final outputs. Examples include Simon, Simon, and Arias (2011)  [124] who analysed the 
productivity growth of 34 Spanish university libraries using an MPI or Löthgren and Tambour (1999) 
[80], who included customer satisfaction in studying the performance of 31 Swedish pharmacies. 
 
Färe and Whittaker (1995) [41] developed an output-oriented distance measure model to evaluate 
137 US dairy farms, while. Färe and Grosskopf (1996)  [42] proposed a similar model with the MPI 
also being calculated. Lozano, Gutierrez, and Moreno (2013)  [79] used a directional distance 
function to study the performance of 39 Spanish airports. 
 
Premachandra, Zhu, Watson, and Galagedera (2012)  [110] extended the additive model of Chen, 
Cook, et al. (2009) for the basic two-stage system to allow for exogenous inputs for the second stage 
in studying the performance of 66 large mutual fund families in the US. Guan and Chen (2012)  [54] 
used the same model to measure the innovation efficiency of 22 OECD countries, with the 
assumption of constant returns to scale. 
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There are more complicated cases with more than two stages and in different structural forms such 
as a series structure, a parallel structure, or a mixture of these, which are collectively called “network 
structures”. The DEA technique to measure the efficiency of systems with a network structure is 
called “network DEA” (Färe & Grosskopf, 2000) [44]. 
3.2 Output-oriented two-stage Model 
As we are using panel data in this study, each yearly data point for each country is treated as a 
separate Decision Making Unit (DMU); e.g. the year 2000 data point for the US is an entirely 
different DMU than the US data point for 2001. We are assuming non-regressive technology, which 
implies that a currently available technology will also be available to all future DMUs, but was not 
available to the past ones. This assumption requires control for technological progress over time and 
can be done by the in/exclusion of the relevant firms.  
An important methodological decision in DEA is whether to apply constant or variable returns to 
scale. The first nonparametric models for efficiency estimation by Charnes et al. (1978) [23] assumed 
constant returns to scale (CRS). Later, Banker et al. (1984) [9] relaxed the CRS assumption to account 
for firms that do not operate at their optimal scale, allowing VRS.  
Although it is generally accepted that the production stage exhibits CRS, the provision of health 
services demonstrates VRS, and most OECD countries operate at a sharply diminishing returns 
region. In other words, although doubling of all resources will lead to doubling of health services 
(CRS), this will not necessarily lead to a similar increase in health outcomes (VRS). Therefore, the 
OECD healthcare system exhibits CRS in production but VRS in the provision stage and as a whole. 
The model consists of two output-oriented stages. For each DMU, the first stage measures the radial 
(equiproportional) efficiency levels of production under CRS, and obtains the efficient services (y*) 
that should have been produced. The second stage, on the other hand, measures the non-radial 
efficiency levels of provision under VRS with desirable and undesirable health outcomes, due to 
countries improving asymmetrically in their health outcomes. This stage alternatively uses the actual 
(y) and efficient (y*) quantities of services as inputs to measure the second stage (β2) and overall (β) 
inefficiency levels, respectively, which allows us to also derive the first stage inefficiency (β1). 
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Weights are adjusted to be proportional to their impacts on the outcomes in terms of years of life lost 
and normalized to have equal impacts for comparable changes. For example, a 1% change in life 
expectancy at birth of an 80 year average is equivalent to a 4% change in life expectancy at age 65 of 
a 20 year average, which requires a relative weight of 4 to 1 (80 to 20) respectively.  
Graph 1 – Multi-Stage Healthcare System 
 
3.3 Model Specification  
DEA relies on a number of fairly weak assumptions to construct the production technology but avoids 
any explicit functional relationship between the inputs and outputs through a production function 
[32]. These assumptions are summarized below. Let Ψ be the feasible set: 
 
a) all observed input-output combinations are possible; (x1, y1) ∈ Ψ. 
b) the production possibility set is convex; Let α ∈ [0, 1]; If (x1, y1), (x2, y2) ∈ Ψ, then (x, y) = 
α(x1, y1) + (1−α)(x2, y2) ∈ Ψ. 
c) inputs and outputs are freely disposable; Let x2 ≥ x1, and y2 ≤ y1. If (x1, y1) ∈ Ψ then (x2, y1) ∈ 
Ψ and (x1, y2) ∈ Ψ 
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First Stage 
Let (xi, yi) represent the input-output bundle of a firm i, assuming input-output bundle observed for N 
firms. Then given the aforementioned assumptions, the CRS production possibility set is  
)},....,3,2,1(;0; y; x y); {(x, T ic Niyx i
N
i
ii
N
i
ii     {i} 
By measuring the radial (equiproportional) efficiency levels of production under constant returns to 
scale (CRS), we obtain the efficient services (y*) that should have been produced. However, the 
convexity and the scalability of the control variables need to be addressed, because the quality (or 
risk) does not scale like the actual outputs, and these controls are subject to VRS by definition, which 
further requires the condition 1
N
i
i  for controls, where qik  is the control k for DMU i.  
The output-oriented radial efficiency of a DMU s:  
)
  1
1
( )y,(x TE
s
ss 
 , where ))1(,(:)(maxs ss yx   ∈ Tc {ii} 
The standard DEA LP problem solved to estimate the efficiency of DMU s, relative to 
contemporaneous CRS frontier is 
Objective: Max θ,    where θ: Radial Output inefficiency, subject to  {iii} 
 ∑λi xij ≤ x0j        j = 1…3     (Input constraint) (1) 
 ∑λiyik ≥ (1 + θ) y0k          k = 1…3    (Output constraint) (2) 
 ∑λi qi1  ≤  qs1                    (Quality constraint with undesirable outcome)        (3) 
 ∑λi qi2  ≥  qs2                    (Risk factors fused into one variable)   (4a) 
 ∑λi qi3  ≥  qs3                    (Control for inequality) (4b) 
 λi ≥ 0,    (5) 
In the maximization problem above (Max θ), constraints (1), (2), and (5) ensure that the benchmark 
unit created from the convex combination of actually observed data points does not use any more 
inputs (resources) than the comparison unit while producing θ* y0k more outputs (services), where the 
θ is the radial inefficiency rate for all outputs. If θ equals 0, then the unit appears efficient in 
producing at least at one output, given the observed data. The inclusion of undesirable output (3) in 
the first stage, first popularized by FGLP89 [38] and FGLY93  [39], acts like a control variable and 
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ensures that the benchmark unit created from the convex combination of reference DMUs, which 
produce θ* y0k more output, has at least the same quality of healthcare. However, the convexity and 
the scalability of the control variables need to be addressed, because the quality (or risk) does not 
scale up or down like the actual outputs, and these controls are subject to VRS by definition.  
Among the various ways to incorporate environmental variables into the DEA framework, we use 
Ruggiero’s 3-stage method [116] to consolidate multiple risk factors into one risk variable (4a), as it 
performed best in virtually all scenarios, being the only model robust to sample size and the number 
of nondiscretionary variables [96], when compared to the other common methods such as Ray (1991) 
[113], Muñiz (2002) [95] and Banker and Morey [10]. The original DEA model without the risk 
factors (4a) is solved and the second-stage regression on the risk factors is performed. Let θ̂ be the 
estimated inefficiency regressed on the risk factors: 
θ̂ = qi2 = α + γ1 r1 + γ2 r2+ γ3 r3+ ε    {iv} 
After construction of qi2 (the combined patient-risk control) from estimating the first inefficiency, the 
model {iii} is solved again. Finally, inequality of access to healthcare enters the problem as yet 
another environmental variable that needs to be controlled for in the model. This is represented in the 
equation (4b), in a similar fashion to the risk factors, but introduced separately.    
Second Stage 
Let (yi, zi) represent the input-output bundle of a firm i, assuming input-output bundle observed for N 
firms. Then given the aforementioned assumptions, the VRS production possibility set is  
)},....,3,2,1(;0;1; z;y  z); {(y, T iv Nizy i
N
i
i
N
i
ii
N
i
ii      {v} 
By measuring the non-radial efficiency levels of provision under variable returns to scale (VRS), we 
obtain the efficient outcomes (z*) that should have been produced. The output-oriented non-radial 
efficiency of a DMU s:  
)
  1
1
( )z,(y TE
s
ss 
 , where ))1(,(:)(max
3
1
kss skkks
k
kkk zyww   

∈ Tv {vi} 
The standard DEA LP problem solved to estimate the efficiency of DMU s, relative to 
contemporaneous VRS frontier is, 
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Objective: Max β = ∑wk* βk,   (β: weighted non-radial outcome inefficiency) 
 subject to   {iii} 
 ∑λi*yij ≤ y0j         j = 1…3     (Input constraint) (1) 
 ∑λi*zik ≥ (1 + βk) * zsk     k = 1, 2      (Desirable Output constraint) (2a) 
 ∑λi*zik ≤ (1 - βk) * zsk      k = 3           (Undesirable Output constraint) (2b) 
 ∑λi*qi1  ≤  qs1                                       (Per capita health expenditure)        (3) 
 ∑λi*qi2 ≥  qs2                                        (Risk factors fused into one variable)   (4a) 
 ∑λi*qi3 ≥  qs3                                        (Control for inequality) (4b) 
 λi ≥ 0,     ∑λi = 1                                   (Variable Returns to Scale) (5) 
At the second stage, we measure the non-radial efficiency levels of provision under VRS (6) with 
desirable (2a), and undesirable (2b) outputs (health outcomes). In the maximization problem above 
(Max β), constraints (1), (2a), (2b), and (5) ensure that the benchmark unit created from the convex 
combination of actually observed data points does not use any more inputs (services) than the 
comparison unit while producing βk* z0k more of desirable and less of undesirable outputs, where the 
βk is the non-radial inefficiency rate for output k, and β = ∑wk* βk is the weighted non-radial 
outcome inefficiency. If βk equals 0 then the unit appears efficient at that specific individual output 
given the observed data. However, this does not mean the unit produces the best possible amount for 
all outputs, as β = ∑wk* βk may still be greater than zero, implying inefficiency in other outputs. 
The inclusion of healthcare expenditures (3) ensures that the benchmark unit is not any more capital 
intensive than the evaluated unit, which is also a proxy for its technological level. Finally, the controls 
for multiple risk factors and inequality of access to healthcare in the first stage are repeated (4a, 4b).  
3.4 Decomposition of Inefficiencies and Impact of Environmental Variables  
In the model, we initially decompose β (outcome inefficiency) into two parts. As in Chen, Cook, and 
Zhu (2010)  [27], the overall efficiency is defined as the product of efficiencies in two consecutive 
stages. Let “1 + β = (1 + β1) * (1 + β2)” where,  
β1: Outcome inefficiency of production,            β2: Outcome inefficiency of provision 
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Using the actual health services as given in the model implicitly assumes the first stage production is 
fully efficient and will only yield β2, the outcome inefficiency of provision. Using the efficient health 
services obtained from the first stage as the inputs, on the other hand, implies no such assumption, 
and yields the total outcome inefficiency (β), from which, β1 can easily be derived. However, it 
should be noted that this decomposition, which allows us to distinguish between the first (production) 
and second (provision) stage inefficiencies, will not be precise due to the non-radial approach adopted 
in the second stage, compared to the radial approach in the first.  
Further relaxing the controls in the model, equations (3), (4a), and (4b), and alternating between the 
actual (y) and efficient (y*) levels of services as inputs allow us to gauge the separate and composite 
effects of the risk factors, inequality, and inadequate expenditure levels on the healthcare outcomes. 
Dropping constraint (3), for example, yields (1 + β) * (1 + β3) with y* as inputs, but (1 + β) * (1 + β3-
2) with y, from which β3-1 can easily be derived. 
Let 1 + Φ = (1 + β) * (1 + β) = (1 + β1) * (1 + β2) * (1 + β3) * (1 + β4), where  
Φ: Total Outcome Loss,  
β: Loss from healthcare inefficiency, and 1 + β = (1 + β1) * (1 + β2) 
            β1: Loss from production inefficiency            β2: Loss from provision inefficiency 
β: Loss from environmental factors, and 1 + β = (1 + β3) * (1 + β4) 
            β3: Loss from risk factors and inequality            β4: Loss from inadequate expenditure 
Different controls enable us to further decompose the impact of environmental variables.  
Let (1 + β3) = (1 + β3-1) * (1 + β3-2) where, Impact of risk factors and inequality, 
            β3-1: on production             β3-2: on provision 
Likewise, let (1 + β4) = (1 + β4-12) * (1 + β4-3) where, Impact of inadequate expenditure, 
            β4-12: on healthcare system,    β4-3: on environmental variables 
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We will further decompose the impact of inequality and risk factors when necessary. Such detailed 
decomposition will not only help us pinpoint where exactly the inefficiencies are, but also what type 
of inefficiencies and what policy implications each country faces. 
3.5 Illustration of the Model 
 
Graph 2 – Decomposition of Inefficiencies 
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4 Data 
Data used in this study are obtained from the Organization for Economic Cooperation and 
Development (OECD) Health Data 2013 [141], which is the broadest source of comparable statistics 
on diverse health systems across OECD countries. The sources and methods of data collection are 
described in detail in the OECD documentation [60]. 
Because countries are not uniform in their reporting practices and not all variables are recorded each 
year, some adjustment of OECD data is unavoidable and common in OECD studies [106, 141]. 
Similarly, in this study, linear interpolation is applied to impute missing values in the time-series for 
particular countries, meaning some of the gaps are filled with average estimates (5-10% of the data 
points).  
The dataset consists of 34 OECD countries and 12 years between 2000 and 2011 for a total of 408 
DMUs. However, the number of included DMUs in the measurements varies by year for a minimum 
of 5 years (170 DMUs) and up to 11 years (378 DMUs) in order to control for technical change 
through time, with the assumption of non-regressive technology. 
Variables  
The variables used to determine efficiency include: Resources, health Services, health 
outcomes, quality of outputs, healthcare expenditures per capita, patient risk characteristics, 
inequality of access to healthcare (See the table 1). 
4.1 Resources (First Stage Inputs): The inclusion of physicians, nurses and hospital beds is pretty 
much standard across most healthcare studies [64, 106, 108, 109] and there is significant homogeneity 
in the data as well.  
4.2 Health Services (Intermediate Products): We use three of the most commonly used hospital 
services, namely doctor consultations, hospital discharge rates, and patient days, as the intermediate 
goods [64, 106, 109], or in other words, the outputs of the first stage, later to be used as inputs of the 
second stage. Because their homogeneity varies and effectiveness on health status depends on 
environmental variables, we control for per capita healthcare expenditure as a proxy for capital 
intensity, in addition to risk factors, and inequality. 
4.3 Health Outcomes (Final Outputs): We use three of the most commonly used health outcomes as 
our outputs of the provision stage [64, 106, 109]. Life expectancy at birth is a good proxy for general 
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healthcare, and life expectancy at age 65 is a better proxy for senior and chronic healthcare, while 
infant mortality is particularly useful to measure more basic and youth healthcare efficiency. 
4.4 Quality of Health Services (First Stage Control): We use Potential years of life lost (PYLL)1 as 
a proxy for service quality at the first stage. It is defined as “a summary measure of premature 
mortality which provides an explicit way of weighting deaths occurring at younger ages, which are, a 
priori, preventable” [142].  
4.5 Per capita Health Expenditures (Second Stage Control): We use healthcare expenditure per 
capita at the second stage, as a proxy for capital intensity and technology level. Both total and public 
health expenditures are employed for robustness checks.  
4.6 Patient-risk Characteristics (General Control): There are three highly standardized and 
commonly used risk characteristics defined in the OECD data set, namely tobacco and alcohol 
consumption, and obesity. Data regarding tobacco and alcohol consumption have been obtained from 
the OECD web site while, the BMI figures, as a proxy for overweight population, were obtained from 
the WHO data set [140]. 
4.7 Inequality of Access to Healthcare (General Control): We use the Gini coefficient and 
alternatively poverty rates for each country as a proxy for inequality of access to healthcare. Although 
not a perfect match, the Gini is a sufficient indicator of healthcare inequality. There are various 
studies in the literature that show clear negative correlations between socioeconomic inequality and 
access to healthcare, both globally [135] and within a country [61]. We find that this correlation is 
stronger in privately oriented healthcare systems. 
4.8 Variables not included in the study: In this study, we have only included the control variables 
that have direct effects on healthcare, in order to avoid diluting the results with too many control 
variables causing underestimation of inefficiency. However, there are other variables that are also 
commonly included in the literature, such as education, income, and to a lesser extent, homicide and 
suicide rates. For instance, we indeed find the homicide and suicide rates [65] to be statistically 
                                            
1 The calculations for PYLL involve adding up deaths occurring at each age and multiplying this with the number of remaining years to live 
up to a selected age limit. The limit of 70 years has been chosen for the calculations in OECD Health Data.  
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significant, but the inclusion of such controls, with the exception of Mexico, does not substantially 
affect the results, since the differences in the rates across OECD countries are small in absolute terms. 
 
The existence of an “education gradient” on health outcomes is widely accepted in the literature [31], 
though it is not clear why this is the case. As Lochner (2011) [78] suggested, the literature has 
produced mixed results, and most studies fail to address the endogeneity of education and health 
behaviors in regressions. Basically we attempt to control for all channels, through which education 
can affect the data. Simply put, individuals with better education also tend to be richer (poverty rates), 
behave better and take better care of themselves (risk factors), and spend more money on healthcare 
(per capita health expenditure). Additionally, the education levels alone are usually not the primary 
factor in health outcomes. Eastern European countries, for example, often suffer from poor health 
outcomes though they are among the most educated nations. This anomaly is primarily seen as a 
“development” issue [2, 3, 111]. 
 
Table 1 - Variables 
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5 Results 
5.1 Inefficiency over time 
Table 8 – OECD Health Outcome Inefficiency over Time 
 The results indicate that the OECD health 
outcome inefficiency is relatively stable, around 
3% over time. Our baseline control with total 
per capita health expenditure and Gini for 
inequality indicates a slight increase in 
inefficiency by 0.28%. This analysis is 
replicated with the use of poverty rates instead, 
yielding a similar 0.44% increase in inefficiency 
and almost identical trend over the years. Using 
public healthcare expenditures, on the other 
hand, produced somewhat different results. The 
average inefficiency is slightly greater at around 3.3%, showing a decrease in inefficiency of 0.35% 
instead, although the general trend is virtually the same.  
Graph 1 – OECD Inefficiency over the Years 
 
  Inefficiency over the years 
OECD 
Total HC 
Exp. & Gini 
Total HC Exp. 
& Poverty 
Public HC Exp. 
& Gini 
2011 3.08% 3.12% 3.14% 
2010 2.96% 3.00% 3.04% 
2009 3.09% 3.13% 3.28% 
2008 2.98% 2.99% 3.04% 
2007 3.11% 3.09% 3.25% 
2006 2.91% 2.94% 3.11% 
2005 2.97% 3.00% 3.19% 
2004 3.06% 2.99% 3.36% 
2003 3.42% 3.38% 3.87% 
2002 3.17% 3.02% 3.62% 
2001 2.79% 2.67% 3.50% 
Average 3.05% 3.03% 3.31% 
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This result may reflect the increasing share of public expenditures in healthcare [60], as public 
expenditure is often found to be more efficient than private in the literature [49]. This is likely why 
the trend is reversed with the inclusion of the relatively less efficient private expenditures.  
However, the change in inefficiency levels is not homogenous across the board. Some countries such 
as Estonia, Ireland, and Portugal have seen remarkable improvements in their healthcare efficiencies 
while some others such as Finland, Slovak Republic, and Turkey became less efficient, probably 
because these countries had a hard time adjusting to the drastic changes in the healthcare sector [17, 
127]. 
5.2 Decomposition of Inefficiency  
Both life expectancy at birth and at age 65 replicate the overall trend, albeit at different levels. 
Inefficiency levels for life expectancy at birth hover around 1.8%, regardless of whether the Gini or 
poverty rate is used as a control. Controlling for public expenditures, however, leads to a noticeable 
rise in average inefficiency, to around 2%. Life expectancy at age 65 yields around 5% inefficiency 
across the board, also resulting in a similar rise in inefficiency with the use of public expenditures for 
control. Overall, controlling for total expenditure shows a fairly stable trend while public expenditures 
show a slight decrease in inefficiency, with similar fluctuations in both cases.  
 
Table 9 & 10 – OECD Inefficiency Life Expectancy at Birth & Age 65 
 
 Table 9 
Inefficiency in Life 
Expectancy at Birth   Table 10 
Inefficiency in Life 
Expectancy at age 65 
OECD 
Total HC 
Exp. & 
Gini 
Total HC 
Exp. & 
Poverty 
Public 
HC Exp. 
& Gini   OECD 
Total HC 
Exp. & 
Gini 
Total HC 
Exp. & 
Poverty 
Public 
HC Exp. 
& Gini 
2011 1.71% 1.71% 1.84%   2011 4.76% 4.72% 4.95% 
2010 1.79% 1.80% 1.92%   2010 4.99% 5.00% 5.25% 
2009 1.74% 1.74% 1.92%   2009 4.74% 4.70% 4.97% 
2008 1.74% 1.72% 1.78%   2008 4.62% 4.59% 4.56% 
2007 1.77% 1.74% 1.90%   2007 4.87% 4.83% 5.08% 
2006 1.61% 1.63% 1.75%   2006 4.50% 4.56% 4.78% 
2005 1.74% 1.75% 1.94%   2005 4.94% 4.97% 5.25% 
2004 1.82% 1.80% 2.06%   2004 4.99% 4.90% 5.58% 
2003 2.02% 2.01% 2.34%   2003 6.28% 6.15% 6.86% 
2002 1.83% 1.80% 2.15%   2002 5.78% 5.61% 6.50% 
2001 1.62% 1.57% 2.13%   2001 4.59% 4.37% 5.99% 
Average 1.76% 1.75% 1.97%   Average 5.01% 4.95% 5.43% 
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Graph 3 – OECD Inefficiency Rates for Life Expectancy at Birth 
 
Graph 4 – OECD Inefficiency Rates for Life Expectancy at aget 65 
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The results show that it is infant mortality that has 
exhibited a rise in the overall inefficiency, with 
consistency across different controls. We are using 
the actual number of deaths here, rather than 
percentages to avoid distortion on the relative 
magnitudes. 
 
Infant mortality inefficiency increases from around 
0.8 to over 1 death (per 1000) between 2001 and 
2011. The results show that although technology has 
rapidly increased, healthcare systems are still trying 
to catch up to the new frontiers, resulting in lower 
efficiency rates, which is expected given the rapid developments in this field. This is a classic 
example of rising productivity with diminishing efficiency. 
 
Graph 5 – OECD Inefficiency Rates for Infant Mortality 
 
Table 11 
Inefficiency in Infant Mortality 
(number of deaths) 
OECD 
Total HC 
Exp. & 
Gini 
Total HC 
Exp. & 
Poverty 
Public 
HC Exp. 
& Gini 
2001 0.78 0.72 0.85 
2002 0.82 0.73 0.89 
2003 0.86 0.84 0.97 
2004 0.87 0.81 0.97 
2005 0.85 0.86 0.89 
2006 0.97 0.97 1.01 
2007 1.00 0.99 1.03 
2008 0.93 0.90 0.96 
2009 1.06 1.06 1.09 
2010 1.00 1.00 0.97 
2011 1.04 1.10 0.98 
Average 0.93 0.91 0.96 
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5.3 Production vs. Provision Inefficiency 
 
The major advantage of a multi-stage efficiency 
analysis is to be able to see the contribution of each 
stage to inefficiency. Our analysis reveals that the 
lion’s share of inefficiency is in provision; about 
79% of the efficiency loss occurs at the provision 
stage, leaving 21% for the production inefficiency. 
This would not be detected in a traditional single 
stage analysis, and would lead to a significant 
underestimation of the inefficiency. Production 
inefficiency, however, is a major issue for some 
countries. More than 60% of inefficiency in the 
U.S., for example, comes from production, in stark contrast to the OECD trend.  
 
A notable result of the study is that the countries that suffer from production inefficiency are mostly 
Nordic or English speaking countries, where relative price levels tend to be higher [76], in addition to 
Mexico and Portugal.  
 
Provision efficiency is similar to the term “effectiveness” in the literature [55, 97, 134], although it is 
defined in terms of health services, rather than resources. As mentioned earlier, a multi-stage analysis 
is required to distinguish whether the inefficiencies are a result of the production or provision of the 
services. That being said, provision efficiency depends primarily on: 
 Quality of health services: Although we control the benchmark unit to have equal or better 
quality, the evaluated country is still allowed to produce lower quality services, which will 
manifest itself as inefficiency in provision. 
 Social institutions and culture: The greatest divide between countries is likely to be the social 
institutions [128] that interactively affect the collective behaviours of individuals. The notoriously 
low life expectancy for males in Eastern European countries is a major example of this kind of 
behavioural patterns. 
 Development level: As Acemoglu argues [2, 3], better institutions lead to higher growth and 
development, which directly or indirectly affects the duration and quality of life as Preston 
showed [111].  
 Other environmental variables that are not directly covered in this study, such as education. 
 Table 12 Inefficiency over the years 
OECD β1 + β2 β1 β2 
2011 3.08% 0.69% 2.37% 
2010 2.96% 0.76% 2.19% 
2009 3.09% 0.76% 2.32% 
2008 2.98% 0.62% 2.35% 
2007 3.11% 0.63% 2.47% 
2006 2.91% 0.52% 2.38% 
2005 2.97% 0.47% 2.49% 
2004 3.06% 0.56% 2.48% 
2003 3.42% 0.63% 2.77% 
2002 3.17% 0.72% 2.44% 
2001 2.79% 0.69% 2.09% 
Average 3.05% 0.65% 2.39% 
Share of Inefficiency 21.31% 78.69% 
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5.4 Impact of Environmental Variables on Health Outcomes 
 
                    Graph 7 – Outcome Losses 
  
Production inefficiency 
(β1) is responsible for 21% 
of the total inefficiency and 
about 12% of the total loss 
in health outcomes in 
OECD countries although 
it is much more significant 
for some countries than 
others. 
 
Provision inefficiency (β2) 
is responsible for 79% of 
the total inefficiency and 
over 43% of the total 
outcome loss, and is the 
single most important 
source of inefficiency, 
affecting most of the 
OECD countries. 
 
Risk factors and inequality also play a significant role in outcome losses. About 2.65% of outcome 
loss is due to environmental variables’ impact on production (β3-1), and a further 7.2% is due to 
provision (β3-2). Together, these are responsible for about 10% of the total outcome loss (β3).  
 
Insufficient healthcare expenditure is an even more important factor in explaining the further outcome 
losses. Increasing expenditures on the healthcare system will reduce the outcome losses by 26%, (β4-
12) while allocating more resources to improve the environment will reduce the losses by over 9%, 
totalling up to a staggering 35% (β4). This is especially true for poorer countries like Estonia, 
Hungary, Poland, and Turkey, as well as, for Greece, Israel and Korea. 
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Although we see a slight increase in the average inefficiency levels (from 2.8% to 3.1%) between 
2001 and 2011, the outcome losses are offset by the gains from the improvement of the environmental 
factors, staying flat at around 3.5%. This is most likely a result of reduction in the smoking rates and 
better healthcare coverage. Moreover, inclusion of the impact of insufficient healthcare expenditures 
shows a substantial decrease in outcome losses from 6.3% to 5.1%.  
Rising expenditures, especially in the less developed countries, led to huge outcome gains. This is 
particularly true for some Eastern European countries like Estonia, which not only considerably 
improved its inefficiency levels from 2.7% in 2001 to 0.5% in 2011, but also further decreased the 
health outcomes losses by 7% through higher healthcare expenditures. A similar success story can be 
told about Ireland, which mostly eliminated its healthcare inefficiency (from 6.3% to 0.7%) and 
further reduced the outcome losses by increasing expenditures. 
Not all OECD countries share the same kind of success stories though. Mexico suffers both from 
higher inefficiency and even worse expenditure losses, resulting in a 4.8% point increase in outcome 
losses. Turkey, on the other hand, experiences mixed results. The inefficiency level skyrockets by 
6.7% point though the increasing healthcare expenditures keep the outcome losses at only 1.9% point. 
The recent healthcare reform in Turkey [17, 127] clearly needs time to take hold and deliver 
improvements.  
5.5 Impact of the inequality and poverty 
 
We see a small but statistically significant impact of inequality on overall OECD health outcomes. 
However, a closer look at the individual countries reveals a very different picture (Table 11). 
Particularly the English speaking countries, where private markets are the norm, seem to be 
significantly affected by social inequality. The US, for instance, suffers an additional 2.37% outcome 
loss from inequality, followed by the UK (1.18%) and Australia (0.68%). 
This impact can also be decomposed into separate outcomes. The impact is replicated in life 
expectancy at birth and especially in infant mortality, with similar characteristics, although the US 
seems to be the only country that is negatively affected in terms of life expectancy at age 65. This 
implies that the systems in those countries create some barriers in access to healthcare, rather than the 
systems themselves being lower quality. Private systems are inherently more susceptible to inequality, 
with relatively higher medical prices, and our results here confirm the higher inequality leads to 
overall worse results. 
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Table 13 - Countries Ordered by the Impact of Inequality on Health Outcomes 
 
 
As shown on graph 6, the impact of inequality is far from homogeneous. Considering the US as our 
prime example, about a 15% reduction in Gini (to 0.32, upper end of the EU spectrum) would be 
sufficient to prevent most of the losses. Life expectancy at age 65 would tolerate even a higher 
inequality around 0.34. Infant mortality, however, is the main source of outcome losses and very 
susceptible to inequality. It would benefit until the Gini drops down to 0.28, near the most egalitarian 
European nations. Using the poverty rates instead of the Gini after necessary scale adjustments yields 
very similar results. It should be noted that about a one-third reduction in Gini halves the expected 
poverty rates2.    
Market structure is the main factor in the US, with phenomenally high prices and the lack of universal 
coverage. However, a diverse immigrant population, as in other English speaking nations, also seems 
to play a role in these outcomes. In other countries, on the other hand, universal healthcare and a 
greater share of public resources seem to cushion the impact of social inequality. 
Chile is a curious example, given its track record of the highest Gini in OECD. The country does not 
seem to be affected by the high degree of inequality, or we simply cannot show an impact within this 
study. Either way, the impact, if it exists, cannot be substantial, considering the country’s results are 
comparable with those of the US, although they operate with far fewer resources, under much worse 
environmental conditions.  
 
                                            
2 OLS: Slope : 0.61, R2 : 0.777, significant at 99.9%  
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Graph 10 – Impact of Inequality on Life Expectancy at Birth and 65 
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Graph 11 – Impact of Inequality on Overall Efficiency and Infant Mortality 
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5.6 A closer look at the healthcare expenditures 
The PPP-adjusted average health expenditure in OECD between 2000 and 2011 was $2669 per capita, 
while the efficient unit spends only $2425 on average, or 90.9% of the actual figure. This is not, 
however, a measure of cost efficiency, as we do not have the price data for each country-year and 
implicitly assume equal prices across the board. However, it is still a helpful figure as countries are 
only contrasted against similar countries, and the figures do not seem to be unreasonable.  
The analysis suggests that Australia, for instance, should cut their spending by a mere 3.5% to be 
considered efficient along with a 1.94% increase in outcomes. However, lower spenders like the 
Czech Republic and Hungary, as well as Greece and Korea, should maintain their expenditure levels 
and focus on improving their outcomes. The largest anomaly is the US, which should decrease its 
expenditure levels from an average of $6812 to merely $2871, which is very unlikely given the price 
levels. An earlier study [89] suggests that the US is actually spending less than Germany with the 
normalized medical prices. So it is not that the US is too cost inefficient, it is just that the US market 
produces too high a level of prices resulting in under-production of services. 
Table 14 – Summarized Impact of OECD Inefficiency and Environmental Variables  
OECD 2000-2011 
Averages 
Actual 
Outcome 
Efficient Outcomes 
b1 b1b2 b1b2b3 b1b2b4 b1b2b3b4 
Life Exp. at Birth 78.61 78.92 79.98 80.17 80.67 81.02 
Years of Loss   0.32 1.38 1.56 2.06 2.42 
Life Exp. at 65 18.29 18.48 19.18 19.29 19.61 19.80 
Years of Loss   0.19 0.89 1.01 1.32 1.52 
Infant Mortality 5.22 5.01 4.47 4.24 4.13 3.72 
Number of Deaths   0.21 0.75 0.98 1.10 1.50 
Expenditure 2,669 2,425 2,442 2,814 2,917 
Percent of Actual 100.0% 90.9% 91.5% 105.4% 109.3% 
Table 15 – Summarized Impact of US Inefficiency and Environmental Variables 
US 2000-2011 
Averages 
Actual 
Outcome 
Efficient Outcomes 
b1 b1b2 b1b2b3 b1b2b4 b1b2b3b4 
Life Exp. at Birth 77.66 79.89 80.79 81.38 80.79 81.38 
Years of Loss   2.23 3.13 3.72 3.13 3.72 
Life Exp. at 65 18.29 19.72 19.77 19.96 19.77 19.96 
Years of Loss   1.43 1.48 1.67 1.48 1.67 
Infant Mortality 6.68 6.20 4.59 2.71 4.59 2.71 
Number of Deaths   0.47 2.09 3.96 2.09 3.96 
Expenditure 6,812 2,781 3,221 2,781 3,221 
Percent of Actual 100.0% 40.8% 47.3% 40.8% 47.3% 
113
   
CAN BEKAROGLU - UNIVERSITY OF CONNECTICUT 
  
Removing the expenditure constraint overall raises the suggested average expenditure to $2814, or 
105.4% of the actual number. Improving the environmental variables requires additional funds, 
arriving further at $2917, or 109.3% of the actual. This implies potential room for higher 
expenditures, even if the systems were efficient, especially for the low spenders like Turkey, which is 
suggested to more than double its expenditures from $722 to $1871. This figure rises to $2161 when 
the environmental development is also taken into account.  
Table 14 summarizes the impact of inefficiency and environmental variables as well as the efficient 
expenditure levels at price parity across the OECD, while Table 15 is US specific for comparison. For 
a detailed report for all other countries, please see the appendix. 
5.7 Scaling up the Resources and Health Services 
DEA allows us to construct a health outcomes frontier to investigate the impact of increasing 
resources on health outcomes with the given observations and technology level. Scaling up the actual 
services will draw the frontier for the “actual production” while scaling directly the resources will 
implicitly assume “efficient production”, resulting in a higher frontier. The difference comes down to 
the production inefficiency at different resource levels. 
 
Graph 12 –Scaling up the Resources and Services - OECD 
 
Allowing for 10% increase intervals under Variable Returns to Scale (VRS) in the provision does not 
necessitate such an increase if such observations are not in the data set. As a result, allowing a 
cumulative 100% increase only required a 38% radial increase in resources.  A closer look at the 
resource use shows us that doctor consultations is the binding constraint here, and OECD countries 
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would especially benefit from a greater number of consultations, along with an 18% in patient days, 
while number of discharges was mostly not a binding factor. 
The efficient frontier results in a 2.49 percentage point increase in health outcomes, rising from 
3.07% to 5.56% while the actual frontier brings in a 2.95 percentage point improvement, from 2.37% 
to 5.32%. Additional resource use seems to reduce the gap, as the efficient and actual production 
frontiers converge due to diminishing returns in provision. 
 
Graph 13 –Scaling up the Resources and Services - US 
 
The general OECD trend can be very different from the individual trends, especially if the bulk of the 
inefficiency of the country in question is in production. There is a substantial difference between the 
actual and efficient frontiers of the US (see Graph 8). The large inefficiency in US production (close 
to 44% under-supply in 2011) leads to huge outcome losses. US healthcare production is so highly 
supply-constrained that even a 10% boost in US resources and health services would eliminate half 
the outcome inefficiency from production, or 1/3 of total inefficiency, benefiting from every drop of 
extra services. At further levels, the efficient and the actual frontiers seem to converge due to sharply 
diminishing returns to scale. 
. 
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Table 16 – Maximum Production Scale 
1 Australia 1.70 18 Japan 1.04 
 2 Austria 1.00 19 Korea 1.00 
3 Belgium 1.00 20 Luxembourg 1.03 
4 Canada 2.00 21 Mexico 2.00 
5 Chile 2.00 22 Netherlands 2.00 
6 Czech R. 1.17 23 N. Zealand 2.00 
7 Denmark 1.37 24 Norway 1.17 
8 Estonia 1.00 25 Poland 1.46 
9 Finland 1.49 26 Portugal 2.00 
10 France 2.00 27 Slovak Republic 1.44 
11 Germany 1.00 28 Slovenia 1.00 
12 Greece 1.81 29 Spain 2.00 
13 Hungary 1.78 30 Sweden 2.00 
14 Iceland 1.00 31 Switzerland 2.00 
15 Ireland 1.65 32 Turkey 2.00 
16 Israel 1.97 33 UK 1.77 
17 Italy 2.00 34 US 2.00 
 
Table 16 shows the maximum production scaling of the individual OECD Countries for 2011. 
Countries with a “1.00” scaling have abundant services produced and would not benefit from 
additional services under VRS. Most resource-scarce countries with a “2.00” scaling, on the other 
hand, would significantly benefit from increasing the amount of services at least at one category. 
Other countries, with a scaling between 1 and 2, would benefit to various degrees, albeit at rapidly 
diminishing returns to scale. 
Inefficiency is also not directly related to scaling of the production. Relatively efficient countries, 
such as Canada, would also benefit from increasing resources as well as inefficient ones such as the 
US, both by over 4% due to the relatively scarce use of services in both countries. Patient days in 
Canada and the US are 54% and 51% of the OECD average respectively, and doctor consultations in 
the US are merely 62% of the OECD average. Overall, the most scaled service in OECD countries, is 
“doctor consultations” (38%, binding for 25 countries), implying the relative scarcity of physicians. 
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5.8 Inefficiency Trends 
OLS analysis shows that all health outcome inefficiencies are highly correlated and statistically 
significant in explaining one another. The inefficiencies in life expectancy at birth explain 89% of the 
variation of the inefficiency at age 65. Likewise, inefficiencies in infant mortality alone explain 22% 
of the inefficiencies at life expectancy at birth3. These relationships between outcome losses only get 
stronger with the inclusion of environmental variables and healthcare spending, reaching to 94% and 
34% respectively4. 
A closer look at the correlations, however, reveals some potentially important insights. The US, for 
instance, has a better inefficiency rate for life expectancy at age 65, but a much worse infant mortality 
inefficiency, given the inefficiency levels for life expectancy at birth. The relationship gets stronger 
for infant mortality with the inclusion of income inequality. This implies that although US healthcare 
is relatively better than the numbers would suggest, but the lack of a universal healthcare system and 
insurance coverage largely contributes to the outcome losses in the US. 
One interesting trend to note here is between two seemingly similar groups of countries: Eastern 
Europeans countries, which heavily suffer from short life expectancies but excel in infant mortality, 
and relatively less educated but otherwise similarly developed countries like Turkey and Mexico, 
which tend to do a better job with life expectancies but suffer from poor infant mortality. Although 
Eastern European countries benefit from higher education early in life, the lack of strong social 
institutions and the accompanying lifestyles seem to have an adverse affect [47, 77, 115]. While half 
of the gains of Turkey and Mexico in life expectancy at birth come from the improvements in infant 
mortality, those countries also severely lag in life expectancy at age 65, implying an overall deficit in 
healthcare quality (see graph 14). 
We also see a pattern regarding the relative development levels of the countries. Less developed 
countries tend to suffer primarily from inadequate expenditures and provision inefficiencies while the 
more developed ones tend to suffer from production inefficiencies. English speaking countries, 
particularly those with diverse immigrant populations, tend to be negatively affected by inequality, 
but the overall impact is rather small. Additionally, Eastern European countries are distinctly different 
in terms of outcome inefficiency, most likely as a result of weak social institutions and different 
cultural values and habits. 
                                            
3 OLS1: Slope : 0.63, R2 : 0.886, significant at 99.9%,  OLS2: Slope : 0.23, R2 : 0.217, significant at 99.9%,   
4 OLS3: Slope : 0.63, R2 : 0.943, significant at 99.9%,  OLS4: Slope : 0.25, R2 : 0.338, significant at 99.9%,   
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5.9 Quality of Services vs. Outcome Inefficiency 
Distinguishing between production and provision inefficiencies inevitably raises the question, “Does 
producing more, but lower quality services lead to better health outcomes?”. Along with other 
studies in the literature [35, 51, 99], our study shows that there are no advantages whatsoever to 
skimping on quality to produce more services.  
Most developing countries have no problem producing the efficient amount of services, but the 
provision efficiency suffers terribly with resulting results. There is a statistically significant and 
substantial correlation between lower quality (higher PYLL) and higher provision inefficiency 
numbers. Likewise, although not statistically significant, lower quality values are also associated with 
higher production inefficiency. 
 
Graph 15 – Low Quality vs. Provision Inefficiency 
 
An increase in service quality may have a complex role in determining the production inefficiency. 
Higher quality in services, which may impose a short run trade off between quality and quantity, 
actually ends up decreasing the demand for services, resulting in better utilization and better provision 
inefficiency. Patients who get a proper treatment in hospitals are less likely to have another hospital 
visit and more likely to have better results in provision.  
119
   
DIFFERENT TYPES OF HEALTHCARE INEFFICIENCIES AND OUTCOME LOSSES 
CHAPTER 3  
5.10 Limitations of the Study 
Main limitations of the study are; 
a) Nonparametric frontier analyses tend to underestimate the inefficiency levels. Due to its 
general construction, the firms on the frontier are assumed to be efficient in the analysis. 
Additionally, the assumption of variable returns to scale in life expectancy may conceal some 
of the potential gains from increasing resources.  
b) The definition of the objective function and the composition of the non-radial inefficiency 
analysis are inherently subjective (see section 3.2 Output-oriented two-stage Model). 
Changing the given weights or adding / dropping one of the health outcomes will affect the 
measured efficiencies.  
c) Country-level aggregate data are far from precise but can still present profound insights, 
especially when applied at multiple stages and with different controls for robustness check. A 
single-stage efficiency analysis based on only health services or health outcomes is inherently 
inferior to a multi-stage analysis that combines both in addition to various controls.  
d) Provision inefficiency is composed of multiple factors that need to be further decomposed. 
Unfortunately the lack of a standard measurement makes this a very difficult task. 
Concentrating on a small subset of more similar countries may provide better precision and 
judgment but has limited appeal. 
e) Decomposition of inequality and risk factors may be imprecise and future data updates and 
possible improvements in the analysis should improve precision and accuracy.   
f) In this study, impacts of risk factors are considered as relative shifts in the production and 
provision functions that constitute some form of disadvantage to countries, which need to be 
considered. However, the “common” characteristics that all countries show will not be 
captured. If, for example, all countries are composed of at least 10% smokers, only the impact 
of smoking rates in excess of 10% will be detected. 
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6 Conclusion 
6.1 Concluding Remarks 
In this study, we have found around 3% inefficiency in healthcare, with a relatively stable long run 
trend, which hides a significant variance in the individual efficiency changes at the country level and 
short run fluctuations due to technological shocks. A large portion of the fluctuations in inefficiency 
comes from infant mortality, and is highly related to the poorer segments of OECD. 
We find that 79% of the inefficiency in OECD countries comes from the provision stage, leaving only 
21% to the production stage, although production inefficiency is a major issue for some countries. 
More than 60% of the US’s inefficiency, for example, comes from production. This sort of production 
inefficiency is apparent in Nordic or English speaking countries with relatively high medical prices, in 
addition to Mexico and Portugal. 
While there are success stories such as Ireland and Estonia, which substantially slashed their 
inefficiency rates, other countries such as Turkey and the Slovak Republic became less efficient 
between 2001 and 2011. The drastic changes in recent healthcare technologies as well as substantial 
reforms in those countries seem to have played a role in this setback.  
Production and provision inefficiencies are jointly responsible for 55% of the total outcome loss. The 
outcome losses are nearly doubled with the inclusion of inadequate healthcare spending which 
constitutes 35% of the outcome losses, and environmental variables, responsible for another 10%. 
Even though we see a slight increase in the average inefficiency levels (from 2.8% to 3.1%) between 
2001 and 2011, the outcome losses are offset by gains from the improvement of environmental 
factors, relatively stable at around 3.5%. Moreover, inclusion of the impact of insufficient healthcare 
expenditures shows a substantial decrease in outcome losses from 6.3% to 5.1%.   
Rising expenditures, especially in the less developed countries, led to huge outcome gains. This is 
particularly true for Ireland and most Eastern European countries. Not all OECD countries share the 
same kind of success stories though. Mexico suffers both from higher inefficiency and even worse 
expenditure losses, while Turkey experiences mixed results with an increasing overall inefficiency 
level but increasing expenditures that curbed the outcome losses. 
We see a significant impact of social inequality on the English speaking countries; especially where 
there are sizable diverse immigrant populations and private markets are more prevalent. The US, for 
instance, suffered an additional 2.37% outcome loss, solely from inequality, followed by the UK 
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(1.18%) and Australia (0.68%). The systems in those countries seem to create some barriers in access 
to healthcare, and are inherently more susceptible to inequality, with overall worse results.  
Our study does not measure cost efficiency due to the lack of medical price data at the country level, 
but it may still be helpful to compare the calculated expenditure levels at price parity for the efficient 
outcomes, as each country is only compared with other similar ones. Our analysis suggests a 9% 
average reduction in healthcare expenditures along with a 3.1% increase in outcomes. One interesting 
example here is the US, which would enjoy a 60% decrease in healthcare expenditure if the price 
levels were on par with the OECD average. 
Interestingly, there is still room for higher expenditures even with the current technology, especially 
for the low spenders such as the Eastern European countries, as well as Turkey, Mexico, Greece, and 
Korea. Our findings suggest a 14% increase in average spending on healthcare systems, and an 
additional 4% to improve the environmental factors, although the amounts greatly vary by country. 
Turkey, for instance, is suggested to increase its expenditures on the healthcare system by 159% and 
another 40% on environmental factors. 
We find significant gains from scaling up the production of health services, especially for the 
countries that employ low quantities of resources or simply underutilize them. A 38% increase in 
health service production, especially doctor consultations would lead to a 2.6% increase in health 
outcomes, which is substantial considering that the total outcome loss is 5.2% in 2011 and the loss 
from inefficiency is 3.1%. This brings the potential total outcome gains up to 7.8% in 2011. These 
gains only partially depend on the production inefficiency of a country, and even the relatively 
efficient but resource scarce countries like Canada would tremendously benefit from it. 
Correlations between different health outcome efficiencies shed more light on the weaknesses of each 
country. Eastern European countries benefit from higher education early in life, but the lack of strong 
social institutions and the accompanying lifestyles seem to have an adverse affect on health outcomes. 
Other similarly developed but less educated countries suffer more from infant mortality, though they 
fare better in life expectancies. The US, a curious example, particularly suffers from high infant 
mortality, similar to some less developed countries, but has relatively better results for life expectancy 
at age 65. This suggests that the actual problem is with the market structure and the healthcare system 
rather than the quality of care itself. 
 
Finally our study shows that there are no advantages whatsoever to skimping on quality to produce a 
greater amount of services. Lower quality services lead to higher inefficiencies both in production and 
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provision in the long run. Development levels and social institutions also seem to be particularly 
important in determining the type of inefficiencies that countries tend to suffer. While less developed 
countries suffer more from provision inefficiency and inadequate healthcare expenditures, more 
developed ones suffer relatively more from production inefficiency, and to a smaller extent, social 
inequality. 
6.2 Policy Implications 
The comprehensive nature of this study enabled us to pinpoint the sources of inefficiencies and 
outcome losses in each country. Although most countries are inefficient in one way or another, the 
type of inefficiencies they suffer and the solutions to those issues might be very different. First of all, 
allocating more resources and/or increased production of services will immensely help most OECD 
countries, especially those which are resource scarce, even if they are relatively efficient like Canada.  
Secondly, English speaking and Northern European countries, as well as Portugal, suffer mostly from 
production inefficiency. This is primarily a market structure issue resulting from high medical prices 
and/or undersupply of health services. The US seems to be the pinnacle of these problems, and 
obviously healthcare systems with easily exploitable inelastic demand and a high level of provider 
concentration should not just be left to the forces of private oligopolistic markets. Increasing the share 
of public control and tighter market regulations, as well as unified consumer policies, will provide 
more leverage to reduce prices and expand the production of services. 
Similarly, English speaking countries in particular are significantly affected by social inequality. A 
universal healthcare system which provides free basic healthcare and universal coverage may 
significantly help those countries remove the social inequality from access to healthcare, where 
private markets are the norm, and thereby avoid the associated outcome losses.   
Countries with low capital intensity and low healthcare spending should primarily seek to increase 
their expenditures on the healthcare systems by employing higher quality and quantity of resources, as 
well as better technology and infrastructure, and investing in higher education. However, we also find 
that foregoing quality for quantity of services does not pay off, and such countries should focus on 
producing higher quality of services first, rather than quantity. 
Additionally, relatively less developed countries will benefit from increasing social awareness, 
establishing and empowering social institutions and norms, and promoting better human and national 
development, which directly or indirectly affect the health outcomes. Education, used in conjunction 
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with strong social policies can be an indispensable tool to lower the risk factors and the outcome 
losses as a result, as well as other losses that appear in provision inefficiency. 
Correlations between different outcome inefficiencies, with or without the impact of environmental 
factors, shed light on where the problems lie in healthcare. The US, for instance, offers a relatively 
good healthcare for those who have access and can afford it, but not for those who cannot. So it is not 
a matter of “quality” in the US, but rather the access to and supply of healthcare. The opposite 
situation holds for egalitarian Eastern European countries, which suffer from relatively high life 
expectancy inefficiencies but enjoy extremely low infant mortality inefficiency. Therefore the main 
problem for countries like Hungary, Estonia, as well as Turkey, is not the access to or supply of 
healthcare, but rather the quality of it. 
With the exception of the English speaking nations, the bulk of the 10% environmental loss comes 
from risk factors. As we noted in the limitations of the study, this figure is an underestimation by 
definition, and measures only the impact arising from the differences across countries. OECD 
countries have made considerable progress in recent years, fighting risk factors such as smoking. This 
is a relatively cheaper and more effective way to prevent premature health issues and deaths. 
Especially countries with high alcohol consumption should work to decrease binge drinking and the 
associated fatalities. Eastern European countries, for instance, are notorious for male binge drinking 
and premature deaths. Normalization of male life expectancy alone would tremendously improve the 
results for those countries. Therefore, especially countries with high alcohol consumption should 
work to decrease binge drinking and the associated fatalities.  
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7 Appendix 
Table 17 – Non-Radial Inefficiency Levels between 2001 and 2011 
   
 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Average 
Australia 2.16% 2.04% 2.19% 1.31% 2.30% 1.80% 1.25% 1.72% 1.36% 2.36% 2.83% 1.94% 
Austria 4.03% 3.85% 3.91% 3.48% 3.66% 3.80% 4.59% 4.35% 5.17% 4.44% 5.07% 4.21% 
Belgium 4.97% 4.35% 4.49% 4.99% 4.64% 5.65% 5.43% 4.88% 6.43% 6.51% 6.30% 5.33% 
Canada 0.68% 0.40% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.31% 0.00% 0.13% 
Chile 1.76% 0.00% 0.25% 0.33% 1.42% 0.00% 0.00% 0.20% 0.25% 0.00% 0.00% 0.38% 
Czech R. 2.44% 1.29% 3.22% 1.31% 1.35% 1.45% 1.73% 2.79% 5.15% 3.43% 1.40% 2.32% 
Denmark 6.58% 6.26% 6.58% 6.56% 6.89% 6.37% 5.24% 5.40% 4.54% 5.40% 4.21% 5.82% 
Estonia 0.45% 0.80% 1.55% 8.22% 6.39% 1.03% 3.47% 6.71% 7.60% 1.13% 2.67% 3.64% 
Finland 4.43% 3.19% 3.76% 3.62% 2.19% 2.57% 1.81% 1.72% 1.35% 0.69% 0.65% 2.36% 
France 1.80% 1.90% 1.46% 1.33% 1.34% 1.35% 1.71% 1.64% 3.67% 2.83% 2.96% 2.00% 
Germany 4.17% 4.10% 4.11% 3.84% 4.02% 4.00% 4.17% 3.99% 5.10% 4.89% 4.76% 4.29% 
Greece 0.46% 0.48% 1.01% 0.41% 0.68% 0.63% 0.73% 0.67% 0.73% 1.01% 0.92% 0.70% 
Hungary 10.42% 10.98% 10.34% 10.76% 11.35% 11.90% 12.75% 12.02% 13.37% 11.60% 10.21% 11.43% 
Iceland 0.00% 0.00% 0.01% 0.18% 0.27% 0.00% 0.00% 0.52% 0.00% 0.00% 0.00% 0.09% 
Ireland 0.65% 0.29% 0.39% 0.83% 1.48% 1.83% 2.30% 3.25% 4.40% 5.00% 6.25% 2.42% 
Israel 0.48% 0.50% 0.47% 0.44% 0.57% 0.28% 0.51% 0.85% 1.09% 2.16% 1.95% 0.85% 
Italy 0.48% 0.21% 1.44% 0.30% 0.71% 0.82% 1.32% 1.34% 1.32% 0.88% 1.08% 0.90% 
Japan 0.50% 0.00% 0.00% 0.00% 0.00% 0.00% 0.17% 0.00% 0.00% 0.00% 0.00% 0.06% 
Korea 1.91% 2.33% 0.68% 1.55% 1.53% 1.11% 0.84% 0.50% 0.62% 0.47% 0.77% 1.12% 
Luxembourg 4.09% 3.14% 1.67% 0.52% 1.96% 2.02% 1.37% 0.91% 4.08% 3.47% 4.81% 2.55% 
Mexico 4.67% 4.85% 4.70% 4.01% 2.24% 1.83% 1.62% 2.10% 1.48% 1.17% 1.13% 2.71% 
Netherlands 4.35% 3.95% 4.08% 4.35% 4.85% 5.38% 5.55% 4.82% 5.94% 6.04% 5.72% 5.00% 
N. Zealand 3.05% 2.80% 0.86% 0.79% 0.50% 0.82% 0.32% 0.69% 0.78% 1.35% 0.93% 1.17% 
Norway 1.76% 2.25% 2.85% 0.48% 3.54% 3.62% 1.28% 2.52% 3.58% 4.05% 4.26% 2.74% 
Poland 4.35% 5.09% 6.41% 5.60% 4.88% 3.73% 4.03% 4.51% 4.63% 5.45% 4.03% 4.79% 
Portugal 2.28% 2.90% 4.37% 3.48% 3.30% 2.70% 2.88% 2.45% 3.11% 4.56% 4.02% 3.28% 
Slovak R. 10.93% 13.34% 13.15% 13.32% 12.38% 10.96% 9.99% 8.99% 8.28% 7.54% 2.06% 10.09% 
Slovenia 2.58% 0.84% 1.74% 1.23% 1.22% 3.27% 5.47% 4.50% 6.72% 5.55% 3.73% 3.35% 
Spain 0.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.21% 0.00% 0.03% 
Sweden 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Switzerland 0.00% 0.00% 0.09% 0.00% 0.00% 0.00% 0.00% 0.43% 1.12% 0.07% 0.06% 0.16% 
Turkey 9.17% 9.24% 10.23% 8.92% 10.32% 10.40% 10.74% 9.25% 4.55% 4.90% 2.55% 8.21% 
UK 2.56% 2.88% 3.06% 3.56% 3.69% 3.89% 3.72% 3.63% 4.07% 4.05% 3.35% 3.50% 
USA 6.38% 6.31% 5.97% 5.68% 6.19% 5.88% 6.00% 6.56% 5.85% 6.40% 6.21% 6.13% 
Average 3.08% 2.96% 3.09% 2.98% 3.11% 2.91% 2.97% 3.06% 3.42% 3.17% 2.79% 3.05% 
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 Table 18 – Life Expectancy at Birth Inefficiency Levels (in Years of Life Lost) 
 
 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Average 
Australia 0.37 0.56 0.31 0.10 0.05 0.00 0.22 0.22 0.22 0.23 0.56 0.26 
Austria 1.30 1.54 1.31 0.70 1.00 1.08 1.53 1.51 1.98 1.83 1.89 1.42 
Belgium 1.90 2.18 1.55 1.69 1.44 1.96 2.27 2.15 2.73 2.58 2.66 2.10 
Canada 0.25 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.00 0.04 
Chile 0.77 0.00 0.01 0.34 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.15 
Czech R. 1.01 0.68 1.74 0.72 0.75 0.80 0.90 1.46 2.71 1.79 0.70 1.21 
Denmark 2.67 2.63 2.64 2.44 2.64 2.51 2.20 2.54 2.30 2.71 2.10 2.49 
Estonia 0.30 0.50 1.04 5.29 4.27 0.70 2.40 4.52 4.85 0.82 1.72 2.40 
Finland 1.80 2.03 2.06 1.60 1.16 1.46 1.41 1.28 1.01 0.46 0.44 1.34 
France 0.12 0.26 0.23 0.15 0.13 0.19 0.65 0.77 1.55 1.12 1.15 0.57 
Germany 1.73 2.01 1.94 1.18 1.20 1.40 1.39 1.64 2.05 1.99 1.95 1.68 
Greece 0.11 0.20 0.43 0.19 0.33 0.13 0.27 0.19 0.25 0.26 0.28 0.24 
Hungary 5.49 5.68 5.70 5.77 6.13 6.36 6.65 6.34 6.69 6.23 5.48 6.05 
Iceland 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Ireland 0.36 0.03 0.15 0.19 0.73 0.31 0.65 1.17 1.79 2.14 2.59 0.92 
Israel 0.04 0.02 0.00 0.02 0.05 0.04 0.09 0.06 0.15 0.49 0.48 0.13 
Italy 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.00 0.36 0.00 0.02 0.04 
Japan 0.20 0.00 0.00 0.00 0.00 0.00 0.09 0.00 0.00 0.00 0.00 0.03 
Korea 0.88 1.17 0.30 0.82 0.79 0.50 0.41 0.25 0.32 0.21 0.28 0.54 
Luxembourg 1.33 1.36 0.43 0.15 1.13 1.12 0.88 0.36 1.64 1.70 2.04 1.10 
Mexico 2.86 2.91 2.80 2.24 1.20 0.99 0.85 1.04 0.70 0.56 0.53 1.52 
Netherlands 1.18 1.45 0.83 0.97 1.07 1.41 1.75 1.70 2.06 2.04 1.97 1.49 
N. Zealand 0.79 0.75 0.22 0.19 0.17 0.16 0.06 0.14 0.11 0.19 0.25 0.27 
Norway 0.39 0.58 0.44 0.00 0.74 0.74 0.40 0.91 1.40 1.68 1.75 0.82 
Poland 2.87 3.25 3.82 3.56 3.15 2.55 2.59 2.78 2.71 3.10 2.38 2.98 
Portugal 1.31 1.81 1.86 2.01 1.80 1.73 1.68 1.50 1.85 2.54 2.43 1.87 
Slovak R. 5.12 6.06 6.04 6.12 5.89 5.23 4.78 4.52 4.08 3.89 1.16 4.81 
Slovenia 1.57 0.55 1.06 0.80 0.80 1.95 2.77 2.64 3.66 3.30 2.02 1.92 
Spain 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Sweden 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Switzerland 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 
Turkey 4.28 4.38 4.41 3.59 4.06 3.96 3.63 2.76 0.56 0.81 0.63 3.01 
UK 1.04 1.35 1.37 1.49 1.41 1.45 1.39 1.36 1.60 1.65 1.35 1.41 
USA 3.31 3.14 2.98 2.79 3.19 3.13 3.14 3.22 2.88 3.11 3.09 3.09 
Average 1.33 1.39 1.34 1.33 1.35 1.23 1.33 1.38 1.54 1.40 1.23 1.35 
126
Table 19 – Life Expectancy at 65 Inefficiency Levels (in Years of Life Lost) 
 
 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Average 
Australia 0.10 0.32 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.18 0.06 
Austria 0.57 0.88 0.72 0.31 0.45 0.56 0.68 0.78 1.21 1.20 1.08 0.77 
Belgium 1.06 1.34 0.82 0.82 0.52 0.84 1.22 1.36 1.59 1.65 1.54 1.16 
Canada 0.09 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.02 
Chile 0.89 0.00 0.00 0.00 0.58 0.00 0.00 0.15 0.08 0.00 0.00 0.15 
Czech R. 1.36 1.07 1.78 0.96 1.30 1.37 1.61 1.21 2.14 1.45 0.63 1.35 
Denmark 2.25 1.65 1.70 1.46 1.69 1.62 1.37 1.35 1.48 1.86 1.41 1.62 
Estonia 0.14 0.26 0.44 2.58 1.76 0.26 0.84 1.69 2.10 0.21 0.54 0.98 
Finland 0.82 1.18 1.26 0.25 0.09 0.27 0.13 0.24 0.38 0.25 0.23 0.46 
France 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.23 0.04 0.00 0.03 
Germany 1.28 1.61 1.55 0.75 0.72 0.95 0.87 0.98 1.40 1.33 1.27 1.15 
Greece 0.04 0.08 0.12 0.10 0.19 0.13 0.16 0.19 0.35 0.32 0.22 0.17 
Hungary 3.23 3.30 3.18 3.21 3.31 3.43 3.72 3.46 3.81 3.40 2.97 3.36 
Iceland 0.00 0.00 0.01 0.20 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.03 
Ireland 0.33 0.01 0.07 0.30 0.63 0.41 0.80 1.19 1.66 1.93 2.11 0.86 
Israel 0.00 0.01 0.00 0.01 0.23 0.02 0.05 0.03 0.33 0.43 0.63 0.16 
Italy 0.00 0.00 0.25 0.00 0.00 0.00 0.10 0.00 0.55 0.21 0.12 0.11 
Japan 0.06 0.00 0.00 0.00 0.00 0.00 0.09 0.00 0.00 0.00 0.00 0.01 
Korea 0.99 1.05 0.58 0.79 0.81 0.66 0.46 0.25 0.31 0.25 0.31 0.59 
Luxembourg 1.11 0.88 0.02 0.10 0.90 0.51 0.57 0.14 1.38 0.98 1.16 0.70 
Mexico 0.75 0.72 0.67 0.50 0.30 0.21 0.21 0.25 0.18 0.08 0.00 0.35 
Netherlands 1.08 1.38 0.78 0.81 0.91 1.28 1.40 1.28 1.63 1.83 1.67 1.28 
N. Zealand 0.00 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 
Norway 0.29 0.47 0.10 0.03 0.43 0.29 0.10 0.50 0.68 1.30 1.25 0.50 
Poland 1.46 1.80 2.16 1.95 1.62 1.08 1.30 1.56 1.71 2.08 1.45 1.65 
Portugal 0.39 1.15 1.08 1.27 1.12 1.05 1.25 1.01 1.29 1.55 1.38 1.14 
Slovak R. 3.64 4.25 4.09 4.09 4.08 3.90 3.60 3.44 3.09 2.97 0.74 3.44 
Slovenia 1.04 0.32 0.71 0.46 0.45 1.19 1.83 1.66 2.52 2.19 1.66 1.28 
Spain 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.00 
Sweden 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Switzerland 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 
Turkey 3.60 3.60 3.55 3.37 3.43 3.23 3.03 2.77 2.15 1.98 1.08 2.89 
UK 0.55 0.78 0.81 1.04 0.87 0.91 1.13 1.03 1.33 1.30 1.04 0.98 
USA 1.50 1.50 1.24 1.18 1.39 1.50 1.34 1.54 1.41 1.59 1.49 1.42 
Average 0.84 0.87 0.82 0.78 0.82 0.75 0.82 0.83 1.03 0.96 0.77 0.84 
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Table 20 – Infant Mortality (in Number of preventable deaths) 
 
 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Average 
Australia 1.33 1.31 1.48 1.02 1.56 1.34 0.90 1.17 1.01 1.70 1.75 1.33 
Austria 2.00 2.21 2.01 2.04 1.63 1.48 1.80 1.73 1.71 0.98 1.65 1.75 
Belgium 1.97 2.18 2.03 2.23 2.17 2.35 1.42 1.53 1.70 1.79 1.59 1.91 
Canada 0.42 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.19 0.00 0.08 
Chile 0.38 0.00 0.36 0.00 0.68 0.00 0.00 0.07 0.21 0.00 0.00 0.15 
Czech R. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Denmark 2.28 2.00 1.60 2.29 2.23 1.63 1.32 1.13 0.56 0.56 0.52 1.46 
Estonia 0.00 0.00 0.00 0.38 0.00 0.00 0.00 0.00 0.00 0.00 0.27 0.06 
Finland 1.23 0.90 1.20 1.12 0.54 0.58 0.17 0.16 0.00 0.00 0.00 0.54 
France 1.02 1.11 0.91 0.82 0.82 0.81 0.79 0.60 1.53 1.27 1.32 1.00 
Germany 1.68 1.87 1.42 1.43 1.69 1.35 1.38 1.33 1.37 1.27 1.10 1.44 
Greece 0.24 0.25 0.32 0.08 0.24 0.25 0.21 0.20 0.18 0.35 0.35 0.24 
Hungary 1.23 1.55 1.12 1.45 1.34 1.48 1.61 1.56 2.23 1.31 1.33 1.47 
Iceland 0.00 0.00 0.00 0.00 0.08 0.00 0.00 0.24 0.00 0.00 0.00 0.03 
Ireland 0.00 0.22 0.13 0.34 0.47 0.75 0.91 0.76 0.94 0.84 1.34 0.61 
Israel 0.30 0.29 0.28 0.26 0.35 0.16 0.35 0.61 0.50 1.11 0.72 0.45 
Italy 0.30 0.15 1.03 0.20 0.48 0.54 0.79 0.82 0.29 0.51 0.65 0.52 
Japan 0.16 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01 
Korea 0.15 0.21 0.05 0.02 0.00 0.01 0.18 0.00 0.06 0.06 0.14 0.08 
Luxembourg 2.22 1.77 0.76 0.10 0.10 0.39 0.05 0.28 0.89 0.73 1.55 0.80 
Mexico 3.19 3.77 3.93 3.81 2.28 1.77 1.76 2.33 1.92 1.56 1.80 2.56 
Netherlands 2.08 2.08 2.36 2.15 2.31 2.26 2.14 1.42 1.82 1.83 1.82 2.02 
N. Zealand 2.98 2.52 0.73 0.63 0.32 0.63 0.23 0.53 0.65 1.15 0.60 1.00 
Norway 0.63 1.23 1.55 0.25 1.52 1.68 0.43 0.88 0.99 0.69 0.84 0.97 
Poland 1.80 0.42 0.41 0.14 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.25 
Portugal 0.51 0.02 1.19 0.40 0.32 0.00 0.00 0.00 0.00 0.41 0.20 0.28 
Slovak R. 1.60 2.53 2.47 2.50 2.02 1.26 1.12 0.44 0.63 0.12 0.00 1.33 
Slovenia 0.25 0.00 0.00 0.00 0.00 0.17 0.63 0.13 0.27 0.16 0.00 0.15 
Spain 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.00 0.01 
Sweden 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Switzerland 0.00 0.00 0.07 0.00 0.00 0.00 0.00 0.55 0.75 0.04 0.04 0.13 
Turkey 1.16 0.62 2.80 2.78 5.25 7.49 11.55 12.54 6.38 8.23 2.61 5.58 
UK 1.07 1.11 1.84 1.79 2.06 1.50 1.36 1.11 1.05 0.96 0.87 1.34 
USA 2.62 2.71 2.94 2.98 2.24 1.67 1.94 2.14 1.86 1.95 1.81 2.26 
Average 1.02 0.98 1.03 0.92 0.96 0.93 0.97 1.01 0.87 0.88 0.73 0.94 
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Table 21 – Low Quality in Services vs. Outcome Inefficiency 
 
Inefficiency    2001-2011 
Averages PYLL Actual Estimated    
Australia 3,109 1.31% 1.25%     
Austria 3,507 4.14% 1.72%  R2 29.9% 
Belgium 3,743 5.31% 1.99%  Slope 0.0012% 
Canada 3,415 0.00% 1.61%  P value 0.0008 
Chile 4,635 0.36% 3.04%    
Czech Rep 4,509 2.30% 2.89%    
Denmark 3,750 4.60% 2.00%    
Estonia 8,079 3.19% 7.09%    
Finland 3,914 1.47% 2.19%    
France 3,807 2.06% 2.07%    
Germany 3,477 4.28% 1.68%    
Greece 3,412 0.70% 1.60%    
Hungary 7,117 11.43% 5.96%    
Iceland 2,636 0.02% 0.69%    
Ireland 3,573 0.43% 1.79%    
Israel 3,141 0.85% 1.29%    
Italy 2,944 0.90% 1.06%    
Japan 2,865 0.05% 0.96%    
Korea 3,870 1.12% 2.14%    
Luxembourg 3,180 2.49% 1.33%    
Mexico 6,839 0.00% 5.63%    
Netherlands 3,164 0.74% 1.31%    
N. Zealand 3,734 0.93% 1.98%    
Norway 3,160 1.56% 1.31%    
Poland 5,997 4.56% 4.64%    
Portugal 4,269 0.02% 2.61%    
Slovak Rep. 5,855 9.88% 4.47%    
Slovenia 4,235 3.06% 2.57%    
Spain 3,275 0.02% 1.44%    
Sweden 2,782 0.00% 0.86%    
Switzerland 2,917 0.01% 1.02%    
Turkey 5,301 8.21% 3.82%    
UK 3,633 3.07% 1.86%    
US 5,011 2.34% 3.48%    
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Table 22 – Production Scaling by Country 
 
 
  Consultations Discharges Patient Days 
1 Australia 1.45 0.93 1.70 
2 Austria 1.00 1.00 1.00 
3 Belgium 1.00 1.00 1.00 
4 Canada 1.25 1.46 2.00 
5 Chile 1.51 1.39 2.00 
6 Czech Rep. 1.17 0.72 0.71 
7 Denmark 1.37 1.01 1.04 
8 Estonia 0.96 0.87 0.76 
9 Finland 1.49 0.84 0.81 
10 France 1.82 0.68 2.00 
11 Germany 1.00 1.00 1.00 
12 Greece 1.81 0.52 0.54 
13 Hungary 1.78 0.65 0.97 
14 Iceland 1.00 1.00 1.00 
15 Ireland 1.65 1.00 1.14 
16 Israel 1.97 0.57 1.72 
17 Italy 1.51 0.97 2.00 
18 Japan 0.93 1.04 0.92 
19 Korea 0.82 0.96 0.78 
20 Luxembourg 1.03 0.98 0.99 
21 Mexico 1.47 1.44 2.00 
22 Netherlands 1.43 0.96 2.00 
23 New Zealand 2.00 0.82 1.32 
24 Norway 1.17 1.05 1.05 
25 Poland 1.46 0.65 0.95 
26 Portugal 2.00 1.10 2.00 
27 Slovak Rep. 1.44 0.59 1.00 
28 Slovenia 1.00 0.74 0.63 
29 Spain 1.33 1.20 2.00 
30 Sweden 2.00 0.90 0.88 
31 Switzerland 2.00 0.82 1.05 
32 Turkey 0.96 0.82 2.00 
33 UK 1.77 0.81 1.16 
34 US 2.00 1.26 1.96 
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